data_1bnx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bnx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 120.832 0.349 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -78.98 -56.82 4.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.216 -0.927 . . . . 0.0 112.049 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.89 -22.39 65.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.433 -0.792 . . . . 0.0 111.075 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 11' ' ' THR . 3.9 tt -77.95 -47.22 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.16 -0.963 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.2 m -61.87 -33.42 74.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.764 -0.585 . . . . 0.0 109.773 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.87 -35.86 75.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.48 -36.33 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mt -79.3 -18.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.207 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.22 -43.66 60.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.245 -0.909 . . . . 0.0 110.368 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.2 -22.25 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 0.0 110.753 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -71.78 -37.82 70.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.24 -0.912 . . . . 0.0 109.63 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.91 -28.71 20.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.511 -0.743 . . . . 0.0 109.672 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.69 -55.08 16.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.619 -0.675 . . . . 0.0 110.128 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.69 72.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.796 -0.565 . . . . 0.0 111.284 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.05 -16.75 61.48 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.706 -0.621 . . . . 0.0 111.617 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.421 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 2.8 t -56.61 -57.79 21.34 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 120.958 -1.089 . . . . 0.0 110.913 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.5 Cg_endo -68.3 -55.3 0.25 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 124.976 3.784 . . . . 0.0 110.674 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.61 -27.95 1.31 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 111.202 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.19 -41.76 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.482 -0.762 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 109.95 -179.536 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.869 0.366 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.8 p -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -29.96 62.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.22 -35.5 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -60.49 -47.63 85.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.02 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.34 -44.85 96.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.717 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.83 -27.19 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.596 -0.69 . . . . 0.0 109.913 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.71 -37.32 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.48 -0.763 . . . . 0.0 109.1 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.19 -54.63 41.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.764 . . . . 0.0 109.412 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.61 -10.05 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.678 -0.639 . . . . 0.0 110.608 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -72.25 -70.02 0.36 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.614 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.93 -31.72 70.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.091 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.74 54.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 110.682 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.64 75.97 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.603 -0.686 . . . . 0.0 111.259 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -19.99 62.25 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.889 -0.507 . . . . 0.0 111.574 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -58.7 16.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.091 -1.006 . . . . 0.0 111.264 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.87 -55.91 0.16 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 125.144 3.896 . . . . 0.0 110.62 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -27.58 2.29 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.137 0.494 . . . . 0.0 110.6 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.17 -35.74 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.418 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.499 1.998 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.052 0.453 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -20.9 37.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.492 -0.755 . . . . 0.0 111.095 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -74.76 -61.8 1.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.782 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.69 -22.39 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.49 -0.756 . . . . 0.0 110.366 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -69.03 -49.15 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.313 -0.867 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.98 -37.19 81.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.44 -0.787 . . . . 0.0 110.107 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.15 -42.02 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.461 -0.774 . . . . 0.0 109.735 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.89 -28.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.687 . . . . 0.0 109.502 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.468 -0.77 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.7 mt -75.65 -25.62 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.7 . . . . 0.0 109.869 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.13 -39.71 95.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.349 -0.844 . . . . 0.0 110.073 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.03 -28.31 27.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.424 -0.798 . . . . 0.0 110.265 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.82 -49.33 73.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.711 . . . . 0.0 110.891 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.69 -51.38 50.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.676 -0.64 . . . . 0.0 111.585 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.83 -9.24 58.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.896 -0.503 . . . . 0.0 111.634 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -47.83 -48.19 61.44 Favored Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.091 -1.006 . . . . 0.0 112.457 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -75.01 -60.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 124.547 3.498 . . . . 0.0 110.771 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.72 -26.78 1.0 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.92 -0.488 . . . . 0.0 111.411 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.5 mt -64.58 -53.16 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.392 -0.818 . . . . 0.0 109.23 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 109.891 -179.633 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.091 0.472 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -58.18 -31.22 67.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.09 -36.38 83.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.92 -44.28 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 110.07 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -56.93 -42.41 79.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 0.0 110.271 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -30.41 71.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.433 -0.792 . . . . 0.0 109.361 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.86 -27.73 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.706 . . . . 0.0 109.755 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.43 -30.4 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.41 -41.8 75.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.585 -0.697 . . . . 0.0 109.737 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.9 mt -75.33 -20.11 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.276 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.32 -56.81 6.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.907 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -25.31 64.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.526 -0.734 . . . . 0.0 110.148 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -54.59 20.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.476 -0.765 . . . . 0.0 110.586 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.77 54.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.56 -0.712 . . . . 0.0 111.629 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.04 -15.36 51.35 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.883 -0.51 . . . . 0.0 111.71 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.404 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -51.18 -52.32 59.95 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.841 -1.162 . . . . 0.0 111.243 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 22' ' ' SER . 39.6 Cg_endo -77.94 -58.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.107 3.871 . . . . 0.0 110.718 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.42 0.83 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.922 -0.486 . . . . 0.0 111.606 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -84.08 -47.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.708 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -62.21 -14.36 37.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -77.96 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.023 -1.048 . . . . 0.0 110.414 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 10' ' ' ILE . 76.2 mt -60.42 -30.84 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.452 -0.78 . . . . 0.0 110.682 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 m -58.65 -45.54 89.11 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -35.69 80.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.0 t -70.3 -24.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.052 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.8 -34.59 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.337 -0.852 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.21 -52.81 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 109.826 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.87 -27.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -60.88 -36.6 79.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 109.598 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.46 -22.93 35.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.978 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.13 67.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.13 60.83 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.496 0.665 . . . . 0.0 110.947 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.8 mm? -85.05 -12.28 53.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.927 -0.483 . . . . 0.0 111.595 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.409 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 2.6 t -52.14 -50.21 80.21 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.886 -1.134 . . . . 0.0 111.304 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.2 Cg_endo -76.0 -62.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.422 0 C-N-CA 124.668 3.579 . . . . 0.0 111.059 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.93 -27.09 1.14 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.803 -0.561 . . . . 0.0 111.386 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 25' ' ' ILE . 41.9 mm -90.13 -41.34 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.417 -0.802 . . . . 0.0 109.971 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.463 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.9 tp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.786 0.326 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 -43.01 99.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.49 -25.96 67.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 10' ' ' ILE . 39.9 mm -65.25 -50.61 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.332 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.3 m -56.58 -39.03 72.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.379 -0.826 . . . . 0.0 109.852 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -35.91 80.52 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.62 -43.8 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.55 -3.52 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 110.039 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.05 -37.86 19.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 16' ' ' ILE . 41.7 mt -86.76 -37.51 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.638 -0.664 . . . . 0.0 109.434 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -53.42 38.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.257 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -68.74 -29.41 67.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.647 . . . . 0.0 109.81 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.38 -52.05 62.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.3 -0.875 . . . . 0.0 110.876 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.61 -56.66 4.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.72 -50.02 66.34 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.348 -0.845 . . . . 0.0 112.793 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 47.1 t -38.8 -52.31 3.69 Favored Pre-proline 0 N--CA 1.515 2.797 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 22' ' ' SER . 35.0 Cg_endo -66.83 -56.43 0.25 Allowed 'Trans proline' 0 N--CA 1.511 2.526 0 C-N-CA 124.199 3.266 . . . . 0.0 110.387 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.38 -27.81 1.8 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.918 -0.489 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -64.95 -65.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 0.0 109.279 179.87 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.777 0.323 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -57.41 -26.86 61.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 110.611 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.74 -58.51 6.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.546 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.18 -19.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.718 -0.614 . . . . 0.0 109.882 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -74.99 -38.87 61.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -41.07 87.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.276 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.15 -48.62 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.12 -17.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -67.79 -52.0 42.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 0.0 109.825 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.93 -23.29 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.455 -0.778 . . . . 0.0 110.126 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.34 -40.2 85.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 109.89 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -31.21 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.506 -0.746 . . . . 0.0 109.649 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.54 44.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.057 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.33 82.8 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.371 0.605 . . . . 0.0 111.305 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.1 -17.41 61.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.796 -0.565 . . . . 0.0 111.753 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.407 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -59.79 -57.79 24.2 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.888 -1.132 . . . . 0.0 111.28 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.7 Cg_endo -69.85 -57.85 0.11 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 125.06 3.84 . . . . 0.0 111.078 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.35 -28.19 1.26 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.937 -0.477 . . . . 0.0 111.181 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.88 -43.36 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 0.0 110.124 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.797 0.332 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 t -62.83 -25.06 68.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -45.95 92.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.764 . . . . 0.0 109.72 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -66.4 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -0.771 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -32.54 73.95 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -37.99 86.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.23 -25.59 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.24 -44.06 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 109.236 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.58 -40.77 97.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.642 -0.661 . . . . 0.0 109.67 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 16' ' ' ILE . 39.2 mm -74.67 -23.6 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.616 -0.678 . . . . 0.0 109.657 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.21 -37.11 86.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -84.97 -35.07 22.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.599 -0.688 . . . . 0.0 110.139 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.93 6.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.759 -0.588 . . . . 0.0 111.274 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.71 -53.87 35.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.596 -0.69 . . . . 0.0 111.767 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.86 -12.32 61.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.692 -0.63 . . . . 0.0 112.031 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 t -59.94 -61.57 7.64 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 120.787 -1.196 . . . . 0.0 110.362 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.13 -58.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.511 2.541 0 C-N-CA 124.941 3.76 . . . . 0.0 111.126 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.58 -28.57 0.98 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.975 -0.453 . . . . 0.0 111.537 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.15 -51.07 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.505 -0.747 . . . . 0.0 109.834 -179.653 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -63.45 -17.6 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.94 -37.52 75.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.69 -54.6 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -0.778 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -28.25 64.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -34.12 62.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.08 -26.98 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.673 -0.642 . . . . 0.0 109.532 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.5 -35.36 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -66.04 -42.81 89.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.609 -0.682 . . . . 0.0 109.861 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 16' ' ' ILE . 41.6 mm -78.79 -21.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -48.78 77.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -86.34 -27.64 24.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.496 -0.752 . . . . 0.0 110.353 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.26 65.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.487 -0.758 . . . . 0.0 110.657 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.73 -51.46 55.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.578 -0.701 . . . . 0.0 111.455 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mp -82.42 -9.21 59.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.794 -0.566 . . . . 0.0 111.835 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.412 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -57.88 -53.32 66.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.978 -1.077 . . . . 0.0 111.265 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -73.67 -60.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 124.865 3.71 . . . . 0.0 110.879 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.08 -27.64 1.44 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.821 -0.549 . . . . 0.0 111.335 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 25' ' ' ILE . 83.5 mt -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.631 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -178.774 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.847 0.356 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -69.68 -31.16 69.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.803 . . . . 0.0 109.789 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.19 -41.97 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 110.574 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.43 -37.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.323 -0.861 . . . . 0.0 109.192 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -29.68 67.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.48 -0.763 . . . . 0.0 109.492 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -30.42 59.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.0 109.747 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.39 -30.5 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.13 -36.27 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.93 -42.45 97.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.61 -0.681 . . . . 0.0 109.196 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.46 -23.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.647 -0.658 . . . . 0.0 109.62 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -43.46 97.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.737 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.03 -27.92 20.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.532 -0.73 . . . . 0.0 110.095 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.77 -53.76 54.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.753 . . . . 0.0 110.117 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.33 73.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.292 0.568 . . . . 0.0 110.867 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.31 -1.17 39.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.942 -0.474 . . . . 0.0 112.073 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.5 m -47.75 -47.38 62.04 Favored Pre-proline 0 N--CA 1.508 2.439 0 O-C-N 120.855 -1.153 . . . . 0.0 112.318 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.7 Cg_endo -78.95 -60.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.405 0 C-N-CA 124.881 3.721 . . . . 0.0 111.208 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.67 -27.7 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.801 -0.562 . . . . 0.0 111.576 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.3 mm -75.5 -43.63 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.245 -0.909 . . . . 0.0 109.631 179.683 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 120.643 0.259 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 p -81.87 -30.0 32.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -67.9 -39.49 83.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.672 -0.643 . . . . 0.0 109.759 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mt -71.5 -42.52 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.531 -0.731 . . . . 0.0 109.578 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -33.07 72.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -34.33 74.41 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.84 -27.95 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 14' ' ' ILE . 50.2 mm -74.86 -33.49 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 108.981 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -69.14 -40.54 78.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.48 -32.38 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.35 -45.98 90.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.513 -0.742 . . . . 0.0 109.248 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -65.57 -36.23 83.15 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.482 0.658 . . . . 0.0 109.44 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -55.02 36.54 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.528 0.68 . . . . 0.0 110.284 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.84 92.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.588 0.708 . . . . 0.0 110.343 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.007 -0.433 . . . . 0.0 111.414 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -59.59 9.62 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.87 -56.99 0.11 Allowed 'Trans proline' 0 N--CA 1.51 2.482 0 C-N-CA 125.03 3.82 . . . . 0.0 110.676 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -27.96 1.01 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.014 0.435 . . . . 0.0 111.241 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.23 -54.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.898 -179.616 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.99 0.424 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.1 m -58.61 -19.75 41.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.354 -0.841 . . . . 0.0 111.46 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.69 -57.56 6.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.142 -0.974 . . . . 0.0 110.723 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 11' ' ' THR . 4.0 tt -59.74 -45.48 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.443 -0.785 . . . . 0.0 110.197 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 2.4 m -58.6 -34.13 70.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.744 -0.597 . . . . 0.0 109.975 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.19 -36.18 74.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.489 -0.757 . . . . 0.0 109.175 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.96 -23.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.813 -0.554 . . . . 0.0 109.861 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 14' ' ' ILE . 79.4 mt -83.99 -29.47 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -74.15 -41.72 61.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 0.0 109.701 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.48 -28.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 110.24 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -56.85 12.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.396 -0.815 . . . . 0.0 109.586 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.85 -30.17 68.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 110.028 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.39 -57.77 11.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 110.08 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.57 56.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.566 -0.709 . . . . 0.0 111.004 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.12 1.44 27.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.816 -0.552 . . . . 0.0 111.678 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 17.4 t -49.11 -45.97 75.56 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.945 -1.097 . . . . 0.0 112.375 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 22' ' ' SER . 41.0 Cg_endo -78.31 -57.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.373 0 C-N-CA 124.608 3.538 . . . . 0.0 110.766 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.23 -28.32 2.96 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.872 -0.517 . . . . 0.0 111.311 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG21 HD11 ' A' ' 25' ' ' ILE . 40.5 mm -83.98 -38.99 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.134 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.564 -0.71 . . . . 0.0 110.081 -179.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 120.939 0.4 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -65.0 -41.41 95.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.57 -40.08 86.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.667 -0.646 . . . . 0.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -67.88 -33.47 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.895 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -56.99 -50.65 72.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.271 -0.893 . . . . 0.0 110.179 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -32.96 73.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 109.392 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.64 -37.21 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.681 -0.637 . . . . 0.0 109.534 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -19.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.624 -0.673 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -68.76 -49.86 55.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 109.685 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.3 -32.84 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.428 -0.795 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.7 97.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -28.27 63.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.17 84.9 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.81 0.815 . . . . 0.0 110.158 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -48.73 52.99 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.501 0.667 . . . . 0.0 111.207 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.55 -13.62 51.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.932 -0.48 . . . . 0.0 111.117 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.479 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 39.9 m -51.04 -48.31 85.22 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.087 -1.008 . . . . 0.0 112.001 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.1 Cg_endo -70.79 -55.26 0.15 Allowed 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 124.265 3.31 . . . . 0.0 109.71 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.56 -28.25 0.91 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.36 -44.06 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.498 1.931 0 O-C-N 121.329 -0.857 . . . . 0.0 109.991 -179.491 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 120.471 0.177 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -58.53 -45.24 89.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.024 -1.047 . . . . 0.0 110.199 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -44.73 93.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.735 . . . . 0.0 109.176 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.45 -22.63 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -68.6 -42.16 78.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.33 -30.33 71.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.564 -0.71 . . . . 0.0 109.217 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.92 -24.26 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.695 -0.628 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.4 mt -84.28 -30.07 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.792 . . . . 0.0 109.801 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 tp -76.39 -34.59 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.74 0.781 . . . . 0.0 109.117 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.86 -45.74 67.54 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.924 -0.485 . . . . 0.0 110.236 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -29.64 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.548 -0.72 . . . . 0.0 109.867 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.85 53.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.476 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.84 74.79 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.519 0.676 . . . . 0.0 110.824 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.0 mt -65.83 -14.17 60.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.544 . . . . 0.0 111.355 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 t -67.27 -60.96 5.17 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 120.978 -1.076 . . . . 0.0 110.145 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.98 -56.05 0.18 Allowed 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 125.072 3.848 . . . . 0.0 110.595 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.26 -28.58 1.33 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.933 -0.479 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.8 mm -81.67 -41.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.48 -0.763 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.0 m . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 109.811 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.081 0.467 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -66.39 -23.44 66.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.163 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.61 -59.88 2.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.388 -0.82 . . . . 0.0 110.294 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 11' ' ' THR . 17.4 tt -56.95 -43.93 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.572 -0.705 . . . . 0.0 110.152 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 21.7 m -61.58 -31.7 71.76 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -36.13 73.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.08 -32.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.68 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt -76.99 -26.09 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.629 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.62 -38.45 83.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.509 -0.744 . . . . 0.0 109.327 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -83.45 -23.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.709 . . . . 0.0 109.941 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.31 -48.66 78.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.863 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -81.55 -41.37 21.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.133 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.55 12.08 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.639 0.733 . . . . 0.0 111.376 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.63 -52.94 27.02 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.41 0.624 . . . . 0.0 110.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.0 mt -84.77 -11.05 56.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.931 -0.481 . . . . 0.0 111.174 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.482 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 16.2 t -50.62 -48.37 82.58 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.107 -0.996 . . . . 0.0 112.35 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.1 Cg_endo -69.1 -57.53 0.13 Allowed 'Trans proline' 0 N--CA 1.51 2.477 0 C-N-CA 124.383 3.389 . . . . 0.0 110.488 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.34 -28.26 1.96 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 111.109 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 mt -80.98 -41.68 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 109.426 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.546 -0.721 . . . . 0.0 109.908 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.921 0.391 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.9 p -66.97 -24.86 66.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.49 -42.67 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.336 -0.852 . . . . 0.0 110.187 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 10' ' ' ILE . 46.4 mm -67.74 -46.64 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.828 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -35.39 78.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 109.342 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.48 -34.88 78.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.7 mm -72.2 -24.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 109.753 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.94 -53.45 31.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.68 -23.39 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 110.224 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -64.36 0.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 109.526 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -22.41 63.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.426 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.04 -59.5 3.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.275 -0.89 . . . . 0.0 110.089 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.35 86.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.383 -0.823 . . . . 0.0 110.264 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mt -71.16 -22.46 62.05 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.445 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -51.55 -58.79 9.62 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.805 -1.185 . . . . 0.0 111.095 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 22' ' ' SER . 34.2 Cg_endo -66.81 -58.93 0.13 Allowed 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 124.93 3.753 . . . . 0.0 111.116 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.8 -27.58 3.09 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.818 -0.551 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 87.9 mt -90.03 -32.52 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.297 -0.877 . . . . 0.0 110.037 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.3 -0.875 . . . . 0.0 110.465 -179.348 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.89 0.376 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -60.05 -19.54 53.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.303 -0.873 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.5 -36.8 81.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.002 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 mm -77.55 -40.11 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.436 -0.79 . . . . 0.0 110.098 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -63.73 -32.81 74.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.501 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 -39.51 75.09 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.28 -36.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 mt -72.38 -26.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.54 -60.22 4.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.7 -8.19 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.586 -0.696 . . . . 0.0 110.202 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.26 -30.02 57.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 0.0 108.717 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -25.92 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.68 -0.637 . . . . 0.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.44 -60.89 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.624 -0.673 . . . . 0.0 110.728 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.44 -47.84 66.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.639 -0.663 . . . . 0.0 111.379 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 tp -82.19 -12.76 57.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.881 -0.512 . . . . 0.0 111.453 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.445 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -49.33 -51.83 54.24 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.019 -1.051 . . . . 0.0 111.79 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -72.39 -55.36 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 124.795 3.664 . . . . 0.0 110.431 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.13 -27.6 2.45 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.017 -0.427 . . . . 0.0 111.063 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mt -73.14 -44.53 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.794 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.288 -0.882 . . . . 0.0 110.332 -179.77 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.825 0.345 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -59.92 -28.38 67.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.72 -38.0 89.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.731 . . . . 0.0 109.246 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -65.97 -36.36 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m -61.72 -37.64 84.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.525 -0.735 . . . . 0.0 109.136 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -32.06 73.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 -30.42 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.48 -32.96 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -65.14 -54.8 24.25 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.46 -18.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.662 -0.649 . . . . 0.0 109.36 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -67.2 -42.02 84.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 108.963 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.68 -30.84 69.6 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -52.13 66.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.654 0.74 . . . . 0.0 109.516 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.98 83.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.447 0.642 . . . . 0.0 110.137 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.75 -3.29 37.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.082 -0.386 . . . . 0.0 111.123 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.418 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 3.6 m -40.65 -51.17 6.94 Favored Pre-proline 0 N--CA 1.51 2.557 0 O-C-N 121.328 -0.857 . . . . 0.0 113.061 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.6 Cg_endo -70.47 -56.71 0.12 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 124.572 3.514 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -26.77 1.53 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.959 -0.463 . . . . 0.0 111.061 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mt -77.12 -44.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 109.185 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.805 . . . . 0.0 109.04 179.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 120.929 0.395 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -27.17 66.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.076 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.03 -37.32 83.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.206 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.494 HG22 HD11 ' A' ' 10' ' ' ILE . 44.3 mm -70.28 -44.14 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 m -59.93 -24.71 64.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.94 -31.95 34.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.415 -0.803 . . . . 0.0 109.31 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.28 -26.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.95 -40.33 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.413 0.625 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.92 -26.57 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.58 -35.35 68.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -34.23 21.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.741 . . . . 0.0 110.178 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -55.44 34.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.487 -0.758 . . . . 0.0 110.686 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.15 -47.85 71.5 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.05 -11.13 59.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.761 -0.587 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -54.34 -56.41 26.81 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.637 -1.289 . . . . 0.0 110.248 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 22' ' ' SER . 38.0 Cg_endo -74.41 -58.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 125.024 3.816 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.74 -29.13 1.76 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.929 -0.482 . . . . 0.0 111.376 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 25' ' ' ILE . 10.1 mm -74.13 -45.83 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.709 . . . . 0.0 110.608 -179.642 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.887 0.375 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -76.23 -27.4 56.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 0.0 110.544 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -48.68 51.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.772 . . . . 0.0 110.029 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 11' ' ' THR . 18.2 tt -62.1 -46.25 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -53.97 -35.94 62.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.66 -0.65 . . . . 0.0 110.746 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -33.99 72.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.8 -29.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.098 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.43 -36.88 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.02 -42.22 98.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.11 -24.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.472 -0.768 . . . . 0.0 109.961 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.32 -53.43 58.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.61 -35.8 60.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.498 -0.751 . . . . 0.0 109.657 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.96 -45.92 15.9 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.859 0.838 . . . . 0.0 111.268 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.43 -52.07 49.4 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.297 0.57 . . . . 0.0 111.321 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -5.94 59.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.824 -0.547 . . . . 0.0 111.639 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 12.7 t -49.8 -47.14 80.31 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.066 -1.021 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -74.42 -56.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.301 3.334 . . . . 0.0 110.477 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -28.13 2.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.029 -0.419 . . . . 0.0 111.25 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.27 -43.13 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.361 -0.837 . . . . 0.0 109.526 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.774 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.861 0.362 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 t -58.36 -20.07 40.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.37 -0.831 . . . . 0.0 111.095 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -46.67 18.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.128 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mt -71.21 -18.43 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.812 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -41.04 20.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.209 -0.932 . . . . 0.0 109.953 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.72 -30.24 67.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.506 -0.746 . . . . 0.0 109.678 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.83 -36.71 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 109.703 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -77.21 -25.24 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.093 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -68.73 -58.34 4.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 108.801 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 16' ' ' ILE . 50.4 mm -64.93 -20.57 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.615 -0.678 . . . . 0.0 109.831 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.25 -51.33 64.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.36 -31.48 70.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.37 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -59.22 5.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.701 -0.625 . . . . 0.0 110.77 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.23 -48.06 83.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.441 -0.787 . . . . 0.0 111.244 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -77.47 -9.19 58.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.878 -0.513 . . . . 0.0 111.68 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.9 t -51.75 -56.87 17.44 Favored Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.777 -1.202 . . . . 0.0 111.071 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.6 Cg_endo -71.59 -55.14 0.13 Allowed 'Trans proline' 0 N--CA 1.512 2.586 0 C-N-CA 124.945 3.764 . . . . 0.0 110.454 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.58 -26.41 2.21 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.913 -0.492 . . . . 0.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.79 -34.96 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.414 -0.804 . . . . 0.0 109.46 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.333 -0.854 . . . . 0.0 110.104 -179.706 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.668 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.59 -6.95 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.643 -0.661 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -121.49 71.08 25.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.37 -51.68 0.08 OUTLIER 'Trans proline' 0 N--CA 1.509 2.434 1 C-N-CA 125.378 4.052 . . . . 0.0 109.787 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.409 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 28.4 t80 -55.42 -21.76 17.28 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -76.66 -31.97 57.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 111.184 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -47.47 7.67 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.912 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -78.98 -56.82 4.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.216 -0.927 . . . . 0.0 112.049 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.89 -22.39 65.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.433 -0.792 . . . . 0.0 111.075 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 11' ' ' THR . 3.9 tt -77.95 -47.22 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.16 -0.963 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.2 m -61.87 -33.42 74.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.764 -0.585 . . . . 0.0 109.773 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.87 -35.86 75.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 69.2 t -66.48 -36.33 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mt -79.3 -18.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.207 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.22 -43.66 60.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.245 -0.909 . . . . 0.0 110.368 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.2 -22.25 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 0.0 110.753 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -71.78 -37.82 70.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.24 -0.912 . . . . 0.0 109.63 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.91 -28.71 20.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.511 -0.743 . . . . 0.0 109.672 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.69 -55.08 16.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.619 -0.675 . . . . 0.0 110.128 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.69 72.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.796 -0.565 . . . . 0.0 111.284 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.05 -16.75 61.48 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.706 -0.621 . . . . 0.0 111.617 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 2.8 t -56.61 -57.79 21.34 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 120.958 -1.089 . . . . 0.0 110.913 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.5 Cg_endo -68.3 -55.3 0.25 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 124.976 3.784 . . . . 0.0 110.674 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.61 -27.95 1.31 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 111.202 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.19 -41.76 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.482 -0.762 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -64.74 0.79 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 109.95 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -58.86 143.53 47.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.7 . . . . 0.0 110.172 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.47 -162.32 24.97 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.58 48.11 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -67.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.344 -1.092 . . . . 0.0 109.293 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -64.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.666 . . . . 0.0 109.4 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.39 130.32 10.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.43 -37.58 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.559 -0.965 . . . . 0.0 109.392 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.442 179.923 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.649 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.456 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.18 -74.43 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.703 . . . . 0.0 109.132 . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 16.2 p90 -137.26 55.48 10.16 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.501 -0.75 . . . . 0.0 110.483 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 39.9 Cg_endo -79.9 -80.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.837 3.691 . . . . 0.0 110.177 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -66.11 -18.84 65.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 109.956 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.58 -34.77 76.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 tp -60.15 -32.55 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.807 -0.558 . . . . 0.0 110.365 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.8 p -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 -29.96 62.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 109.653 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.22 -35.5 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.1 p -60.49 -47.63 85.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.02 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -61.34 -44.85 96.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.717 . . . . 0.0 109.966 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.83 -27.19 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.596 -0.69 . . . . 0.0 109.913 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.2 mt -67.71 -37.32 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.48 -0.763 . . . . 0.0 109.1 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.19 -54.63 41.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.764 . . . . 0.0 109.412 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -73.61 -10.05 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.678 -0.639 . . . . 0.0 110.608 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -72.25 -70.02 0.36 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.614 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.93 -31.72 70.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.091 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.74 54.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 110.682 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.64 75.97 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.603 -0.686 . . . . 0.0 111.259 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -19.99 62.25 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.889 -0.507 . . . . 0.0 111.574 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -57.33 -58.7 16.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.091 -1.006 . . . . 0.0 111.264 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.87 -55.91 0.16 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 125.144 3.896 . . . . 0.0 110.62 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -27.58 2.29 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.137 0.494 . . . . 0.0 110.6 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.17 -35.74 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.418 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 m -56.82 -38.97 73.34 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.6 104.35 8.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.486 -0.759 . . . . 0.0 109.46 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.9 102.07 2.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.34 71.63 0.82 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.82 131.07 48.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.962 . . . . 0.0 109.583 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tp -86.33 -33.92 20.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.489 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.16 161.99 27.66 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.1 -40.63 62.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.976 . . . . 0.0 109.516 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.379 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.637 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 -113.54 -21.77 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -155.13 80.8 4.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.784 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.68 -72.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 1 C-N-CA 125.355 4.037 . . . . 0.0 110.626 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.77 -18.08 38.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.704 -0.622 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.0 -40.31 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.31 -30.25 61.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.581 -0.699 . . . . 0.0 110.153 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -20.9 37.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.492 -0.755 . . . . 0.0 111.095 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -74.76 -61.8 1.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.782 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.7 mt -62.69 -22.39 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.49 -0.756 . . . . 0.0 110.366 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -69.03 -49.15 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.313 -0.867 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.98 -37.19 81.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.44 -0.787 . . . . 0.0 110.107 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.15 -42.02 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.461 -0.774 . . . . 0.0 109.735 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.1 mt -66.89 -28.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.687 . . . . 0.0 109.502 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.468 -0.77 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.7 mt -75.65 -25.62 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.7 . . . . 0.0 109.869 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.13 -39.71 95.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.349 -0.844 . . . . 0.0 110.073 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.03 -28.31 27.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.424 -0.798 . . . . 0.0 110.265 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.82 -49.33 73.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.711 . . . . 0.0 110.891 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.69 -51.38 50.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.676 -0.64 . . . . 0.0 111.585 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 mt -83.83 -9.24 58.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.896 -0.503 . . . . 0.0 111.634 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -47.83 -48.19 61.44 Favored Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.091 -1.006 . . . . 0.0 112.457 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -75.01 -60.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 124.547 3.498 . . . . 0.0 110.771 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.72 -26.78 1.0 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.92 -0.488 . . . . 0.0 111.411 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.5 mt -64.58 -53.16 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.392 -0.818 . . . . 0.0 109.23 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 m -72.24 -67.38 0.55 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 109.891 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.44 165.63 21.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 109.599 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.9 107.59 1.78 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.3 20.63 46.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.45 102.4 15.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.273 -1.134 . . . . 0.0 109.227 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.13 -42.74 62.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.629 -0.669 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.14 133.94 11.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -42.33 89.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.533 -0.98 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.58 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.662 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -121.28 -10.69 8.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.598 -0.689 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 67.16 65.2 0.7 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.93 -1.106 . . . . 0.0 109.134 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.7 Cg_endo -93.61 -79.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 1 C-N-CA 125.929 4.42 . . . . 0.0 112.044 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -89.26 -14.03 36.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.269 -0.895 . . . . 0.0 111.272 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -55.17 -21.92 15.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.433 HD22 ' CD2' ' A' ' 3' ' ' TYR . 4.5 mm? -65.56 -42.67 91.56 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.497 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -58.18 -31.22 67.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.09 -36.38 83.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -68.92 -44.28 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 110.07 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -56.93 -42.41 79.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 0.0 110.271 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -30.41 71.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.433 -0.792 . . . . 0.0 109.361 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -74.86 -27.73 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.706 . . . . 0.0 109.755 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.43 -30.4 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.41 -41.8 75.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.585 -0.697 . . . . 0.0 109.737 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.9 mt -75.33 -20.11 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.276 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.32 -56.81 6.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.907 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -25.31 64.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.526 -0.734 . . . . 0.0 110.148 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -54.59 20.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.476 -0.765 . . . . 0.0 110.586 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.77 54.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.56 -0.712 . . . . 0.0 111.629 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.04 -15.36 51.35 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.883 -0.51 . . . . 0.0 111.71 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.404 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -51.18 -52.32 59.95 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.841 -1.162 . . . . 0.0 111.243 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 22' ' ' SER . 39.6 Cg_endo -77.94 -58.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.107 3.871 . . . . 0.0 110.718 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.42 0.83 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.922 -0.486 . . . . 0.0 111.606 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -84.08 -47.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.4 m -82.53 -68.91 0.66 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.63 -79.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 109.726 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.43 112.44 0.24 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.19 -53.3 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.25 -24.03 67.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -1.037 . . . . 0.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 tp -57.96 -57.0 14.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.63 37.29 0.05 OUTLIER Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.784 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.57 -54.21 3.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -1.085 . . . . 0.0 109.501 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 pttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.559 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.655 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.5 -52.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.591 -0.693 . . . . 0.0 109.44 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 55.33 93.08 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.604 -0.685 . . . . 0.0 110.3 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -87.53 -76.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 1 C-N-CA 125.526 4.151 . . . . 0.0 110.889 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -19.23 61.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -62.11 -49.83 74.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.15 -45.67 14.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.952 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -62.21 -14.36 37.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -77.96 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.023 -1.048 . . . . 0.0 110.414 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 10' ' ' ILE . 76.2 mt -60.42 -30.84 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.452 -0.78 . . . . 0.0 110.682 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 m -58.65 -45.54 89.11 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -35.69 80.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.0 t -70.3 -24.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.052 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.8 -34.59 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.337 -0.852 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.21 -52.81 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 109.826 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.87 -27.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -60.88 -36.6 79.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 109.598 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.46 -22.93 35.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.978 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.13 67.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.13 60.83 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.496 0.665 . . . . 0.0 110.947 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 3.8 mm? -85.05 -12.28 53.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.927 -0.483 . . . . 0.0 111.595 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.409 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 2.6 t -52.14 -50.21 80.21 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.886 -1.134 . . . . 0.0 111.304 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.2 Cg_endo -76.0 -62.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.422 0 C-N-CA 124.668 3.579 . . . . 0.0 111.059 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.93 -27.09 1.14 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.803 -0.561 . . . . 0.0 111.386 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 25' ' ' ILE . 41.9 mm -90.13 -41.34 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.417 -0.802 . . . . 0.0 109.971 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 m -70.83 -67.08 0.53 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.33 111.33 1.33 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.425 -0.797 . . . . 0.0 109.964 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 150.35 160.55 9.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.61 -74.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -84.04 117.83 23.67 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.547 -0.973 . . . . 0.0 109.6 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -62.2 -58.61 7.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.345 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.47 162.55 49.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.45 -56.68 7.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.98 . . . . 0.0 109.269 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.408 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.605 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -130.13 -63.46 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.551 -0.718 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -140.31 66.73 30.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.54 -77.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.791 1 C-N-CA 125.521 4.147 . . . . 0.0 110.524 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -75.32 -26.25 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.494 -0.753 . . . . 0.0 110.018 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -65.89 -23.21 66.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.55 -24.89 38.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.31 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 -43.01 99.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.49 -25.96 67.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 10' ' ' ILE . 39.9 mm -65.25 -50.61 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.332 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.3 m -56.58 -39.03 72.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.379 -0.826 . . . . 0.0 109.852 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -35.91 80.52 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.62 -43.8 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 mp -84.55 -3.52 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 110.039 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -85.05 -37.86 19.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.385 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 16' ' ' ILE . 41.7 mt -86.76 -37.51 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.638 -0.664 . . . . 0.0 109.434 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -53.42 38.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.257 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -68.74 -29.41 67.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.647 . . . . 0.0 109.81 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.38 -52.05 62.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.3 -0.875 . . . . 0.0 110.876 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.61 -56.66 4.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.72 -50.02 66.34 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.348 -0.845 . . . . 0.0 112.793 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 47.1 t -38.8 -52.31 3.69 Favored Pre-proline 0 N--CA 1.515 2.797 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 22' ' ' SER . 35.0 Cg_endo -66.83 -56.43 0.25 Allowed 'Trans proline' 0 N--CA 1.511 2.526 0 C-N-CA 124.199 3.266 . . . . 0.0 110.387 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.38 -27.81 1.8 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.918 -0.489 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mm -64.95 -65.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.5 m -81.07 -64.4 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 0.0 109.279 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -73.06 125.05 26.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.398 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -172.4 29.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.75 44.37 0.26 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.57 179.89 5.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.557 -0.967 . . . . 0.0 109.628 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.22 -28.37 67.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.679 -0.638 . . . . 0.0 109.589 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.06 110.68 2.33 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.32 -49.37 69.85 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.559 -0.965 . . . . 0.0 110.386 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.501 179.756 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.681 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -133.79 -37.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.713 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -155.89 82.84 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.405 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.95 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.102 1 C-N-CA 125.403 4.068 . . . . 0.0 110.79 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.31 -24.91 67.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.779 -0.575 . . . . 0.0 110.143 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -80.39 -68.24 0.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.318 -0.864 . . . . 0.0 111.351 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -21.75 65.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.461 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -57.41 -26.86 61.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 110.611 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.74 -58.51 6.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.546 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.18 -19.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.718 -0.614 . . . . 0.0 109.882 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -74.99 -38.87 61.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -41.07 87.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.276 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.15 -48.62 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.12 -17.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -67.79 -52.0 42.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 0.0 109.825 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.93 -23.29 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.455 -0.778 . . . . 0.0 110.126 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.34 -40.2 85.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 109.89 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -31.21 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.506 -0.746 . . . . 0.0 109.649 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.54 44.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.057 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.33 82.8 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.371 0.605 . . . . 0.0 111.305 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.1 -17.41 61.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.796 -0.565 . . . . 0.0 111.753 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.407 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -59.79 -57.79 24.2 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.888 -1.132 . . . . 0.0 111.28 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.7 Cg_endo -69.85 -57.85 0.11 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 125.06 3.84 . . . . 0.0 111.078 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.35 -28.19 1.26 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.937 -0.477 . . . . 0.0 111.181 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 84.0 mt -79.88 -43.36 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.2 m -59.67 -30.25 68.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 0.0 110.124 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.37 179.08 2.14 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.794 . . . . 0.0 109.553 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.74 -50.2 66.17 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.33 85.6 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.28 158.27 19.73 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.673 -0.898 . . . . 0.0 109.377 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.83 -54.94 4.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.549 -0.719 . . . . 0.0 109.532 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.9 118.62 11.67 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.25 -39.82 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.62 -0.93 . . . . 0.0 109.394 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.3 mttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.402 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.666 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 71.81 115.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.916 0.865 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -164.96 71.87 1.46 Allowed Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -88.24 -63.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 1 C-N-CA 125.667 4.245 . . . . 0.0 110.292 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -50.99 -24.53 3.76 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.825 -0.547 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -82.99 -38.42 22.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.878 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.62 -16.77 60.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 110.147 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 t -62.83 -25.06 68.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -45.95 92.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.764 . . . . 0.0 109.72 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -66.4 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -0.771 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -32.54 73.95 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -37.99 86.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.23 -25.59 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.24 -44.06 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 109.236 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.58 -40.77 97.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.642 -0.661 . . . . 0.0 109.67 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 16' ' ' ILE . 39.2 mm -74.67 -23.6 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.616 -0.678 . . . . 0.0 109.657 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.21 -37.11 86.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -84.97 -35.07 22.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.599 -0.688 . . . . 0.0 110.139 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.93 6.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.759 -0.588 . . . . 0.0 111.274 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.71 -53.87 35.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.596 -0.69 . . . . 0.0 111.767 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -70.86 -12.32 61.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.692 -0.63 . . . . 0.0 112.031 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.2 t -59.94 -61.57 7.64 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 120.787 -1.196 . . . . 0.0 110.362 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -71.13 -58.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.511 2.541 0 C-N-CA 124.941 3.76 . . . . 0.0 111.126 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.58 -28.57 0.98 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.975 -0.453 . . . . 0.0 111.537 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mp -66.15 -51.07 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m -70.15 -65.67 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.505 -0.747 . . . . 0.0 109.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.4 106.7 13.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.661 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.45 -136.44 47.45 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.2 -15.88 7.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.78 49.84 1.79 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -1.188 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mt -90.38 -72.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.45 82.77 0.35 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -62.31 -29.05 70.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 109.615 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.626 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.45 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -83.79 -87.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.615 -0.678 . . . . 0.0 109.421 . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 2' ' ' ARG . 14.4 p90 -163.9 61.9 1.0 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 39.5 Cg_endo -80.47 -77.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.104 1 C-N-CA 125.302 4.001 . . . . 0.0 111.147 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.39 -35.57 75.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.502 -0.749 . . . . 0.0 110.516 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.57 -29.29 69.93 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 tp -90.37 -28.37 18.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.56 -0.713 . . . . 0.0 109.957 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -63.45 -17.6 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.94 -37.52 75.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mp -72.69 -54.6 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -0.778 . . . . 0.0 109.778 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -28.25 64.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -34.12 62.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.08 -26.98 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.673 -0.642 . . . . 0.0 109.532 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.5 -35.36 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -66.04 -42.81 89.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.609 -0.682 . . . . 0.0 109.861 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 16' ' ' ILE . 41.6 mm -78.79 -21.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -48.78 77.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -86.34 -27.64 24.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.496 -0.752 . . . . 0.0 110.353 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.26 65.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.487 -0.758 . . . . 0.0 110.657 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.73 -51.46 55.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.578 -0.701 . . . . 0.0 111.455 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mp -82.42 -9.21 59.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.794 -0.566 . . . . 0.0 111.835 -178.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.412 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -57.88 -53.32 66.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.978 -1.077 . . . . 0.0 111.265 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -73.67 -60.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 124.865 3.71 . . . . 0.0 110.879 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.08 -27.64 1.44 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.821 -0.549 . . . . 0.0 111.335 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 25' ' ' ILE . 83.5 mt -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.631 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -62.67 -61.52 2.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.02 90.1 0.44 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.83 130.32 10.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.82 73.81 0.03 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.6 123.16 22.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.573 -0.957 . . . . 0.0 109.294 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.81 -31.74 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 147.6 11.17 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -48.44 35.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.954 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.431 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.636 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -51.62 12.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 109.318 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER 177.89 -51.15 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.715 . . . . 0.0 109.933 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 40.1 Cg_endo -89.03 -67.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.907 1 C-N-CA 125.403 4.069 . . . . 0.0 110.919 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -48.78 -26.11 2.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.613 -0.679 . . . . 0.0 110.995 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -61.62 -59.43 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.451 -0.78 . . . . 0.0 109.993 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -29.14 67.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.569 -0.707 . . . . 0.0 110.604 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -69.68 -31.16 69.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.803 . . . . 0.0 109.789 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -75.19 -41.97 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 110.574 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mp -63.43 -37.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.323 -0.861 . . . . 0.0 109.192 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -29.68 67.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.48 -0.763 . . . . 0.0 109.492 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -30.42 59.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.0 109.747 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.2 t -75.39 -30.5 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 0.0 109.292 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.13 -36.27 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.93 -42.45 97.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.61 -0.681 . . . . 0.0 109.196 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.46 -23.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.647 -0.658 . . . . 0.0 109.62 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -43.46 97.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.737 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.03 -27.92 20.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.532 -0.73 . . . . 0.0 110.095 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.77 -53.76 54.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.753 . . . . 0.0 110.117 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.33 73.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.292 0.568 . . . . 0.0 110.867 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.31 -1.17 39.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.942 -0.474 . . . . 0.0 112.073 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.5 m -47.75 -47.38 62.04 Favored Pre-proline 0 N--CA 1.508 2.439 0 O-C-N 120.855 -1.153 . . . . 0.0 112.318 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.7 Cg_endo -78.95 -60.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.405 0 C-N-CA 124.881 3.721 . . . . 0.0 111.208 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.67 -27.7 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.801 -0.562 . . . . 0.0 111.576 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.3 mm -75.5 -43.63 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 m -53.25 -50.86 63.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.245 -0.909 . . . . 0.0 109.631 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -90.07 111.2 22.24 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.6 52.1 3.66 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.47 -72.95 0.02 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp -81.34 92.35 6.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.995 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.09 -37.75 88.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.503 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.14 112.44 1.09 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -55.14 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.967 . . . . 0.0 109.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.464 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.655 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -69.1 -38.58 79.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.28 71.86 3.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -90.73 -64.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.857 4.371 . . . . 0.0 111.766 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.42 -22.75 45.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.796 -0.565 . . . . 0.0 111.481 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -82.47 -61.88 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.061 -1.024 . . . . 0.0 110.366 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.08 -8.81 48.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.656 -0.653 . . . . 0.0 110.613 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 p -81.87 -30.0 32.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -67.9 -39.49 83.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.672 -0.643 . . . . 0.0 109.759 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mt -71.5 -42.52 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.531 -0.731 . . . . 0.0 109.578 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -33.07 72.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -34.33 74.41 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.0 t -68.84 -27.95 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 14' ' ' ILE . 50.2 mm -74.86 -33.49 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 108.981 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -69.14 -40.54 78.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.48 -32.38 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.35 -45.98 90.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.513 -0.742 . . . . 0.0 109.248 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -65.57 -36.23 83.15 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.482 0.658 . . . . 0.0 109.44 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -55.02 36.54 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.528 0.68 . . . . 0.0 110.284 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.84 92.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.588 0.708 . . . . 0.0 110.343 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.007 -0.433 . . . . 0.0 111.414 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -59.59 9.62 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.87 -56.99 0.11 Allowed 'Trans proline' 0 N--CA 1.51 2.482 0 C-N-CA 125.03 3.82 . . . . 0.0 110.676 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -27.96 1.01 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.014 0.435 . . . . 0.0 111.241 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 mm -61.23 -54.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 m -83.08 -64.45 1.17 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.898 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -60.34 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.35 -107.78 0.47 Allowed Glycine 0 N--CA 1.5 2.952 0 O-C-N 120.988 -1.07 . . . . 0.0 110.685 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.07 -64.99 0.23 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.0 mt -86.26 178.93 7.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.604 -0.939 . . . . 0.0 109.076 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.56 -52.7 4.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.577 -0.702 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 103.93 0.6 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.01 -48.52 65.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.627 -0.925 . . . . 0.0 109.455 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mttt . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.69 -179.813 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.63 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -131.6 -57.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.613 -0.679 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.423 ' CD2' ' HB2' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -144.91 76.87 13.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.53 -51.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.51 2.477 1 C-N-CA 125.757 4.305 . . . . 0.0 110.507 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -49.97 -23.61 2.11 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.32 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.423 ' HB2' ' CD2' ' A' ' 3' ' ' TYR . 5.5 t80 -76.32 -39.92 52.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.178 -0.951 . . . . 0.0 110.205 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.87 -54.72 41.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.91 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.1 m -58.61 -19.75 41.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.354 -0.841 . . . . 0.0 111.46 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -66.69 -57.56 6.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.142 -0.974 . . . . 0.0 110.723 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 11' ' ' THR . 4.0 tt -59.74 -45.48 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.443 -0.785 . . . . 0.0 110.197 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.416 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 2.4 m -58.6 -34.13 70.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.744 -0.597 . . . . 0.0 109.975 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.19 -36.18 74.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.489 -0.757 . . . . 0.0 109.175 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.96 -23.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.813 -0.554 . . . . 0.0 109.861 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 14' ' ' ILE . 79.4 mt -83.99 -29.47 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -74.15 -41.72 61.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 0.0 109.701 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.48 -28.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 110.24 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -56.85 12.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.396 -0.815 . . . . 0.0 109.586 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.85 -30.17 68.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 110.028 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.39 -57.77 11.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 110.08 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.36 -53.57 56.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.566 -0.709 . . . . 0.0 111.004 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.12 1.44 27.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.816 -0.552 . . . . 0.0 111.678 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 17.4 t -49.11 -45.97 75.56 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.945 -1.097 . . . . 0.0 112.375 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 22' ' ' SER . 41.0 Cg_endo -78.31 -57.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.373 0 C-N-CA 124.608 3.538 . . . . 0.0 110.766 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.23 -28.32 2.96 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.872 -0.517 . . . . 0.0 111.311 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG21 HD11 ' A' ' 25' ' ' ILE . 40.5 mm -83.98 -38.99 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.134 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -60.64 -28.63 68.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.564 -0.71 . . . . 0.0 110.081 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.95 170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.33 -112.1 0.1 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.84 35.75 1.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -53.06 6.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.96 . . . . 0.0 109.276 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tp -71.89 -34.96 69.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.67 -0.644 . . . . 0.0 109.587 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.31 169.71 43.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -59.38 -44.0 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.489 -1.007 . . . . 0.0 109.767 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.452 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.681 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -154.04 -83.9 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.71 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.2 t80 -101.21 -46.68 0.2 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 111.928 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 41.4 Cg_endo -90.26 -70.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 125.106 3.871 . . . . 0.0 111.786 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -49.79 -24.92 2.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.568 -0.708 . . . . 0.0 111.545 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -90.12 -33.06 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.437 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -24.05 63.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -65.0 -41.41 95.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -59.57 -40.08 86.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.667 -0.646 . . . . 0.0 109.895 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -67.88 -33.47 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.895 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -56.99 -50.65 72.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.271 -0.893 . . . . 0.0 110.179 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -32.96 73.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 109.392 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.64 -37.21 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.681 -0.637 . . . . 0.0 109.534 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -19.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.624 -0.673 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -68.76 -49.86 55.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 109.685 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -75.3 -32.84 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.428 -0.795 . . . . 0.0 109.868 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.7 97.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -28.27 63.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.17 84.9 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.81 0.815 . . . . 0.0 110.158 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -48.73 52.99 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.501 0.667 . . . . 0.0 111.207 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.55 -13.62 51.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.932 -0.48 . . . . 0.0 111.117 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.479 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 39.9 m -51.04 -48.31 85.22 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.087 -1.008 . . . . 0.0 112.001 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.1 Cg_endo -70.79 -55.26 0.15 Allowed 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 124.265 3.31 . . . . 0.0 109.71 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.56 -28.25 0.91 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.0 mt -79.36 -44.06 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 0.0 109.67 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -70.07 -65.34 0.74 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.329 -0.857 . . . . 0.0 109.991 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.32 143.26 6.52 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.6 -0.688 . . . . 0.0 110.488 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.34 -134.02 1.28 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.77 -9.2 78.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.72 86.44 2.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.124 -1.221 . . . . 0.0 109.497 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.5 -31.37 32.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 109.192 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.86 -161.02 14.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -80.24 -52.84 7.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.593 -0.945 . . . . 0.0 109.434 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.583 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.671 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -110.69 -9.69 14.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.693 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CZ ' ' CD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -130.07 70.88 82.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.414 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -82.95 -75.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 125.056 3.838 . . . . 0.0 110.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -77.07 -30.38 55.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.61 -13.4 62.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -13.82 48.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -58.53 -45.24 89.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.024 -1.047 . . . . 0.0 110.199 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -44.73 93.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.735 . . . . 0.0 109.176 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.45 -22.63 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.7 m -68.6 -42.16 78.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.33 -30.33 71.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.564 -0.71 . . . . 0.0 109.217 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.92 -24.26 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.695 -0.628 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.4 mt -84.28 -30.07 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.792 . . . . 0.0 109.801 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 tp -76.39 -34.59 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.74 0.781 . . . . 0.0 109.117 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -52.86 -45.74 67.54 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.924 -0.485 . . . . 0.0 110.236 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -29.64 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.548 -0.72 . . . . 0.0 109.867 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.95 -53.85 53.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.476 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.84 74.79 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.519 0.676 . . . . 0.0 110.824 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.0 mt -65.83 -14.17 60.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.544 . . . . 0.0 111.355 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 t -67.27 -60.96 5.17 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 120.978 -1.076 . . . . 0.0 110.145 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.98 -56.05 0.18 Allowed 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 125.072 3.848 . . . . 0.0 110.595 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.26 -28.58 1.33 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.933 -0.479 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.8 mm -81.67 -41.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.48 -0.763 . . . . 0.0 109.166 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.0 m -72.03 -69.46 0.39 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 109.811 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -50.8 161.42 0.35 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.35 -0.844 . . . . 0.0 110.599 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 -130.18 2.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.8 39.08 96.33 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.0 114.82 4.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.675 -0.897 . . . . 0.0 109.806 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.49 -39.28 16.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 0.0 109.229 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.13 158.84 30.9 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -77.68 -35.7 52.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.948 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.55 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.64 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.71 -41.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.561 -0.712 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.407 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -178.39 -51.78 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.0 109.845 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.407 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 38.9 Cg_endo -88.81 -71.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 125.162 3.908 . . . . 0.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -52.64 -24.1 7.81 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -72.23 -45.35 60.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 109.938 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -64.77 -42.91 94.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.597 -0.689 . . . . 0.0 109.954 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -66.39 -23.44 66.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.163 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.61 -59.88 2.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.388 -0.82 . . . . 0.0 110.294 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 11' ' ' THR . 17.4 tt -56.95 -43.93 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.572 -0.705 . . . . 0.0 110.152 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 21.7 m -61.58 -31.7 71.76 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -36.13 73.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.08 -32.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.68 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt -76.99 -26.09 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.629 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.62 -38.45 83.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.509 -0.744 . . . . 0.0 109.327 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -83.45 -23.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.709 . . . . 0.0 109.941 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.31 -48.66 78.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.863 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -81.55 -41.37 21.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.133 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.55 12.08 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.639 0.733 . . . . 0.0 111.376 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.63 -52.94 27.02 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.41 0.624 . . . . 0.0 110.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.0 mt -84.77 -11.05 56.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.931 -0.481 . . . . 0.0 111.174 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.482 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 16.2 t -50.62 -48.37 82.58 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.107 -0.996 . . . . 0.0 112.35 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.1 Cg_endo -69.1 -57.53 0.13 Allowed 'Trans proline' 0 N--CA 1.51 2.477 0 C-N-CA 124.383 3.389 . . . . 0.0 110.488 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.34 -28.26 1.96 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 111.109 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 mt -80.98 -41.68 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 109.426 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -59.88 -27.64 66.87 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.546 -0.721 . . . . 0.0 109.908 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.41 146.61 48.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 109.419 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 166.67 58.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.78 -66.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.06 122.65 31.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.955 . . . . 0.0 109.076 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.98 -44.02 12.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.75 127.76 0.9 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.4 -46.28 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.664 -0.903 . . . . 0.0 109.337 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.532 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -73.54 -54.71 7.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.629 . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 63.4 m-85 -156.79 82.12 3.33 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -79.98 -82.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.226 3.95 . . . . 0.0 110.676 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.71 -25.41 61.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 109.747 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.25 -28.5 69.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.411 -0.806 . . . . 0.0 109.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.12 -28.9 68.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 109.995 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.9 p -66.97 -24.86 66.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.49 -42.67 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.336 -0.852 . . . . 0.0 110.187 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 10' ' ' ILE . 46.4 mm -67.74 -46.64 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.828 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -35.39 78.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 109.342 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.48 -34.88 78.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.7 mm -72.2 -24.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 109.753 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.94 -53.45 31.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.68 -23.39 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 110.224 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -64.36 0.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 109.526 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -22.41 63.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.426 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.04 -59.5 3.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.275 -0.89 . . . . 0.0 110.089 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.35 86.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.383 -0.823 . . . . 0.0 110.264 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mt -71.16 -22.46 62.05 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.445 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.416 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -51.55 -58.79 9.62 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.805 -1.185 . . . . 0.0 111.095 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 22' ' ' SER . 34.2 Cg_endo -66.81 -58.93 0.13 Allowed 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 124.93 3.753 . . . . 0.0 111.116 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.8 -27.58 3.09 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.818 -0.551 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 87.9 mt -90.03 -32.52 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.297 -0.877 . . . . 0.0 110.037 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 m -56.74 -50.1 73.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.3 -0.875 . . . . 0.0 110.465 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -86.01 -51.75 6.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.87 -130.02 8.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.37 62.63 0.03 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 117.99 12.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.981 . . . . 0.0 108.796 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.62 -68.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.545 -0.722 . . . . 0.0 109.768 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.87 160.62 50.46 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.51 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.923 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.7 mttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.495 -179.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.627 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -89.1 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.423 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 173.6 -52.5 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.015 -1.053 . . . . 0.0 109.919 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 41.4 Cg_endo -90.18 -74.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 125.45 4.1 . . . . 0.0 111.495 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.6 22.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 110.649 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -59.68 -53.85 53.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.317 -0.864 . . . . 0.0 110.209 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.8 mt -74.84 -23.64 58.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -60.05 -19.54 53.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.303 -0.873 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.5 -36.8 81.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.002 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 mm -77.55 -40.11 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.436 -0.79 . . . . 0.0 110.098 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 m -63.73 -32.81 74.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.501 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 -39.51 75.09 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.1 t -62.28 -36.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.5 mt -72.38 -26.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.54 -60.22 4.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -73.7 -8.19 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.586 -0.696 . . . . 0.0 110.202 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.26 -30.02 57.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 0.0 108.717 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -25.92 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.68 -0.637 . . . . 0.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.44 -60.89 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.624 -0.673 . . . . 0.0 110.728 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.44 -47.84 66.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.639 -0.663 . . . . 0.0 111.379 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 tp -82.19 -12.76 57.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.881 -0.512 . . . . 0.0 111.453 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.445 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -49.33 -51.83 54.24 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.019 -1.051 . . . . 0.0 111.79 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -72.39 -55.36 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 124.795 3.664 . . . . 0.0 110.431 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.13 -27.6 2.45 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.017 -0.427 . . . . 0.0 111.063 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.8 mt -73.14 -44.53 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.794 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m -54.92 -33.36 62.1 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.288 -0.882 . . . . 0.0 110.332 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -178.65 0.98 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.484 -0.76 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.07 -98.4 0.46 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.99 43.15 0.29 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.61 -44.22 91.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.942 . . . . 0.0 109.378 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tp -74.72 -66.39 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.635 -0.666 . . . . 0.0 109.383 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.63 139.01 0.04 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.15 -55.89 4.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.937 . . . . 0.0 109.699 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.536 -179.836 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.641 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.66 -36.86 3.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 56.11 92.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.115 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.41 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 1 C-N-CA 125.309 4.006 . . . . 0.0 110.675 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.51 -25.26 64.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.094 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -60.92 -44.38 97.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 110.327 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.75 -23.43 25.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.215 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -59.92 -28.38 67.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.72 -38.0 89.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.731 . . . . 0.0 109.246 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.1 mt -65.97 -36.36 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m -61.72 -37.64 84.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.525 -0.735 . . . . 0.0 109.136 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -32.06 73.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 -30.42 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.48 -32.96 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -65.14 -54.8 24.25 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.46 -18.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.662 -0.649 . . . . 0.0 109.36 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -67.2 -42.02 84.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 108.963 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.68 -30.84 69.6 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -52.13 66.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.654 0.74 . . . . 0.0 109.516 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.98 83.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.447 0.642 . . . . 0.0 110.137 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.75 -3.29 37.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.082 -0.386 . . . . 0.0 111.123 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.418 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 3.6 m -40.65 -51.17 6.94 Favored Pre-proline 0 N--CA 1.51 2.557 0 O-C-N 121.328 -0.857 . . . . 0.0 113.061 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.6 Cg_endo -70.47 -56.71 0.12 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 124.572 3.514 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -26.77 1.53 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.959 -0.463 . . . . 0.0 111.061 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.9 mt -77.12 -44.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 109.185 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.5 m -70.48 -69.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.805 . . . . 0.0 109.04 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -89.01 136.98 32.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.369 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -99.84 88.17 0.78 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.19 30.42 9.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -33.22 70.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.983 . . . . 0.0 109.348 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -37.39 85.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.658 . . . . 0.0 109.313 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.82 172.53 19.79 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.61 -57.72 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.933 . . . . 0.0 109.359 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.328 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -63.97 -33.08 74.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.692 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 54.7 m-85 51.0 65.97 6.03 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.454 -0.779 . . . . 0.0 109.979 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 40.9 Cg_endo -89.24 -75.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.75 4.3 . . . . 0.0 111.143 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.83 -21.84 12.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.494 -0.754 . . . . 0.0 110.728 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -60.44 -48.94 79.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -69.36 -42.59 75.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.606 -0.684 . . . . 0.0 109.964 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -27.17 66.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.076 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.03 -37.32 83.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.206 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.494 HG22 HD11 ' A' ' 10' ' ' ILE . 44.3 mm -70.28 -44.14 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 m -59.93 -24.71 64.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.94 -31.95 34.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.415 -0.803 . . . . 0.0 109.31 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.28 -26.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.95 -40.33 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.413 0.625 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.92 -26.57 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.58 -35.35 68.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -34.23 21.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.741 . . . . 0.0 110.178 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -55.44 34.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.487 -0.758 . . . . 0.0 110.686 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.15 -47.85 71.5 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.05 -11.13 59.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.761 -0.587 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -54.34 -56.41 26.81 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.637 -1.289 . . . . 0.0 110.248 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 22' ' ' SER . 38.0 Cg_endo -74.41 -58.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 125.024 3.816 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.74 -29.13 1.76 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.929 -0.482 . . . . 0.0 111.376 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 25' ' ' ILE . 10.1 mm -74.13 -45.83 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -58.02 -42.1 84.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.709 . . . . 0.0 110.608 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -86.0 -79.6 0.25 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.235 -0.916 . . . . 0.0 110.027 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.77 -162.58 35.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 68.36 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.2 155.44 17.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -1.005 . . . . 0.0 109.454 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -55.59 25.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.54 -135.51 3.28 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.65 -51.23 36.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.482 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 pttt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.557 179.541 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.656 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.449 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -80.86 -72.84 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 109.313 . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 24.5 p90 -141.02 56.7 6.82 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 40.7 Cg_endo -81.74 -78.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 124.958 3.772 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -63.62 -15.33 57.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.448 -0.783 . . . . 0.0 110.806 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -53.87 -22.75 10.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.19 -0.944 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.96 -38.82 61.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.495 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -76.23 -27.4 56.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 0.0 110.544 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.06 -48.68 51.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.772 . . . . 0.0 110.029 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 11' ' ' THR . 18.2 tt -62.1 -46.25 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 1.0 OUTLIER -53.97 -35.94 62.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.66 -0.65 . . . . 0.0 110.746 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -33.99 72.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.8 t -66.8 -29.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.098 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 2.4 mp -76.43 -36.88 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.02 -42.22 98.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.11 -24.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.472 -0.768 . . . . 0.0 109.961 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.32 -53.43 58.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.61 -35.8 60.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.498 -0.751 . . . . 0.0 109.657 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.96 -45.92 15.9 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.859 0.838 . . . . 0.0 111.268 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.43 -52.07 49.4 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.297 0.57 . . . . 0.0 111.321 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -5.94 59.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.824 -0.547 . . . . 0.0 111.639 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 12.7 t -49.8 -47.14 80.31 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.066 -1.021 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -74.42 -56.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.301 3.334 . . . . 0.0 110.477 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -28.13 2.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.029 -0.419 . . . . 0.0 111.25 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.27 -43.13 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.361 -0.837 . . . . 0.0 109.526 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.8 m -56.15 -35.89 67.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.22 -170.85 0.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.71 -179.45 3.4 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 39.22 1.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.93 152.57 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.898 . . . . 0.0 109.496 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mt -62.64 -48.44 79.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.93 97.49 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.5 -44.88 13.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.592 -0.946 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.2 tttt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.344 179.671 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.638 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -122.02 -41.63 2.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.562 -0.711 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.3 p90 -141.01 60.03 11.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.627 -0.67 . . . . 0.0 109.911 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 37.9 Cg_endo -80.01 -65.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 125.184 3.923 . . . . 0.0 110.249 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -59.28 -19.33 45.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.905 -0.497 . . . . 0.0 110.552 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -36.33 73.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.88 -48.25 82.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 t -58.36 -20.07 40.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.37 -0.831 . . . . 0.0 111.095 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -46.67 18.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.128 -179.41 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 mt -71.21 -18.43 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.812 . . . . 0.0 110.35 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -41.04 20.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.209 -0.932 . . . . 0.0 109.953 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.72 -30.24 67.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.506 -0.746 . . . . 0.0 109.678 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.3 t -74.83 -36.71 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 109.703 -179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -77.21 -25.24 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.093 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -68.73 -58.34 4.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 108.801 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 16' ' ' ILE . 50.4 mm -64.93 -20.57 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.615 -0.678 . . . . 0.0 109.831 179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.25 -51.33 64.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.36 -31.48 70.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.37 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -59.22 5.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.701 -0.625 . . . . 0.0 110.77 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.23 -48.06 83.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.441 -0.787 . . . . 0.0 111.244 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -77.47 -9.19 58.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.878 -0.513 . . . . 0.0 111.68 -178.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.9 t -51.75 -56.87 17.44 Favored Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.777 -1.202 . . . . 0.0 111.071 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.6 Cg_endo -71.59 -55.14 0.13 Allowed 'Trans proline' 0 N--CA 1.512 2.586 0 C-N-CA 124.945 3.764 . . . . 0.0 110.454 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.58 -26.41 2.21 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.913 -0.492 . . . . 0.0 111.113 -179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.1 mm -89.79 -34.96 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.414 -0.804 . . . . 0.0 109.46 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -57.95 -53.35 59.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.333 -0.854 . . . . 0.0 110.104 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 -73.49 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 109.757 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 -113.95 4.61 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.62 68.31 0.03 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -30.64 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.982 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.04 -48.62 67.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.253 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.41 91.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.81 -56.18 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.966 . . . . 0.0 109.768 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 tttp . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.609 -179.604 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 120.832 0.349 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -78.98 -56.82 4.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.216 -0.927 . . . . 0.0 112.049 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -61.89 -22.39 65.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.433 -0.792 . . . . 0.0 111.075 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 11' ' ' THR . 3.9 tt -77.95 -47.22 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.16 -0.963 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.2 m -61.87 -33.42 74.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.764 -0.585 . . . . 0.0 109.773 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.87 -35.86 75.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 9' ' ' ASP . 69.2 t -66.48 -36.33 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mt -79.3 -18.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.207 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.22 -43.66 60.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.245 -0.909 . . . . 0.0 110.368 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.2 -22.25 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 0.0 110.753 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -71.78 -37.82 70.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.24 -0.912 . . . . 0.0 109.63 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.91 -28.71 20.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.511 -0.743 . . . . 0.0 109.672 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.69 -55.08 16.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.619 -0.675 . . . . 0.0 110.128 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.69 72.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.796 -0.565 . . . . 0.0 111.284 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.05 -16.75 61.48 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.706 -0.621 . . . . 0.0 111.617 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 2.8 t -56.61 -57.79 21.34 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 120.958 -1.089 . . . . 0.0 110.913 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.5 Cg_endo -68.3 -55.3 0.25 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 124.976 3.784 . . . . 0.0 110.674 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.61 -27.95 1.31 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 111.202 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.19 -41.76 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.482 -0.762 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 109.95 -179.536 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' LEU . 31.1 tp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.869 0.366 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.8 p -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -73.72 -29.96 62.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 109.653 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.22 -35.5 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.935 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.1 p -60.49 -47.63 85.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.02 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.8 t70 -61.34 -44.85 96.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.717 . . . . 0.0 109.966 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.5 t -62.83 -27.19 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.596 -0.69 . . . . 0.0 109.913 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.935 HD12 ' HA ' ' A' ' 11' ' ' THR . 25.2 mt -67.71 -37.32 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.48 -0.763 . . . . 0.0 109.1 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.19 -54.63 41.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.764 . . . . 0.0 109.412 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.9 mp -73.61 -10.05 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.678 -0.639 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -72.25 -70.02 0.36 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.614 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.93 -31.72 70.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.091 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.74 54.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 110.682 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.64 75.97 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.603 -0.686 . . . . 0.0 111.259 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -19.99 62.25 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.889 -0.507 . . . . 0.0 111.574 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.403 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -57.33 -58.7 16.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.091 -1.006 . . . . 0.0 111.264 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.9 Cg_endo -69.87 -55.91 0.16 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 125.144 3.896 . . . . 0.0 110.62 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -27.58 2.29 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.137 0.494 . . . . 0.0 110.6 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.17 -35.74 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.418 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.499 1.998 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.052 0.453 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -20.9 37.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.492 -0.755 . . . . 0.0 111.095 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -74.76 -61.8 1.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.782 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 14' ' ' ILE . 54.7 mt -62.69 -22.39 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.49 -0.756 . . . . 0.0 110.366 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -69.03 -49.15 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.313 -0.867 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.98 -37.19 81.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.44 -0.787 . . . . 0.0 110.107 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.15 -42.02 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.461 -0.774 . . . . 0.0 109.735 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 10' ' ' ILE . 66.1 mt -66.89 -28.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.687 . . . . 0.0 109.502 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.468 -0.77 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.7 mt -75.65 -25.62 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.7 . . . . 0.0 109.869 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.13 -39.71 95.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.349 -0.844 . . . . 0.0 110.073 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.03 -28.31 27.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.424 -0.798 . . . . 0.0 110.265 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.82 -49.33 73.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.711 . . . . 0.0 110.891 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.69 -51.38 50.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.676 -0.64 . . . . 0.0 111.585 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 24' ' ' ALA . 4.3 mt -83.83 -9.24 58.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.896 -0.503 . . . . 0.0 111.634 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -47.83 -48.19 61.44 Favored Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.091 -1.006 . . . . 0.0 112.457 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -75.01 -60.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 124.547 3.498 . . . . 0.0 110.771 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -46.72 -26.78 1.0 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.92 -0.488 . . . . 0.0 111.411 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 21' ' ' LEU . 23.5 mt -64.58 -53.16 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.392 -0.818 . . . . 0.0 109.23 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 109.891 -179.633 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 10' ' ' ILE . 4.5 mm? . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.091 0.472 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -58.18 -31.22 67.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.3 t70 -64.09 -36.38 83.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 7' ' ' LEU . 8.6 mt -68.92 -44.28 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 110.07 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -56.93 -42.41 79.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 0.0 110.271 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -30.41 71.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.433 -0.792 . . . . 0.0 109.361 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.2 t -74.86 -27.73 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.706 . . . . 0.0 109.755 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.43 -30.4 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.41 -41.8 75.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.585 -0.697 . . . . 0.0 109.737 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.9 mt -75.33 -20.11 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.276 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.32 -56.81 6.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.907 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -25.31 64.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.526 -0.734 . . . . 0.0 110.148 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -54.59 20.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.476 -0.765 . . . . 0.0 110.586 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.77 54.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.56 -0.712 . . . . 0.0 111.629 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 25' ' ' ILE . 4.5 mp -83.04 -15.36 51.35 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.883 -0.51 . . . . 0.0 111.71 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.404 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -51.18 -52.32 59.95 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.841 -1.162 . . . . 0.0 111.243 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 22' ' ' SER . 39.6 Cg_endo -77.94 -58.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.107 3.871 . . . . 0.0 110.718 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.42 0.83 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.922 -0.486 . . . . 0.0 111.606 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.6 mp -84.08 -47.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.708 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -62.21 -14.36 37.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -77.96 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.023 -1.048 . . . . 0.0 110.414 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.2 mt -60.42 -30.84 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.452 -0.78 . . . . 0.0 110.682 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 m -58.65 -45.54 89.11 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -35.69 80.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.0 t -70.3 -24.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.052 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.8 -34.59 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.337 -0.852 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.21 -52.81 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 109.826 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.87 -27.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -60.88 -36.6 79.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 109.598 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.46 -22.93 35.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.978 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.13 67.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.13 60.83 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.496 0.665 . . . . 0.0 110.947 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -85.05 -12.28 53.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.927 -0.483 . . . . 0.0 111.595 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.409 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 2.6 t -52.14 -50.21 80.21 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.886 -1.134 . . . . 0.0 111.304 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.2 Cg_endo -76.0 -62.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.422 0 C-N-CA 124.668 3.579 . . . . 0.0 111.059 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.93 -27.09 1.14 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.803 -0.561 . . . . 0.0 111.386 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.13 -41.34 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.417 -0.802 . . . . 0.0 109.971 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.463 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.9 tp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.786 0.326 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 -43.01 99.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 13' ' ' VAL . 9.8 t70 -65.49 -25.96 67.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . 39.9 mm -65.25 -50.61 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.332 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.3 m -56.58 -39.03 72.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.379 -0.826 . . . . 0.0 109.852 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -35.91 80.52 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 9' ' ' ASP . 58.3 t -62.62 -43.8 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 10' ' ' ILE . 5.2 mp -84.55 -3.52 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 110.039 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 t80 -85.05 -37.86 19.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.385 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.7 mt -86.76 -37.51 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.638 -0.664 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -53.42 38.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.257 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -68.74 -29.41 67.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.647 . . . . 0.0 109.81 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 15' ' ' PHE . . . -54.38 -52.05 62.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.3 -0.875 . . . . 0.0 110.876 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.61 -56.66 4.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.72 -50.02 66.34 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.348 -0.845 . . . . 0.0 112.793 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 47.1 t -38.8 -52.31 3.69 Favored Pre-proline 0 N--CA 1.515 2.797 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 22' ' ' SER . 35.0 Cg_endo -66.83 -56.43 0.25 Allowed 'Trans proline' 0 N--CA 1.511 2.526 0 C-N-CA 124.199 3.266 . . . . 0.0 110.387 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.38 -27.81 1.8 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.918 -0.489 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 25' ' ' ILE . 28.9 mm -64.95 -65.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 0.0 109.279 179.87 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.777 0.323 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -57.41 -26.86 61.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 110.611 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.74 -58.51 6.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.546 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.18 -19.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.718 -0.614 . . . . 0.0 109.882 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -74.99 -38.87 61.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.738 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -66.92 -41.07 87.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.276 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.15 -48.62 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.12 -17.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -67.79 -52.0 42.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 0.0 109.825 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.2 mp -77.93 -23.29 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.455 -0.778 . . . . 0.0 110.126 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.34 -40.2 85.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 109.89 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -31.21 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.506 -0.746 . . . . 0.0 109.649 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.54 44.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.057 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.33 82.8 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.371 0.605 . . . . 0.0 111.305 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 2.0 mm? -72.1 -17.41 61.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.796 -0.565 . . . . 0.0 111.753 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -59.79 -57.79 24.2 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.888 -1.132 . . . . 0.0 111.28 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.7 Cg_endo -69.85 -57.85 0.11 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 125.06 3.84 . . . . 0.0 111.078 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.35 -28.19 1.26 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.937 -0.477 . . . . 0.0 111.181 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 21' ' ' LEU . 84.0 mt -79.88 -43.36 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 0.0 110.124 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.797 0.332 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 t -62.83 -25.06 68.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -45.95 92.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.764 . . . . 0.0 109.72 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -66.4 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -0.771 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -32.54 73.95 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -37.99 86.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.23 -25.59 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.24 -44.06 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 109.236 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.58 -40.77 97.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.642 -0.661 . . . . 0.0 109.67 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.67 -23.6 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.616 -0.678 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.21 -37.11 86.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -84.97 -35.07 22.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.599 -0.688 . . . . 0.0 110.139 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.93 6.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.759 -0.588 . . . . 0.0 111.274 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.71 -53.87 35.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.596 -0.69 . . . . 0.0 111.767 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD13 ' A' ' 25' ' ' ILE . 5.5 mp -70.86 -12.32 61.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.692 -0.63 . . . . 0.0 112.031 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.2 t -59.94 -61.57 7.64 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 120.787 -1.196 . . . . 0.0 110.362 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 37.2 Cg_endo -71.13 -58.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.511 2.541 0 C-N-CA 124.941 3.76 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.58 -28.57 0.98 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.975 -0.453 . . . . 0.0 111.537 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 mp -66.15 -51.07 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.505 -0.747 . . . . 0.0 109.834 -179.653 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 10' ' ' ILE . 6.1 tp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -63.45 -17.6 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.845 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 t70 -69.94 -37.52 75.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 7' ' ' LEU . 2.3 mp -72.69 -54.6 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -0.778 . . . . 0.0 109.778 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -28.25 64.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -34.12 62.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 9' ' ' ASP . 63.0 t -71.08 -26.98 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.673 -0.642 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.5 -35.36 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -66.04 -42.81 89.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.609 -0.682 . . . . 0.0 109.861 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mm -78.79 -21.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -48.78 77.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -86.34 -27.64 24.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.496 -0.752 . . . . 0.0 110.353 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.26 65.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.487 -0.758 . . . . 0.0 110.657 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.73 -51.46 55.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.578 -0.701 . . . . 0.0 111.455 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD23 HD11 ' A' ' 25' ' ' ILE . 4.1 mp -82.42 -9.21 59.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.794 -0.566 . . . . 0.0 111.835 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -57.88 -53.32 66.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.978 -1.077 . . . . 0.0 111.265 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -73.67 -60.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 124.865 3.71 . . . . 0.0 110.879 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.08 -27.64 1.44 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.821 -0.549 . . . . 0.0 111.335 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.59 HD11 HD23 ' A' ' 21' ' ' LEU . 83.5 mt -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.631 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -178.774 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.847 0.356 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -69.68 -31.16 69.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.803 . . . . 0.0 109.789 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 13' ' ' VAL . 23.2 t70 -75.19 -41.97 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 110.574 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' ILE . 3.0 mp -63.43 -37.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.323 -0.861 . . . . 0.0 109.192 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -29.68 67.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.48 -0.763 . . . . 0.0 109.492 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -30.42 59.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.0 109.747 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.2 t -75.39 -30.5 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 0.0 109.292 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.13 -36.27 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.93 -42.45 97.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.61 -0.681 . . . . 0.0 109.196 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.46 -23.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.647 -0.658 . . . . 0.0 109.62 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -43.46 97.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.737 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.03 -27.92 20.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.532 -0.73 . . . . 0.0 110.095 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.77 -53.76 54.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.753 . . . . 0.0 110.117 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.33 73.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.292 0.568 . . . . 0.0 110.867 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.0 mp -80.31 -1.17 39.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.942 -0.474 . . . . 0.0 112.073 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.5 m -47.75 -47.38 62.04 Favored Pre-proline 0 N--CA 1.508 2.439 0 O-C-N 120.855 -1.153 . . . . 0.0 112.318 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.7 Cg_endo -78.95 -60.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.405 0 C-N-CA 124.881 3.721 . . . . 0.0 111.208 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.67 -27.7 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.801 -0.562 . . . . 0.0 111.576 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 21' ' ' LEU . 24.3 mm -75.5 -43.63 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.245 -0.909 . . . . 0.0 109.631 179.683 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 120.643 0.259 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 p -81.87 -30.0 32.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 m-20 -67.9 -39.49 83.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.672 -0.643 . . . . 0.0 109.759 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mt -71.5 -42.52 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.531 -0.731 . . . . 0.0 109.578 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -33.07 72.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -34.33 74.41 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 9' ' ' ASP . 46.0 t -68.84 -27.95 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.86 -33.49 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 108.981 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -69.14 -40.54 78.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.48 -32.38 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.35 -45.98 90.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.513 -0.742 . . . . 0.0 109.248 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -65.57 -36.23 83.15 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.482 0.658 . . . . 0.0 109.44 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -55.02 36.54 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.528 0.68 . . . . 0.0 110.284 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.84 92.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.588 0.708 . . . . 0.0 110.343 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.007 -0.433 . . . . 0.0 111.414 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -65.16 -59.59 9.62 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.0 Cg_endo -70.87 -56.99 0.11 Allowed 'Trans proline' 0 N--CA 1.51 2.482 0 C-N-CA 125.03 3.82 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -27.96 1.01 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.014 0.435 . . . . 0.0 111.241 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 25' ' ' ILE . 1.1 mm -61.23 -54.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.898 -179.616 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.99 0.424 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.1 m -58.61 -19.75 41.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.354 -0.841 . . . . 0.0 111.46 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 63.0 m-20 -66.69 -57.56 6.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.142 -0.974 . . . . 0.0 110.723 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 11' ' ' THR . 4.0 tt -59.74 -45.48 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.443 -0.785 . . . . 0.0 110.197 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.428 ' N ' HG23 ' A' ' 10' ' ' ILE . 2.4 m -58.6 -34.13 70.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.744 -0.597 . . . . 0.0 109.975 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.19 -36.18 74.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.489 -0.757 . . . . 0.0 109.175 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.4 t -68.96 -23.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.813 -0.554 . . . . 0.0 109.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.4 mt -83.99 -29.47 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -74.15 -41.72 61.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 0.0 109.701 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.48 -28.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 110.24 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -56.85 12.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.396 -0.815 . . . . 0.0 109.586 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.85 -30.17 68.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 110.028 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.39 -57.77 11.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 110.08 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -57.36 -53.57 56.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.566 -0.709 . . . . 0.0 111.004 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.12 1.44 27.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.816 -0.552 . . . . 0.0 111.678 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 17.4 t -49.11 -45.97 75.56 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.945 -1.097 . . . . 0.0 112.375 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 22' ' ' SER . 41.0 Cg_endo -78.31 -57.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.373 0 C-N-CA 124.608 3.538 . . . . 0.0 110.766 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.23 -28.32 2.96 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.872 -0.517 . . . . 0.0 111.311 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -83.98 -38.99 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.134 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.564 -0.71 . . . . 0.0 110.081 -179.681 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 120.939 0.4 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -65.0 -41.41 95.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 t0 -59.57 -40.08 86.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.667 -0.646 . . . . 0.0 109.895 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -67.88 -33.47 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.895 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -56.99 -50.65 72.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.271 -0.893 . . . . 0.0 110.179 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -61.57 -32.96 73.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 109.392 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.8 t -62.64 -37.21 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.681 -0.637 . . . . 0.0 109.534 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -19.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.624 -0.673 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -68.76 -49.86 55.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 109.685 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.7 mp -75.3 -32.84 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.428 -0.795 . . . . 0.0 109.868 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.7 97.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -28.27 63.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.17 84.9 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.81 0.815 . . . . 0.0 110.158 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -48.73 52.99 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.501 0.667 . . . . 0.0 111.207 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -84.55 -13.62 51.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.932 -0.48 . . . . 0.0 111.117 -178.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 39.9 m -51.04 -48.31 85.22 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.087 -1.008 . . . . 0.0 112.001 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.1 Cg_endo -70.79 -55.26 0.15 Allowed 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 124.265 3.31 . . . . 0.0 109.71 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.56 -28.25 0.91 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.508 HG13 HD23 ' A' ' 21' ' ' LEU . 41.0 mt -79.36 -44.06 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 0.0 109.67 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.498 1.931 0 O-C-N 121.329 -0.857 . . . . 0.0 109.991 -179.491 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 120.471 0.177 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -58.53 -45.24 89.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.024 -1.047 . . . . 0.0 110.199 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -44.73 93.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.735 . . . . 0.0 109.176 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.45 -22.63 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 14' ' ' ILE . 5.7 m -68.6 -42.16 78.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.33 -30.33 71.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.564 -0.71 . . . . 0.0 109.217 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.92 -24.26 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.695 -0.628 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 11' ' ' THR . 15.4 mt -84.28 -30.07 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.792 . . . . 0.0 109.801 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 tp -76.39 -34.59 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.74 0.781 . . . . 0.0 109.117 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -52.86 -45.74 67.54 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.924 -0.485 . . . . 0.0 110.236 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -29.64 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.548 -0.72 . . . . 0.0 109.867 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -56.95 -53.85 53.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.476 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.84 74.79 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.519 0.676 . . . . 0.0 110.824 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 17' ' ' TYR . 4.0 mt -65.83 -14.17 60.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.544 . . . . 0.0 111.355 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.6 t -67.27 -60.96 5.17 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 120.978 -1.076 . . . . 0.0 110.145 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 36.6 Cg_endo -68.98 -56.05 0.18 Allowed 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 125.072 3.848 . . . . 0.0 110.595 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.26 -28.58 1.33 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.933 -0.479 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 25' ' ' ILE . 17.8 mm -81.67 -41.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.48 -0.763 . . . . 0.0 109.166 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.0 m . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 109.811 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 7' ' ' LEU . 5.9 tp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.081 0.467 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -66.39 -23.44 66.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.163 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.61 -59.88 2.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.388 -0.82 . . . . 0.0 110.294 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 11' ' ' THR . 17.4 tt -56.95 -43.93 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.572 -0.705 . . . . 0.0 110.152 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.448 ' N ' HG23 ' A' ' 10' ' ' ILE . 21.7 m -61.58 -31.7 71.76 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -36.13 73.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.08 -32.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.68 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt -76.99 -26.09 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.629 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.62 -38.45 83.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.509 -0.744 . . . . 0.0 109.327 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -83.45 -23.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.709 . . . . 0.0 109.941 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.31 -48.66 78.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.863 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -81.55 -41.37 21.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.133 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.55 12.08 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.639 0.733 . . . . 0.0 111.376 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.63 -52.94 27.02 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.41 0.624 . . . . 0.0 110.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.0 mt -84.77 -11.05 56.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.931 -0.481 . . . . 0.0 111.174 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 16.2 t -50.62 -48.37 82.58 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.107 -0.996 . . . . 0.0 112.35 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.1 Cg_endo -69.1 -57.53 0.13 Allowed 'Trans proline' 0 N--CA 1.51 2.477 0 C-N-CA 124.383 3.389 . . . . 0.0 110.488 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.34 -28.26 1.96 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 111.109 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 mt -80.98 -41.68 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 109.426 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.546 -0.721 . . . . 0.0 109.908 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.921 0.391 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.9 p -66.97 -24.86 66.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.3 t70 -74.49 -42.67 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.336 -0.852 . . . . 0.0 110.187 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.74 -46.64 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.828 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -35.39 78.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 109.342 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.48 -34.88 78.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.7 t -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.7 mm -72.2 -24.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 109.753 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.94 -53.45 31.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.68 -23.39 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 110.224 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -64.36 0.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 109.526 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -22.41 63.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.426 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.04 -59.5 3.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.275 -0.89 . . . . 0.0 110.089 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.35 86.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.383 -0.823 . . . . 0.0 110.264 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 25' ' ' ILE . 9.1 mt -71.16 -22.46 62.05 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.445 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -51.55 -58.79 9.62 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.805 -1.185 . . . . 0.0 111.095 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' SER . 34.2 Cg_endo -66.81 -58.93 0.13 Allowed 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 124.93 3.753 . . . . 0.0 111.116 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.8 -27.58 3.09 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.818 -0.551 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 21' ' ' LEU . 87.9 mt -90.03 -32.52 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.297 -0.877 . . . . 0.0 110.037 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.3 -0.875 . . . . 0.0 110.465 -179.348 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.89 0.376 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -60.05 -19.54 53.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.303 -0.873 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.5 -36.8 81.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.002 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 mm -77.55 -40.11 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.436 -0.79 . . . . 0.0 110.098 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.4 m -63.73 -32.81 74.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 -39.51 75.09 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.1 t -62.28 -36.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 11' ' ' THR . 42.5 mt -72.38 -26.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.54 -60.22 4.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 16' ' ' ILE . 4.0 mp -73.7 -8.19 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.586 -0.696 . . . . 0.0 110.202 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.26 -30.02 57.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 0.0 108.717 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -25.92 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.68 -0.637 . . . . 0.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.44 -60.89 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.624 -0.673 . . . . 0.0 110.728 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.44 -47.84 66.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.639 -0.663 . . . . 0.0 111.379 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.2 tp -82.19 -12.76 57.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.881 -0.512 . . . . 0.0 111.453 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -49.33 -51.83 54.24 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.019 -1.051 . . . . 0.0 111.79 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -72.39 -55.36 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 124.795 3.664 . . . . 0.0 110.431 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.13 -27.6 2.45 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.017 -0.427 . . . . 0.0 111.063 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 21' ' ' LEU . 34.8 mt -73.14 -44.53 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.794 . . . . 0.0 109.378 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.288 -0.882 . . . . 0.0 110.332 -179.77 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.825 0.345 . . . . 0.0 110.215 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -59.92 -28.38 67.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.72 -38.0 89.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.731 . . . . 0.0 109.246 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 7' ' ' LEU . 65.1 mt -65.97 -36.36 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m -61.72 -37.64 84.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.525 -0.735 . . . . 0.0 109.136 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -32.06 73.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 -30.42 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.48 -32.96 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -65.14 -54.8 24.25 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.46 -18.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.662 -0.649 . . . . 0.0 109.36 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -67.2 -42.02 84.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 108.963 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.68 -30.84 69.6 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -52.13 66.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.654 0.74 . . . . 0.0 109.516 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -60.66 -47.98 83.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.447 0.642 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -76.75 -3.29 37.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.082 -0.386 . . . . 0.0 111.123 -179.107 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 3.6 m -40.65 -51.17 6.94 Favored Pre-proline 0 N--CA 1.51 2.557 0 O-C-N 121.328 -0.857 . . . . 0.0 113.061 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.6 Cg_endo -70.47 -56.71 0.12 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 124.572 3.514 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -47.54 -26.77 1.53 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.959 -0.463 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HD23 ' A' ' 21' ' ' LEU . 28.9 mt -77.12 -44.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.805 . . . . 0.0 109.04 179.842 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 120.929 0.395 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -27.17 66.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.076 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.3 m-20 -67.03 -37.32 83.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.206 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -70.28 -44.14 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 m -59.93 -24.71 64.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.94 -31.95 34.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.415 -0.803 . . . . 0.0 109.31 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.4 t -74.28 -26.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.95 -40.33 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.413 0.625 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -77.92 -26.57 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.58 -35.35 68.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -34.23 21.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.741 . . . . 0.0 110.178 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' HD13 ' A' ' 16' ' ' ILE . . . -58.03 -55.44 34.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.487 -0.758 . . . . 0.0 110.686 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.15 -47.85 71.5 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.05 -11.13 59.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.761 -0.587 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -54.34 -56.41 26.81 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.637 -1.289 . . . . 0.0 110.248 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 38.0 Cg_endo -74.41 -58.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 125.024 3.816 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.74 -29.13 1.76 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.929 -0.482 . . . . 0.0 111.376 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mm -74.13 -45.83 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.709 . . . . 0.0 110.608 -179.642 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.887 0.375 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -76.23 -27.4 56.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 0.0 110.544 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.5 m-20 -71.06 -48.68 51.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.772 . . . . 0.0 110.029 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.557 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.2 tt -62.1 -46.25 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.451 ' N ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -53.97 -35.94 62.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.66 -0.65 . . . . 0.0 110.746 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -33.99 72.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' ASP . 42.8 t -66.8 -29.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.098 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.557 HD12 ' O ' ' A' ' 10' ' ' ILE . 2.4 mp -76.43 -36.88 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.02 -42.22 98.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.11 -24.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.472 -0.768 . . . . 0.0 109.961 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.32 -53.43 58.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.61 -35.8 60.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.498 -0.751 . . . . 0.0 109.657 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.96 -45.92 15.9 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.859 0.838 . . . . 0.0 111.268 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.43 -52.07 49.4 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.297 0.57 . . . . 0.0 111.321 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -5.94 59.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.824 -0.547 . . . . 0.0 111.639 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 12.7 t -49.8 -47.14 80.31 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.066 -1.021 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -74.42 -56.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.301 3.334 . . . . 0.0 110.477 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -28.13 2.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.029 -0.419 . . . . 0.0 111.25 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.27 -43.13 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.361 -0.837 . . . . 0.0 109.526 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.774 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.861 0.362 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 t -58.36 -20.07 40.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.37 -0.831 . . . . 0.0 111.095 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -78.58 -46.67 18.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.128 -179.41 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 14' ' ' ILE . 22.8 mt -71.21 -18.43 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.812 . . . . 0.0 110.35 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -41.04 20.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.209 -0.932 . . . . 0.0 109.953 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.72 -30.24 67.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.506 -0.746 . . . . 0.0 109.678 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 9' ' ' ASP . 40.3 t -74.83 -36.71 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 109.703 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 10' ' ' ILE . 85.2 mt -77.21 -25.24 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.093 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -68.73 -58.34 4.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 108.801 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.93 -20.57 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.615 -0.678 . . . . 0.0 109.831 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.25 -51.33 64.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.36 -31.48 70.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.37 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -59.22 5.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.701 -0.625 . . . . 0.0 110.77 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.23 -48.06 83.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.441 -0.787 . . . . 0.0 111.244 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 25' ' ' ILE . 2.2 mm? -77.47 -9.19 58.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.878 -0.513 . . . . 0.0 111.68 -178.022 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.9 t -51.75 -56.87 17.44 Favored Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.777 -1.202 . . . . 0.0 111.071 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.6 Cg_endo -71.59 -55.14 0.13 Allowed 'Trans proline' 0 N--CA 1.512 2.586 0 C-N-CA 124.945 3.764 . . . . 0.0 110.454 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 21' ' ' LEU . . . -48.58 -26.41 2.21 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.913 -0.492 . . . . 0.0 111.113 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 HD12 ' A' ' 21' ' ' LEU . 32.1 mm -89.79 -34.96 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.414 -0.804 . . . . 0.0 109.46 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.333 -0.854 . . . . 0.0 110.104 -179.706 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.668 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.59 -6.95 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.643 -0.661 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -121.49 71.08 25.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.37 -51.68 0.08 OUTLIER 'Trans proline' 0 N--CA 1.509 2.434 1 C-N-CA 125.378 4.052 . . . . 0.0 109.787 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.409 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 28.4 t80 -55.42 -21.76 17.28 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -76.66 -31.97 57.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 111.184 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -47.47 7.67 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.912 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -78.98 -56.82 4.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.216 -0.927 . . . . 0.0 112.049 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -61.89 -22.39 65.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.433 -0.792 . . . . 0.0 111.075 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 11' ' ' THR . 3.9 tt -77.95 -47.22 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.16 -0.963 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.2 m -61.87 -33.42 74.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.764 -0.585 . . . . 0.0 109.773 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.87 -35.86 75.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 9' ' ' ASP . 69.2 t -66.48 -36.33 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mt -79.3 -18.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.207 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.22 -43.66 60.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.245 -0.909 . . . . 0.0 110.368 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.2 -22.25 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 0.0 110.753 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -71.78 -37.82 70.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.24 -0.912 . . . . 0.0 109.63 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.91 -28.71 20.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.511 -0.743 . . . . 0.0 109.672 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.69 -55.08 16.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.619 -0.675 . . . . 0.0 110.128 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.69 72.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.796 -0.565 . . . . 0.0 111.284 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.05 -16.75 61.48 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.706 -0.621 . . . . 0.0 111.617 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 2.8 t -56.61 -57.79 21.34 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 120.958 -1.089 . . . . 0.0 110.913 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.5 Cg_endo -68.3 -55.3 0.25 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 124.976 3.784 . . . . 0.0 110.674 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.61 -27.95 1.31 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 111.202 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.19 -41.76 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.482 -0.762 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -64.74 0.79 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 109.95 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -58.86 143.53 47.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.7 . . . . 0.0 110.172 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.47 -162.32 24.97 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.58 48.11 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -67.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.344 -1.092 . . . . 0.0 109.293 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -64.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.666 . . . . 0.0 109.4 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.39 130.32 10.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.43 -37.58 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.559 -0.965 . . . . 0.0 109.392 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.442 179.923 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.649 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.477 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.18 -74.43 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.703 . . . . 0.0 109.132 . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' ' 2' ' ' ARG . 16.2 p90 -137.26 55.48 10.16 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.501 -0.75 . . . . 0.0 110.483 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 39.9 Cg_endo -79.9 -80.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.837 3.691 . . . . 0.0 110.177 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -66.11 -18.84 65.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 109.956 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.58 -34.77 76.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' LEU . 31.1 tp -60.15 -32.55 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.807 -0.558 . . . . 0.0 110.365 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.8 p -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -73.72 -29.96 62.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 109.653 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.22 -35.5 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.935 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.1 p -60.49 -47.63 85.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.02 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.8 t70 -61.34 -44.85 96.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.717 . . . . 0.0 109.966 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.5 t -62.83 -27.19 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.596 -0.69 . . . . 0.0 109.913 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.935 HD12 ' HA ' ' A' ' 11' ' ' THR . 25.2 mt -67.71 -37.32 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.48 -0.763 . . . . 0.0 109.1 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.19 -54.63 41.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.764 . . . . 0.0 109.412 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.9 mp -73.61 -10.05 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.678 -0.639 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -72.25 -70.02 0.36 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.614 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.93 -31.72 70.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.091 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.74 54.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 110.682 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.64 75.97 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.603 -0.686 . . . . 0.0 111.259 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -19.99 62.25 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.889 -0.507 . . . . 0.0 111.574 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.403 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -57.33 -58.7 16.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.091 -1.006 . . . . 0.0 111.264 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.9 Cg_endo -69.87 -55.91 0.16 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 125.144 3.896 . . . . 0.0 110.62 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -27.58 2.29 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.137 0.494 . . . . 0.0 110.6 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.17 -35.74 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.418 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 m -56.82 -38.97 73.34 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.6 104.35 8.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.486 -0.759 . . . . 0.0 109.46 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.9 102.07 2.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.34 71.63 0.82 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.82 131.07 48.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.962 . . . . 0.0 109.583 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tp -86.33 -33.92 20.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.489 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.16 161.99 27.66 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.1 -40.63 62.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.976 . . . . 0.0 109.516 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.379 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.637 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 -113.54 -21.77 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -155.13 80.8 4.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.784 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.68 -72.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 1 C-N-CA 125.355 4.037 . . . . 0.0 110.626 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.77 -18.08 38.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.704 -0.622 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.0 -40.31 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.31 -30.25 61.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.581 -0.699 . . . . 0.0 110.153 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -20.9 37.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.492 -0.755 . . . . 0.0 111.095 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -74.76 -61.8 1.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.782 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 14' ' ' ILE . 54.7 mt -62.69 -22.39 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.49 -0.756 . . . . 0.0 110.366 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -69.03 -49.15 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.313 -0.867 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.98 -37.19 81.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.44 -0.787 . . . . 0.0 110.107 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.15 -42.02 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.461 -0.774 . . . . 0.0 109.735 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 10' ' ' ILE . 66.1 mt -66.89 -28.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.687 . . . . 0.0 109.502 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.468 -0.77 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.7 mt -75.65 -25.62 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.7 . . . . 0.0 109.869 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.13 -39.71 95.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.349 -0.844 . . . . 0.0 110.073 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.03 -28.31 27.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.424 -0.798 . . . . 0.0 110.265 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.82 -49.33 73.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.711 . . . . 0.0 110.891 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.69 -51.38 50.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.676 -0.64 . . . . 0.0 111.585 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 24' ' ' ALA . 4.3 mt -83.83 -9.24 58.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.896 -0.503 . . . . 0.0 111.634 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -47.83 -48.19 61.44 Favored Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.091 -1.006 . . . . 0.0 112.457 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -75.01 -60.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 124.547 3.498 . . . . 0.0 110.771 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -46.72 -26.78 1.0 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.92 -0.488 . . . . 0.0 111.411 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 21' ' ' LEU . 23.5 mt -64.58 -53.16 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.392 -0.818 . . . . 0.0 109.23 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 m -72.24 -67.38 0.55 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 109.891 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.44 165.63 21.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 109.599 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.9 107.59 1.78 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.3 20.63 46.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -90.45 102.4 15.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.273 -1.134 . . . . 0.0 109.227 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.13 -42.74 62.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.629 -0.669 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' HD12 ' A' ' 30' ' ' LEU . . . -100.14 133.94 11.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -42.33 89.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.533 -0.98 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.58 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.662 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -121.28 -10.69 8.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.598 -0.689 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.712 ' CD2' HD21 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 67.16 65.2 0.7 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.93 -1.106 . . . . 0.0 109.134 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.7 Cg_endo -93.61 -79.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 1 C-N-CA 125.929 4.42 . . . . 0.0 112.044 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -89.26 -14.03 36.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.269 -0.895 . . . . 0.0 111.272 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -55.17 -21.92 15.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.712 HD21 ' CD2' ' A' ' 3' ' ' TYR . 4.5 mm? -65.56 -42.67 91.56 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.497 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -58.18 -31.22 67.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.3 t70 -64.09 -36.38 83.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 7' ' ' LEU . 8.6 mt -68.92 -44.28 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 110.07 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -56.93 -42.41 79.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 0.0 110.271 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -30.41 71.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.433 -0.792 . . . . 0.0 109.361 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.2 t -74.86 -27.73 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.706 . . . . 0.0 109.755 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.43 -30.4 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.41 -41.8 75.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.585 -0.697 . . . . 0.0 109.737 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.9 mt -75.33 -20.11 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.276 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.32 -56.81 6.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.907 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -25.31 64.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.526 -0.734 . . . . 0.0 110.148 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -54.59 20.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.476 -0.765 . . . . 0.0 110.586 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.77 54.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.56 -0.712 . . . . 0.0 111.629 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 25' ' ' ILE . 4.5 mp -83.04 -15.36 51.35 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.883 -0.51 . . . . 0.0 111.71 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.404 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -51.18 -52.32 59.95 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.841 -1.162 . . . . 0.0 111.243 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 22' ' ' SER . 39.6 Cg_endo -77.94 -58.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.107 3.871 . . . . 0.0 110.718 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.42 0.83 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.922 -0.486 . . . . 0.0 111.606 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.6 mp -84.08 -47.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.4 m -82.53 -68.91 0.66 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.63 -79.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 109.726 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.43 112.44 0.24 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.19 -53.3 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.25 -24.03 67.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -1.037 . . . . 0.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 tp -57.96 -57.0 14.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.63 37.29 0.05 OUTLIER Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.784 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.57 -54.21 3.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -1.085 . . . . 0.0 109.501 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 pttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.559 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.655 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.5 -52.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.591 -0.693 . . . . 0.0 109.44 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 55.33 93.08 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.604 -0.685 . . . . 0.0 110.3 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -87.53 -76.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 1 C-N-CA 125.526 4.151 . . . . 0.0 110.889 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -19.23 61.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -62.11 -49.83 74.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.15 -45.67 14.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.952 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -62.21 -14.36 37.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -77.96 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.023 -1.048 . . . . 0.0 110.414 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.2 mt -60.42 -30.84 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.452 -0.78 . . . . 0.0 110.682 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 m -58.65 -45.54 89.11 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -35.69 80.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.0 t -70.3 -24.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.052 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.8 -34.59 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.337 -0.852 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.21 -52.81 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 109.826 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.87 -27.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -60.88 -36.6 79.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 109.598 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.46 -22.93 35.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.978 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.13 67.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.13 60.83 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.496 0.665 . . . . 0.0 110.947 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 21' ' ' LEU . 3.8 mm? -85.05 -12.28 53.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.927 -0.483 . . . . 0.0 111.595 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.409 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 2.6 t -52.14 -50.21 80.21 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.886 -1.134 . . . . 0.0 111.304 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.2 Cg_endo -76.0 -62.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.422 0 C-N-CA 124.668 3.579 . . . . 0.0 111.059 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.93 -27.09 1.14 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.803 -0.561 . . . . 0.0 111.386 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.13 -41.34 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.417 -0.802 . . . . 0.0 109.971 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 m -70.83 -67.08 0.53 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.33 111.33 1.33 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.425 -0.797 . . . . 0.0 109.964 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 150.35 160.55 9.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.61 -74.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -84.04 117.83 23.67 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.547 -0.973 . . . . 0.0 109.6 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 31' ' ' LEU . 1.3 mm? -62.2 -58.61 7.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.345 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.47 162.55 49.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.45 -56.68 7.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.98 . . . . 0.0 109.269 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.408 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.605 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -130.13 -63.46 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.551 -0.718 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -140.31 66.73 30.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.54 -77.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.791 1 C-N-CA 125.521 4.147 . . . . 0.0 110.524 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -75.32 -26.25 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.494 -0.753 . . . . 0.0 110.018 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -65.89 -23.21 66.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.55 -24.89 38.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.31 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 -43.01 99.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 13' ' ' VAL . 9.8 t70 -65.49 -25.96 67.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . 39.9 mm -65.25 -50.61 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.332 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.3 m -56.58 -39.03 72.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.379 -0.826 . . . . 0.0 109.852 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -35.91 80.52 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 9' ' ' ASP . 58.3 t -62.62 -43.8 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 10' ' ' ILE . 5.2 mp -84.55 -3.52 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 110.039 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 t80 -85.05 -37.86 19.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.385 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.7 mt -86.76 -37.51 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.638 -0.664 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -53.42 38.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.257 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -68.74 -29.41 67.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.647 . . . . 0.0 109.81 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 15' ' ' PHE . . . -54.38 -52.05 62.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.3 -0.875 . . . . 0.0 110.876 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.61 -56.66 4.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.72 -50.02 66.34 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.348 -0.845 . . . . 0.0 112.793 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 47.1 t -38.8 -52.31 3.69 Favored Pre-proline 0 N--CA 1.515 2.797 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 22' ' ' SER . 35.0 Cg_endo -66.83 -56.43 0.25 Allowed 'Trans proline' 0 N--CA 1.511 2.526 0 C-N-CA 124.199 3.266 . . . . 0.0 110.387 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.38 -27.81 1.8 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.918 -0.489 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 25' ' ' ILE . 28.9 mm -64.95 -65.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.5 m -81.07 -64.4 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 0.0 109.279 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -73.06 125.05 26.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.398 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -172.4 29.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.75 44.37 0.26 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -90.57 179.89 5.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.557 -0.967 . . . . 0.0 109.628 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.22 -28.37 67.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.679 -0.638 . . . . 0.0 109.589 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.637 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -57.06 110.68 2.33 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.32 -49.37 69.85 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.559 -0.965 . . . . 0.0 110.386 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.501 179.756 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.681 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -133.79 -37.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.713 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -155.89 82.84 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.405 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.95 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.102 1 C-N-CA 125.403 4.068 . . . . 0.0 110.79 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.31 -24.91 67.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.779 -0.575 . . . . 0.0 110.143 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -80.39 -68.24 0.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.318 -0.864 . . . . 0.0 111.351 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -21.75 65.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.461 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -57.41 -26.86 61.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 110.611 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.74 -58.51 6.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.546 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.18 -19.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.718 -0.614 . . . . 0.0 109.882 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -74.99 -38.87 61.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.738 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -66.92 -41.07 87.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.276 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.15 -48.62 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.12 -17.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -67.79 -52.0 42.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 0.0 109.825 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.2 mp -77.93 -23.29 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.455 -0.778 . . . . 0.0 110.126 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.34 -40.2 85.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 109.89 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -31.21 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.506 -0.746 . . . . 0.0 109.649 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.54 44.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.057 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.33 82.8 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.371 0.605 . . . . 0.0 111.305 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 2.0 mm? -72.1 -17.41 61.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.796 -0.565 . . . . 0.0 111.753 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -59.79 -57.79 24.2 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.888 -1.132 . . . . 0.0 111.28 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.7 Cg_endo -69.85 -57.85 0.11 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 125.06 3.84 . . . . 0.0 111.078 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.35 -28.19 1.26 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.937 -0.477 . . . . 0.0 111.181 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 21' ' ' LEU . 84.0 mt -79.88 -43.36 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.2 m -59.67 -30.25 68.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 0.0 110.124 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.37 179.08 2.14 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.794 . . . . 0.0 109.553 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.74 -50.2 66.17 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.33 85.6 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -86.28 158.27 19.73 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.673 -0.898 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 31' ' ' LEU . 4.1 mm? -84.83 -54.94 4.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.549 -0.719 . . . . 0.0 109.532 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.9 118.62 11.67 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.25 -39.82 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.62 -0.93 . . . . 0.0 109.394 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.3 mttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.402 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.666 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 71.81 115.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.916 0.865 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -164.96 71.87 1.46 Allowed Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -88.24 -63.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 1 C-N-CA 125.667 4.245 . . . . 0.0 110.292 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -50.99 -24.53 3.76 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.825 -0.547 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -82.99 -38.42 22.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.878 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.62 -16.77 60.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 110.147 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 t -62.83 -25.06 68.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -45.95 92.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.764 . . . . 0.0 109.72 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -66.4 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -0.771 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -32.54 73.95 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -37.99 86.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.23 -25.59 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.24 -44.06 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 109.236 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.58 -40.77 97.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.642 -0.661 . . . . 0.0 109.67 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.67 -23.6 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.616 -0.678 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.21 -37.11 86.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -84.97 -35.07 22.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.599 -0.688 . . . . 0.0 110.139 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.93 6.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.759 -0.588 . . . . 0.0 111.274 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.71 -53.87 35.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.596 -0.69 . . . . 0.0 111.767 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD13 ' A' ' 25' ' ' ILE . 5.5 mp -70.86 -12.32 61.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.692 -0.63 . . . . 0.0 112.031 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.2 t -59.94 -61.57 7.64 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 120.787 -1.196 . . . . 0.0 110.362 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 37.2 Cg_endo -71.13 -58.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.511 2.541 0 C-N-CA 124.941 3.76 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.58 -28.57 0.98 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.975 -0.453 . . . . 0.0 111.537 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 mp -66.15 -51.07 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m -70.15 -65.67 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.505 -0.747 . . . . 0.0 109.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.4 106.7 13.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.661 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.45 -136.44 47.45 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.2 -15.88 7.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.78 49.84 1.79 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -1.188 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mt -90.38 -72.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.45 82.77 0.35 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -62.31 -29.05 70.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 109.615 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.626 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.455 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -83.79 -87.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.615 -0.678 . . . . 0.0 109.421 . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 2' ' ' ARG . 14.4 p90 -163.9 61.9 1.0 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 39.5 Cg_endo -80.47 -77.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.104 1 C-N-CA 125.302 4.001 . . . . 0.0 111.147 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.39 -35.57 75.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.502 -0.749 . . . . 0.0 110.516 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.57 -29.29 69.93 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 10' ' ' ILE . 6.1 tp -90.37 -28.37 18.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.56 -0.713 . . . . 0.0 109.957 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -63.45 -17.6 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.845 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 t70 -69.94 -37.52 75.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 7' ' ' LEU . 2.3 mp -72.69 -54.6 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -0.778 . . . . 0.0 109.778 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -28.25 64.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -34.12 62.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 9' ' ' ASP . 63.0 t -71.08 -26.98 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.673 -0.642 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.5 -35.36 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -66.04 -42.81 89.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.609 -0.682 . . . . 0.0 109.861 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mm -78.79 -21.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -48.78 77.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -86.34 -27.64 24.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.496 -0.752 . . . . 0.0 110.353 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.26 65.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.487 -0.758 . . . . 0.0 110.657 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.73 -51.46 55.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.578 -0.701 . . . . 0.0 111.455 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD23 HD11 ' A' ' 25' ' ' ILE . 4.1 mp -82.42 -9.21 59.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.794 -0.566 . . . . 0.0 111.835 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -57.88 -53.32 66.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.978 -1.077 . . . . 0.0 111.265 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -73.67 -60.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 124.865 3.71 . . . . 0.0 110.879 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.08 -27.64 1.44 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.821 -0.549 . . . . 0.0 111.335 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.59 HD11 HD23 ' A' ' 21' ' ' LEU . 83.5 mt -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.631 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -62.67 -61.52 2.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.02 90.1 0.44 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.83 130.32 10.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.82 73.81 0.03 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.5 mm? -72.6 123.16 22.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.573 -0.957 . . . . 0.0 109.294 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.81 -31.74 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 147.6 11.17 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -48.44 35.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.954 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.431 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . 0.505 ' H1 ' ' HB2' ' A' ' 6' ' ' TYR . . . . . . . . 0 C--O 1.217 -0.636 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -51.62 12.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 109.318 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER 177.89 -51.15 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.715 . . . . 0.0 109.933 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 40.1 Cg_endo -89.03 -67.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.907 1 C-N-CA 125.403 4.069 . . . . 0.0 110.919 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -48.78 -26.11 2.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.613 -0.679 . . . . 0.0 110.995 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.505 ' HB2' ' H1 ' ' A' ' 1' ' ' ACE . 63.4 t80 -61.62 -59.43 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.451 -0.78 . . . . 0.0 109.993 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -29.14 67.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.569 -0.707 . . . . 0.0 110.604 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -69.68 -31.16 69.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.803 . . . . 0.0 109.789 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 13' ' ' VAL . 23.2 t70 -75.19 -41.97 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 110.574 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' ILE . 3.0 mp -63.43 -37.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.323 -0.861 . . . . 0.0 109.192 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -29.68 67.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.48 -0.763 . . . . 0.0 109.492 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -30.42 59.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.0 109.747 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.2 t -75.39 -30.5 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 0.0 109.292 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.13 -36.27 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.93 -42.45 97.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.61 -0.681 . . . . 0.0 109.196 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.46 -23.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.647 -0.658 . . . . 0.0 109.62 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -43.46 97.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.737 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.03 -27.92 20.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.532 -0.73 . . . . 0.0 110.095 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.77 -53.76 54.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.753 . . . . 0.0 110.117 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.33 73.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.292 0.568 . . . . 0.0 110.867 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.0 mp -80.31 -1.17 39.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.942 -0.474 . . . . 0.0 112.073 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.5 m -47.75 -47.38 62.04 Favored Pre-proline 0 N--CA 1.508 2.439 0 O-C-N 120.855 -1.153 . . . . 0.0 112.318 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.7 Cg_endo -78.95 -60.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.405 0 C-N-CA 124.881 3.721 . . . . 0.0 111.208 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.67 -27.7 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.801 -0.562 . . . . 0.0 111.576 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 21' ' ' LEU . 24.3 mm -75.5 -43.63 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 m -53.25 -50.86 63.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.245 -0.909 . . . . 0.0 109.631 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -90.07 111.2 22.24 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.6 52.1 3.66 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.47 -72.95 0.02 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.2 mp -81.34 92.35 6.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.995 . . . . 0.0 109.556 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.09 -37.75 88.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.503 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.14 112.44 1.09 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -55.14 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.967 . . . . 0.0 109.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.464 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.655 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -69.1 -38.58 79.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.28 71.86 3.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -90.73 -64.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.857 4.371 . . . . 0.0 111.766 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.42 -22.75 45.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.796 -0.565 . . . . 0.0 111.481 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -82.47 -61.88 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.061 -1.024 . . . . 0.0 110.366 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.08 -8.81 48.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.656 -0.653 . . . . 0.0 110.613 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 p -81.87 -30.0 32.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 m-20 -67.9 -39.49 83.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.672 -0.643 . . . . 0.0 109.759 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mt -71.5 -42.52 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.531 -0.731 . . . . 0.0 109.578 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -33.07 72.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -34.33 74.41 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 9' ' ' ASP . 46.0 t -68.84 -27.95 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.86 -33.49 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 108.981 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -69.14 -40.54 78.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.48 -32.38 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.35 -45.98 90.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.513 -0.742 . . . . 0.0 109.248 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -65.57 -36.23 83.15 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.482 0.658 . . . . 0.0 109.44 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -55.02 36.54 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.528 0.68 . . . . 0.0 110.284 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.84 92.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.588 0.708 . . . . 0.0 110.343 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.007 -0.433 . . . . 0.0 111.414 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -65.16 -59.59 9.62 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.0 Cg_endo -70.87 -56.99 0.11 Allowed 'Trans proline' 0 N--CA 1.51 2.482 0 C-N-CA 125.03 3.82 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -27.96 1.01 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.014 0.435 . . . . 0.0 111.241 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 25' ' ' ILE . 1.1 mm -61.23 -54.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 m -83.08 -64.45 1.17 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.898 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -60.34 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.35 -107.78 0.47 Allowed Glycine 0 N--CA 1.5 2.952 0 O-C-N 120.988 -1.07 . . . . 0.0 110.685 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.07 -64.99 0.23 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.0 mt -86.26 178.93 7.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.604 -0.939 . . . . 0.0 109.076 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.56 -52.7 4.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.577 -0.702 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 103.93 0.6 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.01 -48.52 65.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.627 -0.925 . . . . 0.0 109.455 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mttt . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.69 -179.813 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.63 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -131.6 -57.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.613 -0.679 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -144.91 76.87 13.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.53 -51.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.51 2.477 1 C-N-CA 125.757 4.305 . . . . 0.0 110.507 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -49.97 -23.61 2.11 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.32 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.436 ' HB2' ' CD2' ' A' ' 3' ' ' TYR . 5.5 t80 -76.32 -39.92 52.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.178 -0.951 . . . . 0.0 110.205 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.87 -54.72 41.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.91 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.1 m -58.61 -19.75 41.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.354 -0.841 . . . . 0.0 111.46 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 63.0 m-20 -66.69 -57.56 6.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.142 -0.974 . . . . 0.0 110.723 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 11' ' ' THR . 4.0 tt -59.74 -45.48 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.443 -0.785 . . . . 0.0 110.197 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.428 ' N ' HG23 ' A' ' 10' ' ' ILE . 2.4 m -58.6 -34.13 70.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.744 -0.597 . . . . 0.0 109.975 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.19 -36.18 74.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.489 -0.757 . . . . 0.0 109.175 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.4 t -68.96 -23.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.813 -0.554 . . . . 0.0 109.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.4 mt -83.99 -29.47 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -74.15 -41.72 61.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 0.0 109.701 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.48 -28.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 110.24 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -56.85 12.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.396 -0.815 . . . . 0.0 109.586 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.85 -30.17 68.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 110.028 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.39 -57.77 11.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 110.08 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -57.36 -53.57 56.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.566 -0.709 . . . . 0.0 111.004 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.12 1.44 27.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.816 -0.552 . . . . 0.0 111.678 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 17.4 t -49.11 -45.97 75.56 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.945 -1.097 . . . . 0.0 112.375 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 22' ' ' SER . 41.0 Cg_endo -78.31 -57.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.373 0 C-N-CA 124.608 3.538 . . . . 0.0 110.766 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.23 -28.32 2.96 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.872 -0.517 . . . . 0.0 111.311 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -83.98 -38.99 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.134 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -60.64 -28.63 68.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.564 -0.71 . . . . 0.0 110.081 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.95 170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.33 -112.1 0.1 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.84 35.75 1.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -53.06 6.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.96 . . . . 0.0 109.276 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tp -71.89 -34.96 69.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.67 -0.644 . . . . 0.0 109.587 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.31 169.71 43.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -59.38 -44.0 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.489 -1.007 . . . . 0.0 109.767 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.452 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.681 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -154.04 -83.9 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.71 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.2 t80 -101.21 -46.68 0.2 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 111.928 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 41.4 Cg_endo -90.26 -70.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 125.106 3.871 . . . . 0.0 111.786 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -49.79 -24.92 2.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.568 -0.708 . . . . 0.0 111.545 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -90.12 -33.06 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.437 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -24.05 63.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -65.0 -41.41 95.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 t0 -59.57 -40.08 86.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.667 -0.646 . . . . 0.0 109.895 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -67.88 -33.47 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.895 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -56.99 -50.65 72.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.271 -0.893 . . . . 0.0 110.179 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -61.57 -32.96 73.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 109.392 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.8 t -62.64 -37.21 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.681 -0.637 . . . . 0.0 109.534 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -19.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.624 -0.673 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -68.76 -49.86 55.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 109.685 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.7 mp -75.3 -32.84 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.428 -0.795 . . . . 0.0 109.868 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.7 97.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -28.27 63.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.17 84.9 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.81 0.815 . . . . 0.0 110.158 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -48.73 52.99 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.501 0.667 . . . . 0.0 111.207 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -84.55 -13.62 51.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.932 -0.48 . . . . 0.0 111.117 -178.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 39.9 m -51.04 -48.31 85.22 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.087 -1.008 . . . . 0.0 112.001 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.1 Cg_endo -70.79 -55.26 0.15 Allowed 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 124.265 3.31 . . . . 0.0 109.71 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.56 -28.25 0.91 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.508 HG13 HD23 ' A' ' 21' ' ' LEU . 41.0 mt -79.36 -44.06 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 0.0 109.67 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -70.07 -65.34 0.74 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.329 -0.857 . . . . 0.0 109.991 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.32 143.26 6.52 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.6 -0.688 . . . . 0.0 110.488 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.34 -134.02 1.28 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.77 -9.2 78.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.72 86.44 2.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.124 -1.221 . . . . 0.0 109.497 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.5 -31.37 32.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 109.192 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.86 -161.02 14.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -80.24 -52.84 7.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.593 -0.945 . . . . 0.0 109.434 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.583 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.671 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -110.69 -9.69 14.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.693 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CZ ' ' CD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -130.07 70.88 82.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.414 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -82.95 -75.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 125.056 3.838 . . . . 0.0 110.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -77.07 -30.38 55.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.61 -13.4 62.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -13.82 48.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -58.53 -45.24 89.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.024 -1.047 . . . . 0.0 110.199 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -44.73 93.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.735 . . . . 0.0 109.176 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.45 -22.63 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 14' ' ' ILE . 5.7 m -68.6 -42.16 78.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.33 -30.33 71.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.564 -0.71 . . . . 0.0 109.217 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.92 -24.26 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.695 -0.628 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 11' ' ' THR . 15.4 mt -84.28 -30.07 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.792 . . . . 0.0 109.801 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 tp -76.39 -34.59 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.74 0.781 . . . . 0.0 109.117 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -52.86 -45.74 67.54 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.924 -0.485 . . . . 0.0 110.236 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -29.64 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.548 -0.72 . . . . 0.0 109.867 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -56.95 -53.85 53.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.476 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.84 74.79 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.519 0.676 . . . . 0.0 110.824 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 17' ' ' TYR . 4.0 mt -65.83 -14.17 60.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.544 . . . . 0.0 111.355 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.6 t -67.27 -60.96 5.17 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 120.978 -1.076 . . . . 0.0 110.145 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 36.6 Cg_endo -68.98 -56.05 0.18 Allowed 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 125.072 3.848 . . . . 0.0 110.595 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.26 -28.58 1.33 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.933 -0.479 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 25' ' ' ILE . 17.8 mm -81.67 -41.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.48 -0.763 . . . . 0.0 109.166 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.0 m -72.03 -69.46 0.39 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 109.811 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -50.8 161.42 0.35 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.35 -0.844 . . . . 0.0 110.599 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 -130.18 2.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.8 39.08 96.33 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.0 114.82 4.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.675 -0.897 . . . . 0.0 109.806 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.49 -39.28 16.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 0.0 109.229 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.13 158.84 30.9 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -77.68 -35.7 52.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.948 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.55 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . 0.564 ' H1 ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 C--O 1.217 -0.64 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.71 -41.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.561 -0.712 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.413 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -178.39 -51.78 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.0 109.845 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 38.9 Cg_endo -88.81 -71.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 125.162 3.908 . . . . 0.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -52.64 -24.1 7.81 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CD1' ' H1 ' ' A' ' 1' ' ' ACE . 18.5 t80 -72.23 -45.35 60.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 109.938 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 7' ' ' LEU . 5.9 tp -64.77 -42.91 94.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.597 -0.689 . . . . 0.0 109.954 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -66.39 -23.44 66.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.163 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.61 -59.88 2.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.388 -0.82 . . . . 0.0 110.294 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 11' ' ' THR . 17.4 tt -56.95 -43.93 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.572 -0.705 . . . . 0.0 110.152 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.448 ' N ' HG23 ' A' ' 10' ' ' ILE . 21.7 m -61.58 -31.7 71.76 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -36.13 73.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.08 -32.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.68 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt -76.99 -26.09 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.629 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.62 -38.45 83.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.509 -0.744 . . . . 0.0 109.327 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -83.45 -23.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.709 . . . . 0.0 109.941 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.31 -48.66 78.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.863 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -81.55 -41.37 21.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.133 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.55 12.08 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.639 0.733 . . . . 0.0 111.376 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.63 -52.94 27.02 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.41 0.624 . . . . 0.0 110.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.0 mt -84.77 -11.05 56.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.931 -0.481 . . . . 0.0 111.174 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 16.2 t -50.62 -48.37 82.58 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.107 -0.996 . . . . 0.0 112.35 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.1 Cg_endo -69.1 -57.53 0.13 Allowed 'Trans proline' 0 N--CA 1.51 2.477 0 C-N-CA 124.383 3.389 . . . . 0.0 110.488 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.34 -28.26 1.96 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 111.109 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 mt -80.98 -41.68 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 109.426 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -59.88 -27.64 66.87 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.546 -0.721 . . . . 0.0 109.908 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.41 146.61 48.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 109.419 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 166.67 58.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.78 -66.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.06 122.65 31.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.955 . . . . 0.0 109.076 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.98 -44.02 12.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.75 127.76 0.9 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.4 -46.28 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.664 -0.903 . . . . 0.0 109.337 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.532 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -73.54 -54.71 7.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.629 . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 63.4 m-85 -156.79 82.12 3.33 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -79.98 -82.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.226 3.95 . . . . 0.0 110.676 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.71 -25.41 61.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 109.747 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.25 -28.5 69.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.411 -0.806 . . . . 0.0 109.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.5 tt -67.12 -28.9 68.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 109.995 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.9 p -66.97 -24.86 66.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.3 t70 -74.49 -42.67 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.336 -0.852 . . . . 0.0 110.187 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.74 -46.64 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.828 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -35.39 78.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 109.342 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.48 -34.88 78.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.7 t -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.7 mm -72.2 -24.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 109.753 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.94 -53.45 31.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.68 -23.39 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 110.224 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -64.36 0.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 109.526 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -22.41 63.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.426 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.04 -59.5 3.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.275 -0.89 . . . . 0.0 110.089 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.35 86.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.383 -0.823 . . . . 0.0 110.264 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 25' ' ' ILE . 9.1 mt -71.16 -22.46 62.05 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.445 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -51.55 -58.79 9.62 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.805 -1.185 . . . . 0.0 111.095 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' SER . 34.2 Cg_endo -66.81 -58.93 0.13 Allowed 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 124.93 3.753 . . . . 0.0 111.116 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.8 -27.58 3.09 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.818 -0.551 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 21' ' ' LEU . 87.9 mt -90.03 -32.52 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.297 -0.877 . . . . 0.0 110.037 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 m -56.74 -50.1 73.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.3 -0.875 . . . . 0.0 110.465 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -86.01 -51.75 6.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.87 -130.02 8.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.37 62.63 0.03 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 117.99 12.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.981 . . . . 0.0 108.796 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.62 -68.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.545 -0.722 . . . . 0.0 109.768 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.87 160.62 50.46 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.51 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.923 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.7 mttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.495 -179.848 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.627 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -89.1 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 173.6 -52.5 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.015 -1.053 . . . . 0.0 109.919 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 41.4 Cg_endo -90.18 -74.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 125.45 4.1 . . . . 0.0 111.495 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.6 22.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 110.649 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -59.68 -53.85 53.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.317 -0.864 . . . . 0.0 110.209 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.8 mt -74.84 -23.64 58.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -60.05 -19.54 53.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.303 -0.873 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.5 -36.8 81.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.002 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 mm -77.55 -40.11 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.436 -0.79 . . . . 0.0 110.098 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.4 m -63.73 -32.81 74.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 -39.51 75.09 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.1 t -62.28 -36.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 11' ' ' THR . 42.5 mt -72.38 -26.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.54 -60.22 4.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.572 ' H ' HD12 ' A' ' 16' ' ' ILE . 4.0 mp -73.7 -8.19 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.586 -0.696 . . . . 0.0 110.202 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.26 -30.02 57.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 0.0 108.717 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -25.92 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.68 -0.637 . . . . 0.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.44 -60.89 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.624 -0.673 . . . . 0.0 110.728 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.44 -47.84 66.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.639 -0.663 . . . . 0.0 111.379 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.2 tp -82.19 -12.76 57.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.881 -0.512 . . . . 0.0 111.453 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -49.33 -51.83 54.24 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.019 -1.051 . . . . 0.0 111.79 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -72.39 -55.36 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 124.795 3.664 . . . . 0.0 110.431 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.13 -27.6 2.45 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.017 -0.427 . . . . 0.0 111.063 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 21' ' ' LEU . 34.8 mt -73.14 -44.53 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.794 . . . . 0.0 109.378 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m -54.92 -33.36 62.1 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.288 -0.882 . . . . 0.0 110.332 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -178.65 0.98 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.484 -0.76 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.07 -98.4 0.46 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.99 43.15 0.29 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.61 -44.22 91.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.942 . . . . 0.0 109.378 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tp -74.72 -66.39 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.635 -0.666 . . . . 0.0 109.383 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.63 139.01 0.04 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.15 -55.89 4.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.937 . . . . 0.0 109.699 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.536 -179.836 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.641 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.66 -36.86 3.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 56.11 92.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.115 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.41 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 1 C-N-CA 125.309 4.006 . . . . 0.0 110.675 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.51 -25.26 64.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.094 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -60.92 -44.38 97.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 110.327 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.75 -23.43 25.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.215 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -59.92 -28.38 67.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.72 -38.0 89.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.731 . . . . 0.0 109.246 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 7' ' ' LEU . 65.1 mt -65.97 -36.36 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m -61.72 -37.64 84.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.525 -0.735 . . . . 0.0 109.136 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -32.06 73.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 -30.42 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.48 -32.96 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -65.14 -54.8 24.25 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.46 -18.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.662 -0.649 . . . . 0.0 109.36 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -67.2 -42.02 84.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 108.963 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.68 -30.84 69.6 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -52.13 66.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.654 0.74 . . . . 0.0 109.516 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -60.66 -47.98 83.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.447 0.642 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -76.75 -3.29 37.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.082 -0.386 . . . . 0.0 111.123 -179.107 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 3.6 m -40.65 -51.17 6.94 Favored Pre-proline 0 N--CA 1.51 2.557 0 O-C-N 121.328 -0.857 . . . . 0.0 113.061 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.6 Cg_endo -70.47 -56.71 0.12 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 124.572 3.514 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -47.54 -26.77 1.53 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.959 -0.463 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HD23 ' A' ' 21' ' ' LEU . 28.9 mt -77.12 -44.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.5 m -70.48 -69.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.805 . . . . 0.0 109.04 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -89.01 136.98 32.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.369 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -99.84 88.17 0.78 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.19 30.42 9.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -71.03 -33.22 70.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.983 . . . . 0.0 109.348 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -37.39 85.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.658 . . . . 0.0 109.313 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.82 172.53 19.79 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.61 -57.72 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.933 . . . . 0.0 109.359 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.328 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -63.97 -33.08 74.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.692 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 54.7 m-85 51.0 65.97 6.03 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.454 -0.779 . . . . 0.0 109.979 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 40.9 Cg_endo -89.24 -75.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.75 4.3 . . . . 0.0 111.143 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.83 -21.84 12.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.494 -0.754 . . . . 0.0 110.728 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -60.44 -48.94 79.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -69.36 -42.59 75.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.606 -0.684 . . . . 0.0 109.964 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -27.17 66.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.076 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.3 m-20 -67.03 -37.32 83.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.206 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -70.28 -44.14 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 m -59.93 -24.71 64.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.94 -31.95 34.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.415 -0.803 . . . . 0.0 109.31 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.4 t -74.28 -26.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.95 -40.33 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.413 0.625 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -77.92 -26.57 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.58 -35.35 68.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -34.23 21.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.741 . . . . 0.0 110.178 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' HD13 ' A' ' 16' ' ' ILE . . . -58.03 -55.44 34.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.487 -0.758 . . . . 0.0 110.686 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.15 -47.85 71.5 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.05 -11.13 59.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.761 -0.587 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -54.34 -56.41 26.81 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.637 -1.289 . . . . 0.0 110.248 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 38.0 Cg_endo -74.41 -58.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 125.024 3.816 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.74 -29.13 1.76 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.929 -0.482 . . . . 0.0 111.376 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mm -74.13 -45.83 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -58.02 -42.1 84.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.709 . . . . 0.0 110.608 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -86.0 -79.6 0.25 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.235 -0.916 . . . . 0.0 110.027 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.77 -162.58 35.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 68.36 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.2 155.44 17.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -1.005 . . . . 0.0 109.454 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -55.59 25.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.54 -135.51 3.28 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.65 -51.23 36.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.482 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 pttt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.557 179.541 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.656 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -80.86 -72.84 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 109.313 . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 24.5 p90 -141.02 56.7 6.82 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 40.7 Cg_endo -81.74 -78.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 124.958 3.772 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -63.62 -15.33 57.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.448 -0.783 . . . . 0.0 110.806 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -53.87 -22.75 10.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.19 -0.944 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.96 -38.82 61.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.495 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -76.23 -27.4 56.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 0.0 110.544 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.5 m-20 -71.06 -48.68 51.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.772 . . . . 0.0 110.029 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.557 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.2 tt -62.1 -46.25 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.451 ' N ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -53.97 -35.94 62.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.66 -0.65 . . . . 0.0 110.746 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -33.99 72.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' ASP . 42.8 t -66.8 -29.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.098 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.557 HD12 ' O ' ' A' ' 10' ' ' ILE . 2.4 mp -76.43 -36.88 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.02 -42.22 98.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.11 -24.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.472 -0.768 . . . . 0.0 109.961 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.32 -53.43 58.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.61 -35.8 60.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.498 -0.751 . . . . 0.0 109.657 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.96 -45.92 15.9 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.859 0.838 . . . . 0.0 111.268 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.43 -52.07 49.4 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.297 0.57 . . . . 0.0 111.321 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -5.94 59.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.824 -0.547 . . . . 0.0 111.639 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 12.7 t -49.8 -47.14 80.31 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.066 -1.021 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -74.42 -56.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.301 3.334 . . . . 0.0 110.477 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -28.13 2.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.029 -0.419 . . . . 0.0 111.25 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.27 -43.13 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.361 -0.837 . . . . 0.0 109.526 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.8 m -56.15 -35.89 67.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.22 -170.85 0.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.71 -179.45 3.4 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 39.22 1.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.93 152.57 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.898 . . . . 0.0 109.496 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mt -62.64 -48.44 79.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.93 97.49 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.5 -44.88 13.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.592 -0.946 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.2 tttt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.344 179.671 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.638 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -122.02 -41.63 2.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.562 -0.711 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.3 p90 -141.01 60.03 11.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.627 -0.67 . . . . 0.0 109.911 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 37.9 Cg_endo -80.01 -65.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 125.184 3.923 . . . . 0.0 110.249 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -59.28 -19.33 45.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.905 -0.497 . . . . 0.0 110.552 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -36.33 73.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.88 -48.25 82.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 t -58.36 -20.07 40.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.37 -0.831 . . . . 0.0 111.095 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -78.58 -46.67 18.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.128 -179.41 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 14' ' ' ILE . 22.8 mt -71.21 -18.43 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.812 . . . . 0.0 110.35 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -41.04 20.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.209 -0.932 . . . . 0.0 109.953 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.72 -30.24 67.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.506 -0.746 . . . . 0.0 109.678 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 9' ' ' ASP . 40.3 t -74.83 -36.71 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 109.703 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 10' ' ' ILE . 85.2 mt -77.21 -25.24 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.093 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -68.73 -58.34 4.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 108.801 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.93 -20.57 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.615 -0.678 . . . . 0.0 109.831 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.25 -51.33 64.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.36 -31.48 70.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.37 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -59.22 5.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.701 -0.625 . . . . 0.0 110.77 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.23 -48.06 83.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.441 -0.787 . . . . 0.0 111.244 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 25' ' ' ILE . 2.2 mm? -77.47 -9.19 58.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.878 -0.513 . . . . 0.0 111.68 -178.022 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.9 t -51.75 -56.87 17.44 Favored Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.777 -1.202 . . . . 0.0 111.071 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.6 Cg_endo -71.59 -55.14 0.13 Allowed 'Trans proline' 0 N--CA 1.512 2.586 0 C-N-CA 124.945 3.764 . . . . 0.0 110.454 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 21' ' ' LEU . . . -48.58 -26.41 2.21 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.913 -0.492 . . . . 0.0 111.113 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 HD12 ' A' ' 21' ' ' LEU . 32.1 mm -89.79 -34.96 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.414 -0.804 . . . . 0.0 109.46 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -57.95 -53.35 59.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.333 -0.854 . . . . 0.0 110.104 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 -73.49 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 109.757 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 -113.95 4.61 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.62 68.31 0.03 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -30.64 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.982 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.466 ' HA ' HD13 ' A' ' 31' ' ' LEU . 4.2 mm? -67.04 -48.62 67.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.253 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.41 91.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.81 -56.18 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.966 . . . . 0.0 109.768 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 tttp . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.609 -179.604 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 120.832 0.349 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -78.98 -56.82 4.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.216 -0.927 . . . . 0.0 112.049 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -61.89 -22.39 65.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.433 -0.792 . . . . 0.0 111.075 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 11' ' ' THR . 3.9 tt -77.95 -47.22 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.16 -0.963 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.2 m -61.87 -33.42 74.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.764 -0.585 . . . . 0.0 109.773 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.87 -35.86 75.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 9' ' ' ASP . 69.2 t -66.48 -36.33 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mt -79.3 -18.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.207 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.22 -43.66 60.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.245 -0.909 . . . . 0.0 110.368 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.2 -22.25 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 0.0 110.753 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -71.78 -37.82 70.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.24 -0.912 . . . . 0.0 109.63 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.91 -28.71 20.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.511 -0.743 . . . . 0.0 109.672 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.69 -55.08 16.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.619 -0.675 . . . . 0.0 110.128 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.69 72.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.796 -0.565 . . . . 0.0 111.284 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.05 -16.75 61.48 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.706 -0.621 . . . . 0.0 111.617 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 2.8 t -56.61 -57.79 21.34 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 120.958 -1.089 . . . . 0.0 110.913 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.5 Cg_endo -68.3 -55.3 0.25 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 124.976 3.784 . . . . 0.0 110.674 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.61 -27.95 1.31 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 111.202 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.19 -41.76 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.482 -0.762 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 109.95 -179.536 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' LEU . 31.1 tp . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.869 0.366 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.8 p -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -73.72 -29.96 62.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 109.653 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.22 -35.5 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.935 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.1 p -60.49 -47.63 85.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.02 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.8 t70 -61.34 -44.85 96.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.717 . . . . 0.0 109.966 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.5 t -62.83 -27.19 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.596 -0.69 . . . . 0.0 109.913 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.935 HD12 ' HA ' ' A' ' 11' ' ' THR . 25.2 mt -67.71 -37.32 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.48 -0.763 . . . . 0.0 109.1 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.19 -54.63 41.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.764 . . . . 0.0 109.412 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.9 mp -73.61 -10.05 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.678 -0.639 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -72.25 -70.02 0.36 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.614 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.93 -31.72 70.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.091 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.74 54.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 110.682 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.64 75.97 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.603 -0.686 . . . . 0.0 111.259 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -19.99 62.25 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.889 -0.507 . . . . 0.0 111.574 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.403 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -57.33 -58.7 16.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.091 -1.006 . . . . 0.0 111.264 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.9 Cg_endo -69.87 -55.91 0.16 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 125.144 3.896 . . . . 0.0 110.62 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -27.58 2.29 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.137 0.494 . . . . 0.0 110.6 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.17 -35.74 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.418 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.499 1.998 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.052 0.453 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -20.9 37.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.492 -0.755 . . . . 0.0 111.095 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -74.76 -61.8 1.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.782 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 14' ' ' ILE . 54.7 mt -62.69 -22.39 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.49 -0.756 . . . . 0.0 110.366 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -69.03 -49.15 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.313 -0.867 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.98 -37.19 81.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.44 -0.787 . . . . 0.0 110.107 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.15 -42.02 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.461 -0.774 . . . . 0.0 109.735 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 10' ' ' ILE . 66.1 mt -66.89 -28.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.687 . . . . 0.0 109.502 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.468 -0.77 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.7 mt -75.65 -25.62 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.7 . . . . 0.0 109.869 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.13 -39.71 95.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.349 -0.844 . . . . 0.0 110.073 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.03 -28.31 27.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.424 -0.798 . . . . 0.0 110.265 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.82 -49.33 73.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.711 . . . . 0.0 110.891 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.69 -51.38 50.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.676 -0.64 . . . . 0.0 111.585 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 24' ' ' ALA . 4.3 mt -83.83 -9.24 58.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.896 -0.503 . . . . 0.0 111.634 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -47.83 -48.19 61.44 Favored Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.091 -1.006 . . . . 0.0 112.457 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -75.01 -60.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 124.547 3.498 . . . . 0.0 110.771 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -46.72 -26.78 1.0 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.92 -0.488 . . . . 0.0 111.411 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 21' ' ' LEU . 23.5 mt -64.58 -53.16 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.392 -0.818 . . . . 0.0 109.23 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 109.891 -179.633 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.476 ' HA ' HD12 ' A' ' 10' ' ' ILE . 4.5 mm? . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.091 0.472 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -58.18 -31.22 67.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.3 t70 -64.09 -36.38 83.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 7' ' ' LEU . 8.6 mt -68.92 -44.28 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 110.07 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -56.93 -42.41 79.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 0.0 110.271 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -30.41 71.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.433 -0.792 . . . . 0.0 109.361 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.2 t -74.86 -27.73 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.706 . . . . 0.0 109.755 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.43 -30.4 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.41 -41.8 75.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.585 -0.697 . . . . 0.0 109.737 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.9 mt -75.33 -20.11 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.276 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.32 -56.81 6.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.907 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -25.31 64.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.526 -0.734 . . . . 0.0 110.148 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -54.59 20.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.476 -0.765 . . . . 0.0 110.586 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.77 54.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.56 -0.712 . . . . 0.0 111.629 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 25' ' ' ILE . 4.5 mp -83.04 -15.36 51.35 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.883 -0.51 . . . . 0.0 111.71 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.404 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -51.18 -52.32 59.95 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.841 -1.162 . . . . 0.0 111.243 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 22' ' ' SER . 39.6 Cg_endo -77.94 -58.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.107 3.871 . . . . 0.0 110.718 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.42 0.83 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.922 -0.486 . . . . 0.0 111.606 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.6 mp -84.08 -47.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.708 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -62.21 -14.36 37.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -77.96 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.023 -1.048 . . . . 0.0 110.414 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.2 mt -60.42 -30.84 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.452 -0.78 . . . . 0.0 110.682 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 m -58.65 -45.54 89.11 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -35.69 80.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.0 t -70.3 -24.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.052 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.8 -34.59 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.337 -0.852 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.21 -52.81 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 109.826 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.87 -27.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -60.88 -36.6 79.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 109.598 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.46 -22.93 35.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.978 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.13 67.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.13 60.83 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.496 0.665 . . . . 0.0 110.947 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -85.05 -12.28 53.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.927 -0.483 . . . . 0.0 111.595 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.409 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 2.6 t -52.14 -50.21 80.21 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.886 -1.134 . . . . 0.0 111.304 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.2 Cg_endo -76.0 -62.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.422 0 C-N-CA 124.668 3.579 . . . . 0.0 111.059 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.93 -27.09 1.14 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.803 -0.561 . . . . 0.0 111.386 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.13 -41.34 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.417 -0.802 . . . . 0.0 109.971 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.495 1.825 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.463 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.9 tp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 120.786 0.326 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 -43.01 99.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 13' ' ' VAL . 9.8 t70 -65.49 -25.96 67.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . 39.9 mm -65.25 -50.61 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.332 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.3 m -56.58 -39.03 72.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.379 -0.826 . . . . 0.0 109.852 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -35.91 80.52 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 9' ' ' ASP . 58.3 t -62.62 -43.8 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 10' ' ' ILE . 5.2 mp -84.55 -3.52 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 110.039 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 t80 -85.05 -37.86 19.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.385 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.7 mt -86.76 -37.51 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.638 -0.664 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -53.42 38.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.257 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -68.74 -29.41 67.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.647 . . . . 0.0 109.81 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 15' ' ' PHE . . . -54.38 -52.05 62.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.3 -0.875 . . . . 0.0 110.876 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.61 -56.66 4.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.72 -50.02 66.34 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.348 -0.845 . . . . 0.0 112.793 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 47.1 t -38.8 -52.31 3.69 Favored Pre-proline 0 N--CA 1.515 2.797 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 22' ' ' SER . 35.0 Cg_endo -66.83 -56.43 0.25 Allowed 'Trans proline' 0 N--CA 1.511 2.526 0 C-N-CA 124.199 3.266 . . . . 0.0 110.387 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.38 -27.81 1.8 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.918 -0.489 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 25' ' ' ILE . 28.9 mm -64.95 -65.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 0.0 109.279 179.87 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 120.777 0.323 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -57.41 -26.86 61.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 110.611 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.74 -58.51 6.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.546 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.18 -19.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.718 -0.614 . . . . 0.0 109.882 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -74.99 -38.87 61.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.738 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -66.92 -41.07 87.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.276 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.15 -48.62 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.12 -17.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -67.79 -52.0 42.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 0.0 109.825 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.2 mp -77.93 -23.29 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.455 -0.778 . . . . 0.0 110.126 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.34 -40.2 85.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 109.89 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -31.21 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.506 -0.746 . . . . 0.0 109.649 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.54 44.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.057 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.33 82.8 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.371 0.605 . . . . 0.0 111.305 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 2.0 mm? -72.1 -17.41 61.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.796 -0.565 . . . . 0.0 111.753 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -59.79 -57.79 24.2 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.888 -1.132 . . . . 0.0 111.28 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.7 Cg_endo -69.85 -57.85 0.11 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 125.06 3.84 . . . . 0.0 111.078 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.35 -28.19 1.26 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.937 -0.477 . . . . 0.0 111.181 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 21' ' ' LEU . 84.0 mt -79.88 -43.36 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 0.0 110.124 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.797 0.332 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 t -62.83 -25.06 68.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -45.95 92.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.764 . . . . 0.0 109.72 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -66.4 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -0.771 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -32.54 73.95 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -37.99 86.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.23 -25.59 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.24 -44.06 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 109.236 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.58 -40.77 97.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.642 -0.661 . . . . 0.0 109.67 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.67 -23.6 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.616 -0.678 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.21 -37.11 86.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -84.97 -35.07 22.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.599 -0.688 . . . . 0.0 110.139 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.93 6.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.759 -0.588 . . . . 0.0 111.274 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.71 -53.87 35.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.596 -0.69 . . . . 0.0 111.767 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD13 ' A' ' 25' ' ' ILE . 5.5 mp -70.86 -12.32 61.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.692 -0.63 . . . . 0.0 112.031 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.2 t -59.94 -61.57 7.64 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 120.787 -1.196 . . . . 0.0 110.362 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 37.2 Cg_endo -71.13 -58.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.511 2.541 0 C-N-CA 124.941 3.76 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.58 -28.57 0.98 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.975 -0.453 . . . . 0.0 111.537 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 mp -66.15 -51.07 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.505 -0.747 . . . . 0.0 109.834 -179.653 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 10' ' ' ILE . 6.1 tp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.074 0.464 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -63.45 -17.6 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.845 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 t70 -69.94 -37.52 75.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 7' ' ' LEU . 2.3 mp -72.69 -54.6 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -0.778 . . . . 0.0 109.778 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -28.25 64.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -34.12 62.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 9' ' ' ASP . 63.0 t -71.08 -26.98 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.673 -0.642 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.5 -35.36 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -66.04 -42.81 89.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.609 -0.682 . . . . 0.0 109.861 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mm -78.79 -21.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -48.78 77.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -86.34 -27.64 24.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.496 -0.752 . . . . 0.0 110.353 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.26 65.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.487 -0.758 . . . . 0.0 110.657 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.73 -51.46 55.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.578 -0.701 . . . . 0.0 111.455 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.59 HD23 HD11 ' A' ' 25' ' ' ILE . 4.1 mp -82.42 -9.21 59.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.794 -0.566 . . . . 0.0 111.835 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -57.88 -53.32 66.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.978 -1.077 . . . . 0.0 111.265 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -73.67 -60.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 124.865 3.71 . . . . 0.0 110.879 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.08 -27.64 1.44 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.821 -0.549 . . . . 0.0 111.335 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.59 HD11 HD23 ' A' ' 21' ' ' LEU . 83.5 mt -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.631 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -178.774 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 120.847 0.356 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -69.68 -31.16 69.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.803 . . . . 0.0 109.789 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 13' ' ' VAL . 23.2 t70 -75.19 -41.97 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 110.574 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' ILE . 3.0 mp -63.43 -37.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.323 -0.861 . . . . 0.0 109.192 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -29.68 67.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.48 -0.763 . . . . 0.0 109.492 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -30.42 59.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.0 109.747 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.2 t -75.39 -30.5 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 0.0 109.292 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.13 -36.27 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.93 -42.45 97.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.61 -0.681 . . . . 0.0 109.196 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.46 -23.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.647 -0.658 . . . . 0.0 109.62 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -43.46 97.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.737 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.03 -27.92 20.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.532 -0.73 . . . . 0.0 110.095 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.77 -53.76 54.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.753 . . . . 0.0 110.117 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.33 73.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.292 0.568 . . . . 0.0 110.867 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.0 mp -80.31 -1.17 39.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.942 -0.474 . . . . 0.0 112.073 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.5 m -47.75 -47.38 62.04 Favored Pre-proline 0 N--CA 1.508 2.439 0 O-C-N 120.855 -1.153 . . . . 0.0 112.318 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.7 Cg_endo -78.95 -60.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.405 0 C-N-CA 124.881 3.721 . . . . 0.0 111.208 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.67 -27.7 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.801 -0.562 . . . . 0.0 111.576 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 21' ' ' LEU . 24.3 mm -75.5 -43.63 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.245 -0.909 . . . . 0.0 109.631 179.683 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 120.643 0.259 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 p -81.87 -30.0 32.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 m-20 -67.9 -39.49 83.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.672 -0.643 . . . . 0.0 109.759 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mt -71.5 -42.52 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.531 -0.731 . . . . 0.0 109.578 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -33.07 72.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -34.33 74.41 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 9' ' ' ASP . 46.0 t -68.84 -27.95 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.86 -33.49 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 108.981 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -69.14 -40.54 78.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.48 -32.38 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.35 -45.98 90.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.513 -0.742 . . . . 0.0 109.248 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -65.57 -36.23 83.15 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.482 0.658 . . . . 0.0 109.44 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -55.02 36.54 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.528 0.68 . . . . 0.0 110.284 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.84 92.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.588 0.708 . . . . 0.0 110.343 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.007 -0.433 . . . . 0.0 111.414 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -65.16 -59.59 9.62 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.0 Cg_endo -70.87 -56.99 0.11 Allowed 'Trans proline' 0 N--CA 1.51 2.482 0 C-N-CA 125.03 3.82 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -27.96 1.01 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.014 0.435 . . . . 0.0 111.241 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 25' ' ' ILE . 1.1 mm -61.23 -54.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.898 -179.616 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 120.99 0.424 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.1 m -58.61 -19.75 41.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.354 -0.841 . . . . 0.0 111.46 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 63.0 m-20 -66.69 -57.56 6.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.142 -0.974 . . . . 0.0 110.723 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 11' ' ' THR . 4.0 tt -59.74 -45.48 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.443 -0.785 . . . . 0.0 110.197 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.428 ' N ' HG23 ' A' ' 10' ' ' ILE . 2.4 m -58.6 -34.13 70.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.744 -0.597 . . . . 0.0 109.975 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.19 -36.18 74.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.489 -0.757 . . . . 0.0 109.175 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.4 t -68.96 -23.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.813 -0.554 . . . . 0.0 109.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.4 mt -83.99 -29.47 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -74.15 -41.72 61.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 0.0 109.701 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.48 -28.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 110.24 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -56.85 12.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.396 -0.815 . . . . 0.0 109.586 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.85 -30.17 68.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 110.028 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.39 -57.77 11.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 110.08 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -57.36 -53.57 56.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.566 -0.709 . . . . 0.0 111.004 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.12 1.44 27.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.816 -0.552 . . . . 0.0 111.678 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 17.4 t -49.11 -45.97 75.56 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.945 -1.097 . . . . 0.0 112.375 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 22' ' ' SER . 41.0 Cg_endo -78.31 -57.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.373 0 C-N-CA 124.608 3.538 . . . . 0.0 110.766 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.23 -28.32 2.96 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.872 -0.517 . . . . 0.0 111.311 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -83.98 -38.99 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.134 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.564 -0.71 . . . . 0.0 110.081 -179.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 120.939 0.4 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -65.0 -41.41 95.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 t0 -59.57 -40.08 86.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.667 -0.646 . . . . 0.0 109.895 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -67.88 -33.47 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.895 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -56.99 -50.65 72.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.271 -0.893 . . . . 0.0 110.179 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -61.57 -32.96 73.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 109.392 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.8 t -62.64 -37.21 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.681 -0.637 . . . . 0.0 109.534 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -19.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.624 -0.673 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -68.76 -49.86 55.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 109.685 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.7 mp -75.3 -32.84 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.428 -0.795 . . . . 0.0 109.868 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.7 97.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -28.27 63.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.17 84.9 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.81 0.815 . . . . 0.0 110.158 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -48.73 52.99 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.501 0.667 . . . . 0.0 111.207 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -84.55 -13.62 51.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.932 -0.48 . . . . 0.0 111.117 -178.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 39.9 m -51.04 -48.31 85.22 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.087 -1.008 . . . . 0.0 112.001 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.1 Cg_endo -70.79 -55.26 0.15 Allowed 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 124.265 3.31 . . . . 0.0 109.71 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.56 -28.25 0.91 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.508 HG13 HD23 ' A' ' 21' ' ' LEU . 41.0 mt -79.36 -44.06 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 0.0 109.67 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.498 1.931 0 O-C-N 121.329 -0.857 . . . . 0.0 109.991 -179.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 120.471 0.177 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -58.53 -45.24 89.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.024 -1.047 . . . . 0.0 110.199 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -44.73 93.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.735 . . . . 0.0 109.176 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.45 -22.63 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 14' ' ' ILE . 5.7 m -68.6 -42.16 78.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.33 -30.33 71.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.564 -0.71 . . . . 0.0 109.217 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.92 -24.26 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.695 -0.628 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 11' ' ' THR . 15.4 mt -84.28 -30.07 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.792 . . . . 0.0 109.801 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 tp -76.39 -34.59 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.74 0.781 . . . . 0.0 109.117 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -52.86 -45.74 67.54 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.924 -0.485 . . . . 0.0 110.236 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -29.64 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.548 -0.72 . . . . 0.0 109.867 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -56.95 -53.85 53.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.476 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.84 74.79 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.519 0.676 . . . . 0.0 110.824 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 17' ' ' TYR . 4.0 mt -65.83 -14.17 60.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.544 . . . . 0.0 111.355 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.6 t -67.27 -60.96 5.17 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 120.978 -1.076 . . . . 0.0 110.145 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 36.6 Cg_endo -68.98 -56.05 0.18 Allowed 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 125.072 3.848 . . . . 0.0 110.595 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.26 -28.58 1.33 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.933 -0.479 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 25' ' ' ILE . 17.8 mm -81.67 -41.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.48 -0.763 . . . . 0.0 109.166 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.0 m . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 109.811 -179.901 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 7' ' ' LEU . 5.9 tp . . . . . 0 N--CA 1.495 1.807 0 CA-C-O 121.081 0.467 . . . . 0.0 109.954 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -66.39 -23.44 66.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.163 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.61 -59.88 2.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.388 -0.82 . . . . 0.0 110.294 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 11' ' ' THR . 17.4 tt -56.95 -43.93 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.572 -0.705 . . . . 0.0 110.152 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.448 ' N ' HG23 ' A' ' 10' ' ' ILE . 21.7 m -61.58 -31.7 71.76 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -36.13 73.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.08 -32.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.68 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt -76.99 -26.09 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.629 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.62 -38.45 83.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.509 -0.744 . . . . 0.0 109.327 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -83.45 -23.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.709 . . . . 0.0 109.941 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.31 -48.66 78.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.863 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -81.55 -41.37 21.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.133 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.55 12.08 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.639 0.733 . . . . 0.0 111.376 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.63 -52.94 27.02 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.41 0.624 . . . . 0.0 110.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.0 mt -84.77 -11.05 56.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.931 -0.481 . . . . 0.0 111.174 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 16.2 t -50.62 -48.37 82.58 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.107 -0.996 . . . . 0.0 112.35 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.1 Cg_endo -69.1 -57.53 0.13 Allowed 'Trans proline' 0 N--CA 1.51 2.477 0 C-N-CA 124.383 3.389 . . . . 0.0 110.488 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.34 -28.26 1.96 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 111.109 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 mt -80.98 -41.68 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 109.426 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m . . . . . 0 N--CA 1.496 1.834 0 O-C-N 121.546 -0.721 . . . . 0.0 109.908 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.5 tt . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.921 0.391 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.9 p -66.97 -24.86 66.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.3 t70 -74.49 -42.67 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.336 -0.852 . . . . 0.0 110.187 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.74 -46.64 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.828 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -35.39 78.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 109.342 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.48 -34.88 78.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.7 t -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.7 mm -72.2 -24.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 109.753 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.94 -53.45 31.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.68 -23.39 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 110.224 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -64.36 0.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 109.526 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -22.41 63.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.426 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.04 -59.5 3.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.275 -0.89 . . . . 0.0 110.089 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.35 86.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.383 -0.823 . . . . 0.0 110.264 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 25' ' ' ILE . 9.1 mt -71.16 -22.46 62.05 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.445 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -51.55 -58.79 9.62 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.805 -1.185 . . . . 0.0 111.095 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' SER . 34.2 Cg_endo -66.81 -58.93 0.13 Allowed 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 124.93 3.753 . . . . 0.0 111.116 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.8 -27.58 3.09 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.818 -0.551 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 21' ' ' LEU . 87.9 mt -90.03 -32.52 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.297 -0.877 . . . . 0.0 110.037 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.3 -0.875 . . . . 0.0 110.465 -179.348 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 120.89 0.376 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -60.05 -19.54 53.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.303 -0.873 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.5 -36.8 81.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.002 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 mm -77.55 -40.11 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.436 -0.79 . . . . 0.0 110.098 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.4 m -63.73 -32.81 74.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 -39.51 75.09 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.1 t -62.28 -36.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 11' ' ' THR . 42.5 mt -72.38 -26.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.54 -60.22 4.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 16' ' ' ILE . 4.0 mp -73.7 -8.19 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.586 -0.696 . . . . 0.0 110.202 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.26 -30.02 57.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 0.0 108.717 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -25.92 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.68 -0.637 . . . . 0.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.44 -60.89 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.624 -0.673 . . . . 0.0 110.728 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.44 -47.84 66.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.639 -0.663 . . . . 0.0 111.379 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.2 tp -82.19 -12.76 57.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.881 -0.512 . . . . 0.0 111.453 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -49.33 -51.83 54.24 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.019 -1.051 . . . . 0.0 111.79 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -72.39 -55.36 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 124.795 3.664 . . . . 0.0 110.431 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.13 -27.6 2.45 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.017 -0.427 . . . . 0.0 111.063 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 21' ' ' LEU . 34.8 mt -73.14 -44.53 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.794 . . . . 0.0 109.378 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.288 -0.882 . . . . 0.0 110.332 -179.77 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.825 0.345 . . . . 0.0 110.215 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -59.92 -28.38 67.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.72 -38.0 89.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.731 . . . . 0.0 109.246 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 7' ' ' LEU . 65.1 mt -65.97 -36.36 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m -61.72 -37.64 84.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.525 -0.735 . . . . 0.0 109.136 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -32.06 73.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 -30.42 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.48 -32.96 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -65.14 -54.8 24.25 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.46 -18.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.662 -0.649 . . . . 0.0 109.36 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -67.2 -42.02 84.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 108.963 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.68 -30.84 69.6 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -52.13 66.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.654 0.74 . . . . 0.0 109.516 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -60.66 -47.98 83.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.447 0.642 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -76.75 -3.29 37.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.082 -0.386 . . . . 0.0 111.123 -179.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 3.6 m -40.65 -51.17 6.94 Favored Pre-proline 0 N--CA 1.51 2.557 0 O-C-N 121.328 -0.857 . . . . 0.0 113.061 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.6 Cg_endo -70.47 -56.71 0.12 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 124.572 3.514 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -47.54 -26.77 1.53 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.959 -0.463 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HD23 ' A' ' 21' ' ' LEU . 28.9 mt -77.12 -44.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.805 . . . . 0.0 109.04 179.842 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 120.929 0.395 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -27.17 66.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.076 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.3 m-20 -67.03 -37.32 83.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.206 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -70.28 -44.14 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 m -59.93 -24.71 64.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.94 -31.95 34.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.415 -0.803 . . . . 0.0 109.31 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.4 t -74.28 -26.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.95 -40.33 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.413 0.625 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -77.92 -26.57 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.58 -35.35 68.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -34.23 21.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.741 . . . . 0.0 110.178 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' HD13 ' A' ' 16' ' ' ILE . . . -58.03 -55.44 34.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.487 -0.758 . . . . 0.0 110.686 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.15 -47.85 71.5 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.05 -11.13 59.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.761 -0.587 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -54.34 -56.41 26.81 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.637 -1.289 . . . . 0.0 110.248 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 38.0 Cg_endo -74.41 -58.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 125.024 3.816 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.74 -29.13 1.76 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.929 -0.482 . . . . 0.0 111.376 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mm -74.13 -45.83 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.709 . . . . 0.0 110.608 -179.642 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 120.887 0.375 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -76.23 -27.4 56.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 0.0 110.544 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.5 m-20 -71.06 -48.68 51.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.772 . . . . 0.0 110.029 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.557 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.2 tt -62.1 -46.25 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.451 ' N ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -53.97 -35.94 62.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.66 -0.65 . . . . 0.0 110.746 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -33.99 72.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' ASP . 42.8 t -66.8 -29.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.098 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.557 HD12 ' O ' ' A' ' 10' ' ' ILE . 2.4 mp -76.43 -36.88 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.02 -42.22 98.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.11 -24.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.472 -0.768 . . . . 0.0 109.961 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.32 -53.43 58.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.61 -35.8 60.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.498 -0.751 . . . . 0.0 109.657 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.96 -45.92 15.9 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.859 0.838 . . . . 0.0 111.268 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.43 -52.07 49.4 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.297 0.57 . . . . 0.0 111.321 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -5.94 59.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.824 -0.547 . . . . 0.0 111.639 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 12.7 t -49.8 -47.14 80.31 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.066 -1.021 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -74.42 -56.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.301 3.334 . . . . 0.0 110.477 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -28.13 2.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.029 -0.419 . . . . 0.0 111.25 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.27 -43.13 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.361 -0.837 . . . . 0.0 109.526 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.774 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 120.861 0.362 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 t -58.36 -20.07 40.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.37 -0.831 . . . . 0.0 111.095 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -78.58 -46.67 18.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.128 -179.41 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 14' ' ' ILE . 22.8 mt -71.21 -18.43 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.812 . . . . 0.0 110.35 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -41.04 20.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.209 -0.932 . . . . 0.0 109.953 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.72 -30.24 67.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.506 -0.746 . . . . 0.0 109.678 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 9' ' ' ASP . 40.3 t -74.83 -36.71 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 109.703 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 10' ' ' ILE . 85.2 mt -77.21 -25.24 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.093 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -68.73 -58.34 4.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 108.801 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.93 -20.57 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.615 -0.678 . . . . 0.0 109.831 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.25 -51.33 64.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.36 -31.48 70.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.37 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -59.22 5.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.701 -0.625 . . . . 0.0 110.77 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.23 -48.06 83.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.441 -0.787 . . . . 0.0 111.244 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 25' ' ' ILE . 2.2 mm? -77.47 -9.19 58.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.878 -0.513 . . . . 0.0 111.68 -178.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.9 t -51.75 -56.87 17.44 Favored Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.777 -1.202 . . . . 0.0 111.071 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.6 Cg_endo -71.59 -55.14 0.13 Allowed 'Trans proline' 0 N--CA 1.512 2.586 0 C-N-CA 124.945 3.764 . . . . 0.0 110.454 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 21' ' ' LEU . . . -48.58 -26.41 2.21 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.913 -0.492 . . . . 0.0 111.113 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 HD12 ' A' ' 21' ' ' LEU . 32.1 mm -89.79 -34.96 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.414 -0.804 . . . . 0.0 109.46 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.497 1.922 0 O-C-N 121.333 -0.854 . . . . 0.0 110.104 -179.706 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.668 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.59 -6.95 12.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.643 -0.661 . . . . 0.0 110.404 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -121.49 71.08 25.64 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.161 -0.962 . . . . 0.0 110.124 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -77.37 -51.68 0.08 OUTLIER 'Trans proline' 0 N--CA 1.509 2.434 1 C-N-CA 125.378 4.052 . . . . 0.0 109.787 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.409 ' O ' ' CD1' ' A' ' 5' ' ' TYR . 28.4 t80 -55.42 -21.76 17.28 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -76.66 -31.97 57.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.041 -1.037 . . . . 0.0 111.184 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.59 -47.47 7.67 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.321 -0.862 . . . . 0.0 111.912 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -78.98 -56.82 4.1 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.216 -0.927 . . . . 0.0 112.049 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -61.89 -22.39 65.52 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.433 -0.792 . . . . 0.0 111.075 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 11' ' ' THR . 3.9 tt -77.95 -47.22 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.16 -0.963 . . . . 0.0 109.346 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 3.2 m -61.87 -33.42 74.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.764 -0.585 . . . . 0.0 109.773 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.87 -35.86 75.01 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.528 -0.732 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.812 HG23 ' O ' ' A' ' 9' ' ' ASP . 69.2 t -66.48 -36.33 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.0 mt -79.3 -18.59 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.673 -0.642 . . . . 0.0 110.207 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -73.22 -43.66 60.89 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.245 -0.909 . . . . 0.0 110.368 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.4 mt -90.2 -22.25 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 0.0 110.753 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -71.78 -37.82 70.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.24 -0.912 . . . . 0.0 109.63 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -88.91 -28.71 20.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.511 -0.743 . . . . 0.0 109.672 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.69 -55.08 16.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.619 -0.675 . . . . 0.0 110.128 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.92 -50.69 72.4 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.796 -0.565 . . . . 0.0 111.284 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.6 mt -73.05 -16.75 61.48 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.706 -0.621 . . . . 0.0 111.617 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 2.8 t -56.61 -57.79 21.34 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 120.958 -1.089 . . . . 0.0 110.913 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.5 Cg_endo -68.3 -55.3 0.25 Allowed 'Trans proline' 0 N--CA 1.513 2.629 0 C-N-CA 124.976 3.784 . . . . 0.0 110.674 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.61 -27.95 1.31 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 111.202 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.0 mt -81.19 -41.76 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.482 -0.762 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.1 m -66.08 -64.74 0.79 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.436 -0.79 . . . . 0.0 109.95 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -58.86 143.53 47.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.581 -0.7 . . . . 0.0 110.172 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.47 -162.32 24.97 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 20.58 48.11 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.54 -67.99 0.81 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.344 -1.092 . . . . 0.0 109.293 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -64.99 0.8 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.635 -0.666 . . . . 0.0 109.4 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -89.39 130.32 10.13 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -83.43 -37.58 23.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.559 -0.965 . . . . 0.0 109.392 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.442 179.923 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.649 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.477 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.18 -74.43 0.25 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.576 -0.703 . . . . 0.0 109.132 . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' ' 2' ' ' ARG . 16.2 p90 -137.26 55.48 10.16 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.501 -0.75 . . . . 0.0 110.483 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 39.9 Cg_endo -79.9 -80.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.102 0 C-N-CA 124.837 3.691 . . . . 0.0 110.177 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -66.11 -18.84 65.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.355 -0.841 . . . . 0.0 109.956 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -61.58 -34.77 76.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 7' ' ' LEU . 31.1 tp -60.15 -32.55 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.807 -0.558 . . . . 0.0 110.365 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.8 p -70.23 -31.02 68.25 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.405 -0.809 . . . . 0.0 109.832 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -73.72 -29.96 62.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.602 -0.686 . . . . 0.0 109.653 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.8 mm -77.22 -35.5 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.439 -0.788 . . . . 0.0 109.489 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.935 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.1 p -60.49 -47.63 85.32 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.514 -0.741 . . . . 0.0 110.02 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.629 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.8 t70 -61.34 -44.85 96.49 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.552 -0.717 . . . . 0.0 109.966 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.5 t -62.83 -27.19 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.596 -0.69 . . . . 0.0 109.913 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.935 HD12 ' HA ' ' A' ' 11' ' ' THR . 25.2 mt -67.71 -37.32 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.48 -0.763 . . . . 0.0 109.1 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -61.19 -54.63 41.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.477 -0.764 . . . . 0.0 109.412 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.9 mp -73.61 -10.05 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.678 -0.639 . . . . 0.0 110.608 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -72.25 -70.02 0.36 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.131 -0.981 . . . . 0.0 109.614 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -59.93 -31.72 70.11 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.554 -0.716 . . . . 0.0 110.091 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.95 -53.74 54.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.559 -0.713 . . . . 0.0 110.682 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.64 75.97 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.603 -0.686 . . . . 0.0 111.259 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 76.6 mt -71.3 -19.99 62.25 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.889 -0.507 . . . . 0.0 111.574 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.403 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.5 OUTLIER -57.33 -58.7 16.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.091 -1.006 . . . . 0.0 111.264 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.9 Cg_endo -69.87 -55.91 0.16 Allowed 'Trans proline' 0 N--CA 1.512 2.568 0 C-N-CA 125.144 3.896 . . . . 0.0 110.62 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.98 -27.58 2.29 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 121.137 0.494 . . . . 0.0 110.6 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.17 -35.74 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.508 -0.745 . . . . 0.0 109.418 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.5 m -56.82 -38.97 73.34 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.447 -0.783 . . . . 0.0 110.296 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.6 104.35 8.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.486 -0.759 . . . . 0.0 109.46 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.9 102.07 2.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.34 71.63 0.82 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 tp -61.82 131.07 48.63 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.565 -0.962 . . . . 0.0 109.583 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 tp -86.33 -33.92 20.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.548 -0.72 . . . . 0.0 109.489 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.16 161.99 27.66 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.1 -40.63 62.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.54 -0.976 . . . . 0.0 109.516 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 mtmt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.379 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.637 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 32.2 mtp85 -113.54 -21.77 10.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.367 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -155.13 80.8 4.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.784 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.68 -72.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 1 C-N-CA 125.355 4.037 . . . . 0.0 110.626 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.77 -18.08 38.96 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.704 -0.622 . . . . 0.0 110.553 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.0 -40.31 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 110.002 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.2 mt -74.31 -30.25 61.98 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.581 -0.699 . . . . 0.0 110.153 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -20.9 37.85 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.492 -0.755 . . . . 0.0 111.095 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -74.76 -61.8 1.76 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.236 -0.915 . . . . 0.0 110.782 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 14' ' ' ILE . 54.7 mt -62.69 -22.39 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.49 -0.756 . . . . 0.0 110.366 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.2 m -69.03 -49.15 60.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.313 -0.867 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.98 -37.19 81.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.44 -0.787 . . . . 0.0 110.107 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.15 -42.02 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.461 -0.774 . . . . 0.0 109.735 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 10' ' ' ILE . 66.1 mt -66.89 -28.43 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.6 -0.687 . . . . 0.0 109.502 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.468 -0.77 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.7 mt -75.65 -25.62 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.581 -0.7 . . . . 0.0 109.869 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -63.13 -39.71 95.46 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.349 -0.844 . . . . 0.0 110.073 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.03 -28.31 27.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.424 -0.798 . . . . 0.0 110.265 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.82 -49.33 73.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.562 -0.711 . . . . 0.0 110.891 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.69 -51.38 50.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.676 -0.64 . . . . 0.0 111.585 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD23 ' HB3' ' A' ' 24' ' ' ALA . 4.3 mt -83.83 -9.24 58.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.896 -0.503 . . . . 0.0 111.634 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -47.83 -48.19 61.44 Favored Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.091 -1.006 . . . . 0.0 112.457 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -75.01 -60.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.3 0 C-N-CA 124.547 3.498 . . . . 0.0 110.771 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -46.72 -26.78 1.0 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.92 -0.488 . . . . 0.0 111.411 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 21' ' ' LEU . 23.5 mt -64.58 -53.16 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.392 -0.818 . . . . 0.0 109.23 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.1 m -72.24 -67.38 0.55 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.403 -0.811 . . . . 0.0 109.891 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.44 165.63 21.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 109.599 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.9 107.59 1.78 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.3 20.63 46.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -90.45 102.4 15.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.273 -1.134 . . . . 0.0 109.227 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.0 tt -73.13 -42.74 62.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.629 -0.669 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' O ' HD12 ' A' ' 30' ' ' LEU . . . -100.14 133.94 11.5 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -42.33 89.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.533 -0.98 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.953 -1.023 . . . . 0.0 109.58 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.662 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -121.28 -10.69 8.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.598 -0.689 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.712 ' CD2' HD21 ' A' ' 7' ' ' LEU . 0.4 OUTLIER 67.16 65.2 0.7 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.93 -1.106 . . . . 0.0 109.134 -179.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 43.7 Cg_endo -93.61 -79.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.891 1 C-N-CA 125.929 4.42 . . . . 0.0 112.044 -178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -89.26 -14.03 36.78 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.269 -0.895 . . . . 0.0 111.272 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -55.17 -21.92 15.36 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.962 . . . . 0.0 110.646 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.712 HD21 ' CD2' ' A' ' 3' ' ' TYR . 4.5 mm? -65.56 -42.67 91.56 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.268 -0.895 . . . . 0.0 110.497 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -58.18 -31.22 67.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.497 -0.752 . . . . 0.0 110.99 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.633 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.3 t70 -64.09 -36.38 83.84 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.34 -0.85 . . . . 0.0 110.472 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 7' ' ' LEU . 8.6 mt -68.92 -44.28 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 110.07 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -56.93 -42.41 79.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 0.0 110.271 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -30.41 71.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.433 -0.792 . . . . 0.0 109.361 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.2 t -74.86 -27.73 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.706 . . . . 0.0 109.755 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.9 mt -76.43 -30.4 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.434 -0.791 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.41 -41.8 75.92 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.585 -0.697 . . . . 0.0 109.737 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.9 mt -75.33 -20.11 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.276 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.32 -56.81 6.42 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 0.0 109.907 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.88 -25.31 64.56 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.526 -0.734 . . . . 0.0 110.148 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.81 -54.59 20.97 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.476 -0.765 . . . . 0.0 110.586 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.18 -47.77 54.36 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.56 -0.712 . . . . 0.0 111.629 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.497 ' O ' HD13 ' A' ' 25' ' ' ILE . 4.5 mp -83.04 -15.36 51.35 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.883 -0.51 . . . . 0.0 111.71 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.404 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -51.18 -52.32 59.95 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.841 -1.162 . . . . 0.0 111.243 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 22' ' ' SER . 39.6 Cg_endo -77.94 -58.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 125.107 3.871 . . . . 0.0 110.718 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.78 -27.42 0.83 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.922 -0.486 . . . . 0.0 111.606 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.6 mp -84.08 -47.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.477 -0.764 . . . . 0.0 108.957 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.4 m -82.53 -68.91 0.66 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.324 -0.86 . . . . 0.0 109.958 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -72.63 -79.58 0.07 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.426 -0.796 . . . . 0.0 109.726 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.43 112.44 0.24 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 157.19 -53.3 0.4 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.25 -24.03 67.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.437 -1.037 . . . . 0.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.5 tp -57.96 -57.0 14.78 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.63 37.29 0.05 OUTLIER Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.784 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -91.57 -54.21 3.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -1.085 . . . . 0.0 109.501 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.6 pttt . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.559 -179.728 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.655 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.5 -52.98 0.08 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.591 -0.693 . . . . 0.0 109.44 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 55.33 93.08 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.604 -0.685 . . . . 0.0 110.3 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -87.53 -76.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.949 1 C-N-CA 125.526 4.151 . . . . 0.0 110.889 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -19.23 61.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.915 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -62.11 -49.83 74.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.188 -0.945 . . . . 0.0 110.519 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.15 -45.67 14.84 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.56 -0.713 . . . . 0.0 110.952 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.5 p -62.21 -14.36 37.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.38 -0.825 . . . . 0.0 111.167 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.3 -77.96 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.023 -1.048 . . . . 0.0 110.414 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 76.2 mt -60.42 -30.84 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.452 -0.78 . . . . 0.0 110.682 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.9 m -58.65 -45.54 89.11 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.269 -0.894 . . . . 0.0 110.507 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -35.69 80.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.507 -0.746 . . . . 0.0 109.822 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.0 t -70.3 -24.08 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.598 -0.689 . . . . 0.0 110.052 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.8 -34.59 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.337 -0.852 . . . . 0.0 109.137 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.21 -52.81 52.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.537 -0.727 . . . . 0.0 109.826 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.87 -27.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.545 -0.722 . . . . 0.0 109.728 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -60.88 -36.6 79.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 109.598 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -82.46 -22.93 35.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.978 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.4 -49.13 67.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -0.812 . . . . 0.0 109.67 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.93 -48.13 60.83 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.496 0.665 . . . . 0.0 110.947 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 21' ' ' LEU . 3.8 mm? -85.05 -12.28 53.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.927 -0.483 . . . . 0.0 111.595 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.409 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 2.6 t -52.14 -50.21 80.21 Favored Pre-proline 0 N--CA 1.501 2.121 0 O-C-N 120.886 -1.134 . . . . 0.0 111.304 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.2 Cg_endo -76.0 -62.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.422 0 C-N-CA 124.668 3.579 . . . . 0.0 111.059 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.93 -27.09 1.14 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.803 -0.561 . . . . 0.0 111.386 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.13 -41.34 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.417 -0.802 . . . . 0.0 109.971 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.7 m -70.83 -67.08 0.53 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.296 -0.877 . . . . 0.0 109.572 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -59.33 111.33 1.33 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.425 -0.797 . . . . 0.0 109.964 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 150.35 160.55 9.38 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -143.61 -74.0 0.03 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -84.04 117.83 23.67 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.547 -0.973 . . . . 0.0 109.6 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.422 ' HA ' HD13 ' A' ' 31' ' ' LEU . 1.3 mm? -62.2 -58.61 7.11 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.345 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.47 162.55 49.43 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -68.45 -56.68 7.6 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.98 . . . . 0.0 109.269 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.408 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.605 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 -130.13 -63.46 0.9 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.551 -0.718 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -140.31 66.73 30.9 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.666 -0.646 . . . . 0.0 109.749 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.54 -77.49 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.791 1 C-N-CA 125.521 4.147 . . . . 0.0 110.524 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -75.32 -26.25 58.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.494 -0.753 . . . . 0.0 110.018 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -65.89 -23.21 66.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.42 -0.8 . . . . 0.0 110.195 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 29.9 tp -80.55 -24.89 38.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.327 -0.858 . . . . 0.0 110.31 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m -61.53 -43.01 99.65 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 13' ' ' VAL . 9.8 t70 -65.49 -25.96 67.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.615 -0.678 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 14' ' ' ILE . 39.9 mm -65.25 -50.61 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.303 -0.873 . . . . 0.0 109.332 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.3 m -56.58 -39.03 72.83 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.379 -0.826 . . . . 0.0 109.852 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -35.91 80.52 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 9' ' ' ASP . 58.3 t -62.62 -43.8 98.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 10' ' ' ILE . 5.2 mp -84.55 -3.52 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.541 -0.724 . . . . 0.0 110.039 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.712 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.1 t80 -85.05 -37.86 19.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.385 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.7 mt -86.76 -37.51 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.638 -0.664 . . . . 0.0 109.434 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -53.42 38.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.657 -0.652 . . . . 0.0 109.257 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -68.74 -29.41 67.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.647 . . . . 0.0 109.81 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 15' ' ' PHE . . . -54.38 -52.05 62.87 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.3 -0.875 . . . . 0.0 110.876 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.61 -56.66 4.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.72 -50.02 66.34 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.348 -0.845 . . . . 0.0 112.793 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.451 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 47.1 t -38.8 -52.31 3.69 Favored Pre-proline 0 N--CA 1.515 2.797 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 22' ' ' SER . 35.0 Cg_endo -66.83 -56.43 0.25 Allowed 'Trans proline' 0 N--CA 1.511 2.526 0 C-N-CA 124.199 3.266 . . . . 0.0 110.387 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.38 -27.81 1.8 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.918 -0.489 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 25' ' ' ILE . 28.9 mm -64.95 -65.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.5 m -81.07 -64.4 1.2 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.59 -0.694 . . . . 0.0 109.279 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -73.06 125.05 26.74 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 109.398 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.84 -172.4 29.7 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.75 44.37 0.26 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.637 HD12 ' H ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -90.57 179.89 5.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.557 -0.967 . . . . 0.0 109.628 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tp -68.22 -28.37 67.18 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.679 -0.638 . . . . 0.0 109.589 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.637 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -57.06 110.68 2.33 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.32 -49.37 69.85 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.559 -0.965 . . . . 0.0 110.386 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.9 ttpp . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.501 179.756 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.681 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -133.79 -37.44 0.92 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.56 -0.713 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -155.89 82.84 3.59 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.393 -0.817 . . . . 0.0 109.405 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.95 -66.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.102 1 C-N-CA 125.403 4.068 . . . . 0.0 110.79 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -62.31 -24.91 67.58 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.779 -0.575 . . . . 0.0 110.143 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -80.39 -68.24 0.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.318 -0.864 . . . . 0.0 111.351 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -21.75 65.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.521 -0.737 . . . . 0.0 110.461 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -57.41 -26.86 61.75 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.372 -0.83 . . . . 0.0 110.611 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.74 -58.51 6.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.546 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.18 -19.22 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.718 -0.614 . . . . 0.0 109.882 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 m -74.99 -38.87 61.51 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.186 -0.946 . . . . 0.0 109.964 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.738 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.4 OUTLIER -66.92 -41.07 87.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.585 -0.697 . . . . 0.0 109.276 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.15 -48.62 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.12 -17.33 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.59 -0.694 . . . . 0.0 109.939 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -67.79 -52.0 42.32 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 0.0 109.825 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.738 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.2 mp -77.93 -23.29 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.455 -0.778 . . . . 0.0 110.126 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -67.34 -40.2 85.85 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.322 -0.861 . . . . 0.0 109.89 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -31.21 22.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.506 -0.746 . . . . 0.0 109.649 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.54 44.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.057 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.76 -47.33 82.8 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.371 0.605 . . . . 0.0 111.305 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 2.0 mm? -72.1 -17.41 61.99 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.796 -0.565 . . . . 0.0 111.753 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.7 OUTLIER -59.79 -57.79 24.2 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 120.888 -1.132 . . . . 0.0 111.28 -179.012 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.7 Cg_endo -69.85 -57.85 0.11 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 125.06 3.84 . . . . 0.0 111.078 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.35 -28.19 1.26 Allowed 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.937 -0.477 . . . . 0.0 111.181 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 21' ' ' LEU . 84.0 mt -79.88 -43.36 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.495 -0.753 . . . . 0.0 109.066 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.2 m -59.67 -30.25 68.63 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 0.0 110.124 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.37 179.08 2.14 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.43 -0.794 . . . . 0.0 109.553 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.74 -50.2 66.17 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.33 85.6 0.05 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -86.28 158.27 19.73 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.673 -0.898 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 31' ' ' LEU . 4.1 mm? -84.83 -54.94 4.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.549 -0.719 . . . . 0.0 109.532 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.9 118.62 11.67 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.25 -39.82 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.62 -0.93 . . . . 0.0 109.394 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.3 mttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.402 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.666 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 71.81 115.61 0.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.916 0.865 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -164.96 71.87 1.46 Allowed Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -88.24 -63.8 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.929 1 C-N-CA 125.667 4.245 . . . . 0.0 110.292 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -50.99 -24.53 3.76 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.825 -0.547 . . . . 0.0 110.868 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -82.99 -38.42 22.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.37 -0.831 . . . . 0.0 109.878 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.62 -16.77 60.77 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.567 -0.708 . . . . 0.0 110.147 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.0 t -62.83 -25.06 68.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.205 -0.934 . . . . 0.0 110.041 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.19 -45.95 92.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.477 -0.764 . . . . 0.0 109.72 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -66.4 -34.31 69.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -0.771 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.11 -32.54 73.95 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.58 -37.99 86.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.23 -25.59 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.9 mm -72.24 -44.06 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 109.236 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -62.58 -40.77 97.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.642 -0.661 . . . . 0.0 109.67 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.67 -23.6 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.616 -0.678 . . . . 0.0 109.657 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.21 -37.11 86.29 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 109.551 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -84.97 -35.07 22.26 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.599 -0.688 . . . . 0.0 110.139 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -58.93 6.38 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.759 -0.588 . . . . 0.0 111.274 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.71 -53.87 35.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.596 -0.69 . . . . 0.0 111.767 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.813 ' O ' HD13 ' A' ' 25' ' ' ILE . 5.5 mp -70.86 -12.32 61.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.692 -0.63 . . . . 0.0 112.031 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.2 t -59.94 -61.57 7.64 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 120.787 -1.196 . . . . 0.0 110.362 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 37.2 Cg_endo -71.13 -58.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.511 2.541 0 C-N-CA 124.941 3.76 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.58 -28.57 0.98 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.975 -0.453 . . . . 0.0 111.537 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.813 HD13 ' O ' ' A' ' 21' ' ' LEU . 1.2 mp -66.15 -51.07 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m -70.15 -65.67 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.505 -0.747 . . . . 0.0 109.834 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.4 106.7 13.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.581 -0.699 . . . . 0.0 109.661 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.45 -136.44 47.45 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.2 -15.88 7.24 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tt -89.78 49.84 1.79 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.181 -1.188 . . . . 0.0 109.693 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mt -90.38 -72.23 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.208 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -125.45 82.77 0.35 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -62.31 -29.05 70.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.689 -0.889 . . . . 0.0 109.615 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.556 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.626 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.455 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -83.79 -87.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.615 -0.678 . . . . 0.0 109.421 . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CD1' ' HB3' ' A' ' 2' ' ' ARG . 14.4 p90 -163.9 61.9 1.0 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.0 109.595 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 39.5 Cg_endo -80.47 -77.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.104 1 C-N-CA 125.302 4.001 . . . . 0.0 111.147 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.39 -35.57 75.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.502 -0.749 . . . . 0.0 110.516 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -61.57 -29.29 69.93 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.418 -0.801 . . . . 0.0 110.07 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 10' ' ' ILE . 6.1 tp -90.37 -28.37 18.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.56 -0.713 . . . . 0.0 109.957 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.9 m -63.45 -17.6 62.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.587 -0.696 . . . . 0.0 110.348 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.845 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 t70 -69.94 -37.52 75.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 109.446 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 7' ' ' LEU . 2.3 mp -72.69 -54.6 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.456 -0.778 . . . . 0.0 109.778 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.36 -28.25 64.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.534 -0.729 . . . . 0.0 109.914 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.66 -34.12 62.65 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 9' ' ' ASP . 63.0 t -71.08 -26.98 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.673 -0.642 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.5 -35.36 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.529 -0.732 . . . . 0.0 109.559 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -66.04 -42.81 89.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.609 -0.682 . . . . 0.0 109.861 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mm -78.79 -21.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.589 -0.694 . . . . 0.0 110.149 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.56 -48.78 77.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.282 -0.886 . . . . 0.0 109.919 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -86.34 -27.64 24.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.496 -0.752 . . . . 0.0 110.353 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.03 -52.26 65.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.487 -0.758 . . . . 0.0 110.657 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.73 -51.46 55.97 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.578 -0.701 . . . . 0.0 111.455 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.59 HD23 HD11 ' A' ' 25' ' ' ILE . 4.1 mp -82.42 -9.21 59.53 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.794 -0.566 . . . . 0.0 111.835 -178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -57.88 -53.32 66.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 120.978 -1.077 . . . . 0.0 111.265 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -73.67 -60.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.346 0 C-N-CA 124.865 3.71 . . . . 0.0 110.879 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.08 -27.64 1.44 Allowed 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.821 -0.549 . . . . 0.0 111.335 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.59 HD11 HD23 ' A' ' 21' ' ' LEU . 83.5 mt -90.41 -43.82 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.434 -0.791 . . . . 0.0 110.631 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -62.67 -61.52 2.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -69.02 90.1 0.44 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -77.83 130.32 10.13 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.82 73.81 0.03 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 30' ' ' LEU . 1.5 mm? -72.6 123.16 22.65 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.573 -0.957 . . . . 0.0 109.294 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.81 -31.74 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.63 -0.669 . . . . 0.0 109.852 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 147.6 11.17 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.11 -48.44 35.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.578 -0.954 . . . . 0.0 109.399 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.431 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . 0.505 ' H1 ' ' HB2' ' A' ' 6' ' ' TYR . . . . . . . . 0 C--O 1.217 -0.636 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -51.62 12.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 109.318 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER 177.89 -51.15 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.715 . . . . 0.0 109.933 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 3' ' ' TYR . 40.1 Cg_endo -89.03 -67.63 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.907 1 C-N-CA 125.403 4.069 . . . . 0.0 110.919 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -48.78 -26.11 2.19 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.613 -0.679 . . . . 0.0 110.995 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.505 ' HB2' ' H1 ' ' A' ' 1' ' ' ACE . 63.4 t80 -61.62 -59.43 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.451 -0.78 . . . . 0.0 109.993 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.54 -29.14 67.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.569 -0.707 . . . . 0.0 110.604 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.0 t -69.68 -31.16 69.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.414 -0.803 . . . . 0.0 109.789 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 13' ' ' VAL . 23.2 t70 -75.19 -41.97 56.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.569 -0.707 . . . . 0.0 110.574 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.471 ' H ' HD12 ' A' ' 10' ' ' ILE . 3.0 mp -63.43 -37.47 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.323 -0.861 . . . . 0.0 109.192 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.53 -29.68 67.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.48 -0.763 . . . . 0.0 109.492 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.52 -30.42 59.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.507 -0.746 . . . . 0.0 109.747 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.2 t -75.39 -30.5 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.444 -0.785 . . . . 0.0 109.292 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.13 -36.27 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.93 -42.45 97.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.61 -0.681 . . . . 0.0 109.196 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.46 -23.4 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.647 -0.658 . . . . 0.0 109.62 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -43.46 97.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.737 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -89.03 -27.92 20.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.532 -0.73 . . . . 0.0 110.095 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.77 -53.76 54.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.496 -0.753 . . . . 0.0 110.117 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.16 -50.33 73.16 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.292 0.568 . . . . 0.0 110.867 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' ILE . 7.0 mp -80.31 -1.17 39.84 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.942 -0.474 . . . . 0.0 112.073 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.432 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 1.5 m -47.75 -47.38 62.04 Favored Pre-proline 0 N--CA 1.508 2.439 0 O-C-N 120.855 -1.153 . . . . 0.0 112.318 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' A' ' 22' ' ' SER . 38.7 Cg_endo -78.95 -60.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.509 2.405 0 C-N-CA 124.881 3.721 . . . . 0.0 111.208 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.67 -27.7 2.05 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.801 -0.562 . . . . 0.0 111.576 -178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 21' ' ' LEU . 24.3 mm -75.5 -43.63 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.426 -0.796 . . . . 0.0 109.234 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.2 m -53.25 -50.86 63.92 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.245 -0.909 . . . . 0.0 109.631 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -90.07 111.2 22.24 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.6 52.1 3.66 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.47 -72.95 0.02 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 30' ' ' LEU . 6.2 mp -81.34 92.35 6.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.508 -0.995 . . . . 0.0 109.556 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.09 -37.75 88.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.559 -0.713 . . . . 0.0 109.503 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.14 112.44 1.09 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.93 -55.14 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.557 -0.967 . . . . 0.0 109.342 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.464 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.655 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.8 ttm105 -69.1 -38.58 79.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.531 -0.73 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -159.28 71.86 3.43 Favored Pre-proline 0 N--CA 1.493 1.699 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -90.73 -64.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.885 1 C-N-CA 125.857 4.371 . . . . 0.0 111.766 -178.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -57.42 -22.75 45.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.796 -0.565 . . . . 0.0 111.481 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -82.47 -61.88 1.77 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.061 -1.024 . . . . 0.0 110.366 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mt -69.08 -8.81 48.64 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.656 -0.653 . . . . 0.0 110.613 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.7 p -81.87 -30.0 32.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.505 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 13' ' ' VAL . 69.9 m-20 -67.9 -39.49 83.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.672 -0.643 . . . . 0.0 109.759 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.7 mt -71.5 -42.52 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.531 -0.731 . . . . 0.0 109.578 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.29 -33.07 72.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.462 -0.774 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.36 -34.33 74.41 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 9' ' ' ASP . 46.0 t -68.84 -27.95 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.2 mm -74.86 -33.49 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 108.981 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -69.14 -40.54 78.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.567 -0.708 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 21.2 mt -72.48 -32.38 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.53 -0.731 . . . . 0.0 109.526 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.35 -45.98 90.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.513 -0.742 . . . . 0.0 109.248 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -65.57 -36.23 83.15 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.482 0.658 . . . . 0.0 109.44 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 -55.02 36.54 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.528 0.68 . . . . 0.0 110.284 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.56 -45.84 92.43 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.588 0.708 . . . . 0.0 110.343 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.32 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 122.007 -0.433 . . . . 0.0 111.414 -178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.401 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -65.16 -59.59 9.62 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.925 -1.109 . . . . 0.0 110.455 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.0 Cg_endo -70.87 -56.99 0.11 Allowed 'Trans proline' 0 N--CA 1.51 2.482 0 C-N-CA 125.03 3.82 . . . . 0.0 110.676 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.93 -27.96 1.01 Allowed 'General case' 0 N--CA 1.504 2.261 0 CA-C-O 121.014 0.435 . . . . 0.0 111.241 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 25' ' ' ILE . 1.1 mm -61.23 -54.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.7 m -83.08 -64.45 1.17 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.567 -0.708 . . . . 0.0 109.898 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -60.34 -87.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.513 -0.742 . . . . 0.0 109.713 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 51.35 -107.78 0.47 Allowed Glycine 0 N--CA 1.5 2.952 0 O-C-N 120.988 -1.07 . . . . 0.0 110.685 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.07 -64.99 0.23 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.0 mt -86.26 178.93 7.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.604 -0.939 . . . . 0.0 109.076 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.56 -52.7 4.76 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.577 -0.702 . . . . 0.0 109.762 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 103.93 0.6 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.01 -48.52 65.5 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.627 -0.925 . . . . 0.0 109.455 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mttt . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 117.944 -1.026 . . . . 0.0 109.69 -179.813 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.63 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -131.6 -57.04 1.0 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.613 -0.679 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CD2' ' HB2' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -144.91 76.87 13.58 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -81.53 -51.62 0.04 OUTLIER 'Trans proline' 0 N--CA 1.51 2.477 1 C-N-CA 125.757 4.305 . . . . 0.0 110.507 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -49.97 -23.61 2.11 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.32 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.436 ' HB2' ' CD2' ' A' ' 3' ' ' TYR . 5.5 t80 -76.32 -39.92 52.79 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.178 -0.951 . . . . 0.0 110.205 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.87 -54.72 41.16 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.48 -0.763 . . . . 0.0 110.91 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.1 m -58.61 -19.75 41.4 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.354 -0.841 . . . . 0.0 111.46 -178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 13' ' ' VAL . 63.0 m-20 -66.69 -57.56 6.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.142 -0.974 . . . . 0.0 110.723 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' N ' ' A' ' 11' ' ' THR . 4.0 tt -59.74 -45.48 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.443 -0.785 . . . . 0.0 110.197 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.428 ' N ' HG23 ' A' ' 10' ' ' ILE . 2.4 m -58.6 -34.13 70.77 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.744 -0.597 . . . . 0.0 109.975 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.19 -36.18 74.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.489 -0.757 . . . . 0.0 109.175 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.4 t -68.96 -23.16 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.813 -0.554 . . . . 0.0 109.861 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.4 mt -83.99 -29.47 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -74.15 -41.72 61.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.326 -0.859 . . . . 0.0 109.701 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.8 mm -74.48 -28.89 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.702 -0.624 . . . . 0.0 110.24 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.88 -56.85 12.26 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.396 -0.815 . . . . 0.0 109.586 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.85 -30.17 68.79 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.611 -0.68 . . . . 0.0 110.028 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.39 -57.77 11.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 110.08 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -57.36 -53.57 56.68 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.566 -0.709 . . . . 0.0 111.004 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -80.12 1.44 27.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.816 -0.552 . . . . 0.0 111.678 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.429 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 17.4 t -49.11 -45.97 75.56 Favored Pre-proline 0 N--CA 1.502 2.157 0 O-C-N 120.945 -1.097 . . . . 0.0 112.375 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' A' ' 22' ' ' SER . 41.0 Cg_endo -78.31 -57.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.508 2.373 0 C-N-CA 124.608 3.538 . . . . 0.0 110.766 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.23 -28.32 2.96 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.872 -0.517 . . . . 0.0 111.311 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 40.5 mm -83.98 -38.99 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.398 -0.814 . . . . 0.0 109.134 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.6 m -60.64 -28.63 68.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.564 -0.71 . . . . 0.0 110.081 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.95 170.88 1.9 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.413 -0.804 . . . . 0.0 109.283 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.33 -112.1 0.1 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -145.84 35.75 1.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -53.06 6.09 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.568 -0.96 . . . . 0.0 109.276 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tp -71.89 -34.96 69.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.67 -0.644 . . . . 0.0 109.587 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.31 169.71 43.98 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -59.38 -44.0 92.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.489 -1.007 . . . . 0.0 109.767 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.452 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.681 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -154.04 -83.9 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.71 . . . . 0.0 109.13 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.438 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 25.2 t80 -101.21 -46.68 0.2 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.389 -0.819 . . . . 0.0 111.928 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 41.4 Cg_endo -90.26 -70.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 125.106 3.871 . . . . 0.0 111.786 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -49.79 -24.92 2.64 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.568 -0.708 . . . . 0.0 111.545 -178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -90.12 -33.06 16.4 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 110.437 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -24.05 63.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.336 -0.853 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.6 t -65.0 -41.41 95.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.68 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.9 t0 -59.57 -40.08 86.19 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.667 -0.646 . . . . 0.0 109.895 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.4 mt -67.88 -33.47 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.895 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -56.99 -50.65 72.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.271 -0.893 . . . . 0.0 110.179 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.655 ' O ' HD12 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -61.57 -32.96 73.08 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 109.392 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 9' ' ' ASP . 41.8 t -62.64 -37.21 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.681 -0.637 . . . . 0.0 109.534 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.18 -19.48 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.624 -0.673 . . . . 0.0 109.429 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -68.76 -49.86 55.27 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.1 -1.0 . . . . 0.0 109.685 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 12' ' ' ASP . 3.7 mp -75.3 -32.84 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.428 -0.795 . . . . 0.0 109.868 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -41.7 97.58 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -28.27 63.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.17 84.9 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.81 0.815 . . . . 0.0 110.158 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.08 -48.73 52.99 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 121.501 0.667 . . . . 0.0 111.207 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.508 HD23 HG13 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -84.55 -13.62 51.28 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.932 -0.48 . . . . 0.0 111.117 -178.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.504 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 39.9 m -51.04 -48.31 85.22 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.087 -1.008 . . . . 0.0 112.001 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.1 Cg_endo -70.79 -55.26 0.15 Allowed 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 124.265 3.31 . . . . 0.0 109.71 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.56 -28.25 0.91 Allowed 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.508 HG13 HD23 ' A' ' 21' ' ' LEU . 41.0 mt -79.36 -44.06 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 0.0 109.67 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.7 m -70.07 -65.34 0.74 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.329 -0.857 . . . . 0.0 109.991 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -49.32 143.26 6.52 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.6 -0.688 . . . . 0.0 110.488 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.34 -134.02 1.28 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.77 -9.2 78.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.72 86.44 2.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.124 -1.221 . . . . 0.0 109.497 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.5 -31.37 32.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 109.192 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.86 -161.02 14.02 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -80.24 -52.84 7.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.593 -0.945 . . . . 0.0 109.434 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.583 -179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.671 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.4 mmt-85 -110.69 -9.69 14.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.592 -0.693 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CZ ' ' CD1' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -130.07 70.88 82.3 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.185 -0.947 . . . . 0.0 109.414 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -82.95 -75.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 125.056 3.838 . . . . 0.0 110.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -77.07 -30.38 55.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.59 -0.694 . . . . 0.0 110.05 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -68.61 -13.4 62.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.93 -13.82 48.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.8 m -58.53 -45.24 89.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.024 -1.047 . . . . 0.0 110.199 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -63.48 -44.73 93.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.523 -0.735 . . . . 0.0 109.176 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.5 mm -62.45 -22.63 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 109.447 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.71 ' HA ' HD12 ' A' ' 14' ' ' ILE . 5.7 m -68.6 -42.16 78.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.369 -0.832 . . . . 0.0 109.156 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.33 -30.33 71.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.564 -0.71 . . . . 0.0 109.217 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -75.92 -24.26 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.695 -0.628 . . . . 0.0 110.16 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 11' ' ' THR . 15.4 mt -84.28 -30.07 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.792 . . . . 0.0 109.801 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -71.04 -38.31 72.56 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 tp -76.39 -34.59 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.74 0.781 . . . . 0.0 109.117 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -52.86 -45.74 67.54 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.924 -0.485 . . . . 0.0 110.236 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.72 -29.64 51.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.548 -0.72 . . . . 0.0 109.867 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -56.95 -53.85 53.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.457 -0.777 . . . . 0.0 110.476 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.54 -46.84 74.79 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.519 0.676 . . . . 0.0 110.824 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 17' ' ' TYR . 4.0 mt -65.83 -14.17 60.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.83 -0.544 . . . . 0.0 111.355 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 1.6 t -67.27 -60.96 5.17 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 120.978 -1.076 . . . . 0.0 110.145 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 22' ' ' SER . 36.6 Cg_endo -68.98 -56.05 0.18 Allowed 'Trans proline' 0 N--CA 1.512 2.607 0 C-N-CA 125.072 3.848 . . . . 0.0 110.595 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.26 -28.58 1.33 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.933 -0.479 . . . . 0.0 111.188 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 25' ' ' ILE . 17.8 mm -81.67 -41.89 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.48 -0.763 . . . . 0.0 109.166 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 37.0 m -72.03 -69.46 0.39 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.397 -0.815 . . . . 0.0 109.811 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -50.8 161.42 0.35 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.35 -0.844 . . . . 0.0 110.599 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.29 -130.18 2.63 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.8 39.08 96.33 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 tp -64.0 114.82 4.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.675 -0.897 . . . . 0.0 109.806 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.49 -39.28 16.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.633 -0.667 . . . . 0.0 109.229 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.13 158.84 30.9 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -77.68 -35.7 52.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.589 -0.948 . . . . 0.0 109.502 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.55 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . 0.564 ' H1 ' ' CD1' ' A' ' 6' ' ' TYR . . . . . . . . 0 C--O 1.217 -0.64 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.71 -41.68 0.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.561 -0.712 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.413 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -178.39 -51.78 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.826 . . . . 0.0 109.845 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 38.9 Cg_endo -88.81 -71.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 125.162 3.908 . . . . 0.0 110.511 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -52.64 -24.1 7.81 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.564 ' CD1' ' H1 ' ' A' ' 1' ' ' ACE . 18.5 t80 -72.23 -45.35 60.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.351 -0.843 . . . . 0.0 109.938 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 7' ' ' LEU . 5.9 tp -64.77 -42.91 94.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.597 -0.689 . . . . 0.0 109.954 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 p -66.39 -23.44 66.32 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.537 -0.727 . . . . 0.0 110.163 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -70.61 -59.88 2.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.388 -0.82 . . . . 0.0 110.294 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 11' ' ' THR . 17.4 tt -56.95 -43.93 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.572 -0.705 . . . . 0.0 110.152 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.448 ' N ' HG23 ' A' ' 10' ' ' ILE . 21.7 m -61.58 -31.7 71.76 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.55 -36.13 73.49 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.573 -0.704 . . . . 0.0 109.169 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.3 t -69.08 -32.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.722 -0.611 . . . . 0.0 109.68 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 69.9 mt -76.99 -26.09 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.629 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -67.62 -38.45 83.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.509 -0.744 . . . . 0.0 109.327 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mm -83.45 -23.19 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.565 -0.709 . . . . 0.0 109.941 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -62.31 -48.66 78.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.861 . . . . 0.0 109.863 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -81.55 -41.37 21.72 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.133 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.75 -42.55 12.08 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 121.639 0.733 . . . . 0.0 111.376 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -49.63 -52.94 27.02 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 121.41 0.624 . . . . 0.0 110.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.0 mt -84.77 -11.05 56.57 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.931 -0.481 . . . . 0.0 111.174 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.509 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 16.2 t -50.62 -48.37 82.58 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.107 -0.996 . . . . 0.0 112.35 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.1 Cg_endo -69.1 -57.53 0.13 Allowed 'Trans proline' 0 N--CA 1.51 2.477 0 C-N-CA 124.383 3.389 . . . . 0.0 110.488 -179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.34 -28.26 1.96 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.071 -0.393 . . . . 0.0 111.109 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.8 mt -80.98 -41.68 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.408 -0.807 . . . . 0.0 109.426 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.4 m -59.88 -27.64 66.87 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.546 -0.721 . . . . 0.0 109.908 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.41 146.61 48.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 109.419 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 166.67 58.64 0.03 OUTLIER Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -135.78 -66.53 0.06 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mt -87.06 122.65 31.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.577 -0.955 . . . . 0.0 109.076 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.98 -44.02 12.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.632 -0.668 . . . . 0.0 109.322 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.75 127.76 0.9 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.4 -46.28 64.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.664 -0.903 . . . . 0.0 109.337 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.532 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.646 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' O ' ' CG ' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -73.54 -54.71 7.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 109.629 . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.406 ' CG ' ' O ' ' A' ' 2' ' ' ARG . 63.4 m-85 -156.79 82.12 3.33 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -79.98 -82.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 125.226 3.95 . . . . 0.0 110.676 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -72.71 -25.41 61.22 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.276 -0.89 . . . . 0.0 109.747 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -62.25 -28.5 69.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.411 -0.806 . . . . 0.0 109.877 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 7' ' ' LEU . 1.5 tt -67.12 -28.9 68.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.53 -0.731 . . . . 0.0 109.995 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 90.9 p -66.97 -24.86 66.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.533 -0.729 . . . . 0.0 110.355 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.713 ' O ' HG23 ' A' ' 13' ' ' VAL . 2.3 t70 -74.49 -42.67 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.336 -0.852 . . . . 0.0 110.187 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.4 mm -67.74 -46.64 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.828 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.86 -35.39 78.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.448 -0.782 . . . . 0.0 109.342 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.48 -34.88 78.92 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.7 t -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.7 mm -72.2 -24.86 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.614 -0.679 . . . . 0.0 109.753 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.94 -53.45 31.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -0.81 . . . . 0.0 110.042 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.68 -23.39 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.521 -0.737 . . . . 0.0 110.224 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 -64.36 0.87 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.406 -0.809 . . . . 0.0 109.526 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -22.41 63.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.426 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.04 -59.5 3.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.275 -0.89 . . . . 0.0 110.089 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.87 -44.35 86.55 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.383 -0.823 . . . . 0.0 110.264 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.469 ' HB3' HD11 ' A' ' 25' ' ' ILE . 9.1 mt -71.16 -22.46 62.05 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.445 -178.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -51.55 -58.79 9.62 Favored Pre-proline 0 N--CA 1.506 2.369 0 O-C-N 120.805 -1.185 . . . . 0.0 111.095 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' SER . 34.2 Cg_endo -66.81 -58.93 0.13 Allowed 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 124.93 3.753 . . . . 0.0 111.116 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.8 -27.58 3.09 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.818 -0.551 . . . . 0.0 111.393 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 21' ' ' LEU . 87.9 mt -90.03 -32.52 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.297 -0.877 . . . . 0.0 110.037 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 m -56.74 -50.1 73.24 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.3 -0.875 . . . . 0.0 110.465 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -86.01 -51.75 6.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.457 -0.777 . . . . 0.0 109.857 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.87 -130.02 8.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 166.37 62.63 0.03 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.53 117.99 12.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.981 . . . . 0.0 108.796 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.3 mt -88.62 -68.23 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.545 -0.722 . . . . 0.0 109.768 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.87 160.62 50.46 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -83.51 -66.2 0.92 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.923 . . . . 0.0 109.494 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.7 mttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.495 -179.848 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.627 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.63 -89.1 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 0.0 109.497 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER 173.6 -52.5 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.015 -1.053 . . . . 0.0 109.919 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 41.4 Cg_endo -90.18 -74.95 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.972 1 C-N-CA 125.45 4.1 . . . . 0.0 111.495 -178.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.6 22.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.575 -0.703 . . . . 0.0 110.649 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -59.68 -53.85 53.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.317 -0.864 . . . . 0.0 110.209 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.8 mt -74.84 -23.64 58.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.566 -0.709 . . . . 0.0 110.142 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.2 m -60.05 -19.54 53.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.303 -0.873 . . . . 0.0 110.459 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.73 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -67.5 -36.8 81.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.265 -0.897 . . . . 0.0 110.002 -179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.9 mm -77.55 -40.11 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.436 -0.79 . . . . 0.0 110.098 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.45 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.4 m -63.73 -32.81 74.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.21 -39.51 75.09 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 9' ' ' ASP . 45.1 t -62.28 -36.55 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 11' ' ' THR . 42.5 mt -72.38 -26.54 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.669 -0.644 . . . . 0.0 109.596 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -61.54 -60.22 4.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.428 -0.795 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.572 HD12 ' H ' ' A' ' 16' ' ' ILE . 4.0 mp -73.7 -8.19 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.586 -0.696 . . . . 0.0 110.202 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -76.26 -30.02 57.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 0.0 108.717 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -89.77 -25.92 20.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.68 -0.637 . . . . 0.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.44 -60.89 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.624 -0.673 . . . . 0.0 110.728 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.44 -47.84 66.16 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.639 -0.663 . . . . 0.0 111.379 -178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.2 tp -82.19 -12.76 57.94 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.881 -0.512 . . . . 0.0 111.453 -178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.465 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -49.33 -51.83 54.24 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.019 -1.051 . . . . 0.0 111.79 -179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.5 Cg_endo -72.39 -55.36 0.11 Allowed 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 124.795 3.664 . . . . 0.0 110.431 -179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.13 -27.6 2.45 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 122.017 -0.427 . . . . 0.0 111.063 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 21' ' ' LEU . 34.8 mt -73.14 -44.53 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.429 -0.794 . . . . 0.0 109.378 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 m -54.92 -33.36 62.1 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.288 -0.882 . . . . 0.0 110.332 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.74 -178.65 0.98 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.484 -0.76 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.07 -98.4 0.46 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.99 43.15 0.29 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.61 -44.22 91.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.598 -0.942 . . . . 0.0 109.378 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tp -74.72 -66.39 0.75 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.635 -0.666 . . . . 0.0 109.383 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.63 139.01 0.04 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -83.15 -55.89 4.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.607 -0.937 . . . . 0.0 109.699 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.536 -179.836 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.641 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.66 -36.86 3.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 56.11 92.66 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.455 -0.778 . . . . 0.0 110.115 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -86.41 -79.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 1 C-N-CA 125.309 4.006 . . . . 0.0 110.675 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -68.51 -25.26 64.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.094 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -60.92 -44.38 97.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.422 -0.799 . . . . 0.0 110.327 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.75 -23.43 25.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.49 -0.756 . . . . 0.0 110.215 -179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -59.92 -28.38 67.56 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.284 -0.885 . . . . 0.0 109.675 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.72 -38.0 89.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.531 -0.731 . . . . 0.0 109.246 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.468 HD12 ' HG ' ' A' ' 7' ' ' LEU . 65.1 mt -65.97 -36.36 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.5 m -61.72 -37.64 84.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.525 -0.735 . . . . 0.0 109.136 179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.74 -32.06 73.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 -30.42 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -65.48 -32.96 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -65.14 -54.8 24.25 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.0 mm -62.46 -18.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.662 -0.649 . . . . 0.0 109.36 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -67.2 -42.02 84.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 108.963 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.68 -30.84 69.6 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.4 -52.13 66.52 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.654 0.74 . . . . 0.0 109.516 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' HD2' ' A' ' 23' ' ' PRO . . . -60.66 -47.98 83.84 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.447 0.642 . . . . 0.0 110.137 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -76.75 -3.29 37.43 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.082 -0.386 . . . . 0.0 111.123 -179.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 3.6 m -40.65 -51.17 6.94 Favored Pre-proline 0 N--CA 1.51 2.557 0 O-C-N 121.328 -0.857 . . . . 0.0 113.061 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 22' ' ' SER . 36.6 Cg_endo -70.47 -56.71 0.12 Allowed 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 124.572 3.514 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB3' HD23 ' A' ' 21' ' ' LEU . . . -47.54 -26.77 1.53 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.959 -0.463 . . . . 0.0 111.061 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.533 HG13 HD23 ' A' ' 21' ' ' LEU . 28.9 mt -77.12 -44.91 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.448 -0.783 . . . . 0.0 109.185 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.5 m -70.48 -69.1 0.38 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.805 . . . . 0.0 109.04 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -89.01 136.98 32.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.604 -0.685 . . . . 0.0 109.369 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -99.84 88.17 0.78 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.19 30.42 9.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.7 OUTLIER -71.03 -33.22 70.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.53 -0.983 . . . . 0.0 109.348 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.33 -37.39 85.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.646 -0.658 . . . . 0.0 109.313 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 110.82 172.53 19.79 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.61 -57.72 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.614 -0.933 . . . . 0.0 109.359 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.328 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -63.97 -33.08 74.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.594 -0.692 . . . . 0.0 109.548 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.402 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 54.7 m-85 51.0 65.97 6.03 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.454 -0.779 . . . . 0.0 109.979 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 40.9 Cg_endo -89.24 -75.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.75 4.3 . . . . 0.0 111.143 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -54.83 -21.84 12.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.494 -0.754 . . . . 0.0 110.728 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -60.44 -48.94 79.57 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.209 -0.932 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -69.36 -42.59 75.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.606 -0.684 . . . . 0.0 109.964 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -27.17 66.57 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.484 -0.76 . . . . 0.0 110.076 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.3 m-20 -67.03 -37.32 83.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.511 -0.743 . . . . 0.0 109.206 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -70.28 -44.14 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 m -59.93 -24.71 64.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.656 -0.652 . . . . 0.0 109.847 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.94 -31.95 34.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.415 -0.803 . . . . 0.0 109.31 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 9' ' ' ASP . 60.4 t -74.28 -26.03 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 49.7 mm -81.95 -40.33 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.98 -41.6 98.21 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.413 0.625 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.561 HD13 ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -77.92 -26.57 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.422 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.58 -35.35 68.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.382 -0.824 . . . . 0.0 109.959 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.63 -34.23 21.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.515 -0.741 . . . . 0.0 110.178 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.561 ' HB3' HD13 ' A' ' 16' ' ' ILE . . . -58.03 -55.44 34.86 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.487 -0.758 . . . . 0.0 110.686 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.15 -47.85 71.5 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.689 -0.632 . . . . 0.0 111.482 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 mp -79.05 -11.13 59.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.761 -0.587 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -54.34 -56.41 26.81 Favored Pre-proline 0 N--CA 1.502 2.129 0 O-C-N 120.637 -1.289 . . . . 0.0 110.248 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 38.0 Cg_endo -74.41 -58.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 125.024 3.816 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.74 -29.13 1.76 Allowed 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.929 -0.482 . . . . 0.0 111.376 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.1 mm -74.13 -45.83 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 44.2 m -58.02 -42.1 84.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.565 -0.709 . . . . 0.0 110.608 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -86.0 -79.6 0.25 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.235 -0.916 . . . . 0.0 110.027 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.77 -162.58 35.99 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.54 68.36 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.2 155.44 17.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.491 -1.005 . . . . 0.0 109.454 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -55.59 25.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.562 -0.711 . . . . 0.0 109.544 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.54 -135.51 3.28 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -69.65 -51.23 36.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.523 -0.986 . . . . 0.0 109.482 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 pttt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.557 179.541 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.656 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.452 ' HB3' ' CD1' ' A' ' 3' ' ' TYR . 0.2 OUTLIER -80.86 -72.84 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.548 -0.72 . . . . 0.0 109.313 . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 24.5 p90 -141.02 56.7 6.82 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 40.7 Cg_endo -81.74 -78.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.505 2.168 0 C-N-CA 124.958 3.772 . . . . 0.0 110.756 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -63.62 -15.33 57.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.448 -0.783 . . . . 0.0 110.806 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -53.87 -22.75 10.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.19 -0.944 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.0 tp -74.96 -38.82 61.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.495 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.8 m -76.23 -27.4 56.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 0.0 110.544 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 3.5 m-20 -71.06 -48.68 51.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.466 -0.772 . . . . 0.0 110.029 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.557 ' O ' HD12 ' A' ' 14' ' ' ILE . 18.2 tt -62.1 -46.25 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.507 -0.746 . . . . 0.0 109.719 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.451 ' N ' HG23 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -53.97 -35.94 62.33 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.66 -0.65 . . . . 0.0 110.746 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.95 -33.99 72.84 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.388 -0.82 . . . . 0.0 109.213 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' ASP . 42.8 t -66.8 -29.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.098 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.557 HD12 ' O ' ' A' ' 10' ' ' ILE . 2.4 mp -76.43 -36.88 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.337 -0.852 . . . . 0.0 109.322 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.02 -42.22 98.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mm -75.11 -24.19 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.472 -0.768 . . . . 0.0 109.961 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -59.32 -53.43 58.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.355 -0.841 . . . . 0.0 109.994 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -75.61 -35.8 60.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.498 -0.751 . . . . 0.0 109.657 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.96 -45.92 15.9 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.859 0.838 . . . . 0.0 111.268 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.43 -52.07 49.4 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.297 0.57 . . . . 0.0 111.321 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.11 -5.94 59.11 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.824 -0.547 . . . . 0.0 111.639 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.453 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 12.7 t -49.8 -47.14 80.31 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.066 -1.021 . . . . 0.0 111.994 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.9 Cg_endo -74.42 -56.43 0.07 OUTLIER 'Trans proline' 0 N--CA 1.508 2.363 0 C-N-CA 124.301 3.334 . . . . 0.0 110.477 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.69 -28.13 2.28 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 122.029 -0.419 . . . . 0.0 111.25 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.2 mt -75.27 -43.13 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.361 -0.837 . . . . 0.0 109.526 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.8 m -56.15 -35.89 67.66 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.212 -0.93 . . . . 0.0 109.681 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -71.22 -170.85 0.52 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.71 -179.45 3.4 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.29 39.22 1.68 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 tp -63.93 152.57 39.54 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.673 -0.898 . . . . 0.0 109.496 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.1 mt -62.64 -48.44 79.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.582 -0.699 . . . . 0.0 109.563 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.93 97.49 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.5 -44.88 13.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.592 -0.946 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.2 tttt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.344 179.671 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.638 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -122.02 -41.63 2.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.562 -0.711 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.459 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.3 p90 -141.01 60.03 11.87 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.627 -0.67 . . . . 0.0 109.911 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 3' ' ' TYR . 37.9 Cg_endo -80.01 -65.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 125.184 3.923 . . . . 0.0 110.249 179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -59.28 -19.33 45.23 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.905 -0.497 . . . . 0.0 110.552 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -36.33 73.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.153 -0.967 . . . . 0.0 109.658 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.88 -48.25 82.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.584 -0.697 . . . . 0.0 110.724 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 t -58.36 -20.07 40.69 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.37 -0.831 . . . . 0.0 111.095 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -78.58 -46.67 18.86 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.169 -0.957 . . . . 0.0 110.128 -179.41 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 14' ' ' ILE . 22.8 mt -71.21 -18.43 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.4 -0.812 . . . . 0.0 110.35 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.33 -41.04 20.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.209 -0.932 . . . . 0.0 109.953 -179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.72 -30.24 67.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.506 -0.746 . . . . 0.0 109.678 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 9' ' ' ASP . 40.3 t -74.83 -36.71 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.634 -0.666 . . . . 0.0 109.703 -179.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 10' ' ' ILE . 85.2 mt -77.21 -25.24 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.0 110.093 -179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -68.73 -58.34 4.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 108.801 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.93 -20.57 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.615 -0.678 . . . . 0.0 109.831 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -64.25 -51.33 64.14 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 109.401 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.36 -31.48 70.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.503 -0.748 . . . . 0.0 109.37 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -59.22 5.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.701 -0.625 . . . . 0.0 110.77 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.23 -48.06 83.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.441 -0.787 . . . . 0.0 111.244 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 25' ' ' ILE . 2.2 mm? -77.47 -9.19 58.75 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.878 -0.513 . . . . 0.0 111.68 -178.022 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.414 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 1.9 t -51.75 -56.87 17.44 Favored Pre-proline 0 N--CA 1.504 2.262 0 O-C-N 120.777 -1.202 . . . . 0.0 111.071 -179.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 22' ' ' SER . 37.6 Cg_endo -71.59 -55.14 0.13 Allowed 'Trans proline' 0 N--CA 1.512 2.586 0 C-N-CA 124.945 3.764 . . . . 0.0 110.454 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB3' HD13 ' A' ' 21' ' ' LEU . . . -48.58 -26.41 2.21 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.913 -0.492 . . . . 0.0 111.113 -179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG12 HD12 ' A' ' 21' ' ' LEU . 32.1 mm -89.79 -34.96 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.414 -0.804 . . . . 0.0 109.46 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -57.95 -53.35 59.22 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.333 -0.854 . . . . 0.0 110.104 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -76.41 -73.49 0.28 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.514 -0.741 . . . . 0.0 109.757 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 -113.95 4.61 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.62 68.31 0.03 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -30.64 68.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.53 -0.982 . . . . 0.0 109.42 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.466 ' HA ' HD13 ' A' ' 31' ' ' LEU . 4.2 mm? -67.04 -48.62 67.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.253 179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.41 91.15 0.1 OUTLIER Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.81 -56.18 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.558 -0.966 . . . . 0.0 109.768 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.8 tttp . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.609 -179.604 . . . . . . . . 0 0 . 1 stop_ save_